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Abstract 
 
The research described herein focuses on the synthesis of chiral pinene-pyridine derivatives, 
and their application in asymmetric catalysis. Both transition metal catalysed and 
organocatalytic transformations were investigated.  
 
Chiral pyridine-phosphines based on α-pinene were synthesised and applied as efficient P,N-
ligands for the enantioselective palladium(II)-catalysed Baeyer-Villiger oxidation of prochiral 
3-substituted cyclobutanones to furnish chiral γ-butyrolactones in up to 81% ee. Complexes 
of these ligands with iridium can also promote asymmetric hydrogenation of olefins in up to 
83% ee. 
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Novel N,N’-dioxides were synthesised from α-pinene and a range of 2-pyridine-
acetophenones by employing Kröhnke annulation reaction as the key cyclisation step. 
Although poor enantioselectivity was achieved (up to 12% ee), high reactivity of the 
catalysts is, however, promising. 
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Preface 
The demand for enantiopure chiral compounds is continuously rising over the years, 
primarily due to the development of pharmaceuticals but also for the flavour and aroma 
chemicals as well as agricultural chemicals. The global annual sales of single-enantiomer 
compounds are expected to exceed £7 billion by the end of 2009.1  
This explosive growth of the enantiopure compounds market is directly linked with the fact 
that enantiomers of a chiral compound can have dramatically different biological activities. 
To prevent any tragic accidents such as the Thalidomide case, the U.S. Food & Drug 
Administration issued, in 1992, a policy on stereoisomeric drugs. Racemates can be sold 
(FDA still occasionally approves them) but the enantiomers must be characterised 
pharmacologically and toxicologically. Since one enantiomer could be unsafe or merely 
inactive baggage, and the cost of characterisation is so high, the drug industry has shifted to 
making single-enantiomer forms of chiral compounds. Furthermore, the switch from a 
racemic to a single-enantiomer initially done to improve the therapeutic activities of drugs, is 
more and more used for economic consideration as it allows pharmaceutical companies to 
extend the patent protection of their blockbusters.2 
Chemists possess a variety of chiral technologies to create enantiomerically pure compounds. 
While the classical resolution of racemates has the obvious drawback of affording molecules 
with a maximum of 50% yield, asymmetric syntheses involving the chiral pool or chiral 
auxiliaries3 are typically more cost effective. Therefore, the most elegant and “atom 
economic” transformation to introduce chirality into a molecule is by using catalytic 
asymmetric synthesis. Until recently, the majority of catalytic asymmetric reactions 
employed two kinds of catalysts: chiral complexes based on transition metals4 and enzymes.5 
Metals have a large array of reactivity patterns that can easily be tuned by varying ligands. 
But, due to some drawbacks inherent to metals, such as their cost, their toxicity and the 
difficulty to remove their traces from the desired product, a complementary type of catalysis 
has emerged in the last few years, namely organocatalysis.6,7 
Far too often, catalysts are designed for a particular reaction. Therefore, we aim to develop 
novel versatile chiral pyridines (based on the inexpensive pinene moiety) which can be used 
either as ligands for transition metals (Metal Catalysis) or on their own (Organocatalysis).  
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Graphical Abstract 
Chapter 1. Pinene in Asymmetric Reactions 
N Ar
R  
                                       (+)-α-pinene – 100 g @ £18 (Aldrich) 
Pinene has been used over the years as an inexpensive source of chirality for various 
asymmetric reactions. 
 
Chapter 2. Metal Catalysed Asymmetric Reactions 
 
A novel class of ligands, the unsymmetrical P,N-ligands, has recently been developed and 
showed good level of enantioselectivity in various reactions particularly where the privileged 
chiral C2-symmetric ligands fail. 
Interestingly, it was only in 1994, more than a 
century after the reaction discovery, that the first 
asymmetric Baeyer-Villiger oxidation was 
reported. 
The different metals used will be specially 
reviewed here. 
 
 
Asymmetric hydrogenation of unfunctionalised 
olefins with iridium-based catalysts is a recent 
breakthrough.  
General aspects and recent advances will be 
particularly highlighted in this chapter. 
 
 
Chapter 3. Synthesis and Application of Pinene-Derivative Pyridines I 
 
In this chapter, the synthesis of six novel P,N-ligands from (+)-α-pinene is described. Their 
application for the asymmetric iridium-catalysed hydrogenation of olefins and the palladium-
catalysed Baeyer-Villiger oxidation of cyclobutanones will be discussed here. 
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Chapter 4. Organocatalysis – Activation of Si with Lewis bases 
Activation of the cheap and non-toxic silicon atom by a Lewis base (LB) has proven to be an 
efficient method to avoid the use of transition metals.  
 
Herein, we report the literature overview of several 
chiral Lewis bases utilised for the asymmetric 
allylation of benzaldehyde with allyl trichlorosilane. 
 
 
 
Chapter 5. Synthesis and Application of Pinene-Derivative Pyridines II 
 
Novel pyridines N-oxides were designed after the “privileged” pinene-pyridine fused 
structure (see chapter 3). Their synthesis and application in the asymmetric allylation reaction 
of benzaldehyde is reported here. 
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1 Pinene in Asymmetric Reactions 
1.1 Introduction 
Since Nature has provided a wide variety of chiral materials, they are obvious and usually 
inexpensive sources to generate new chiral auxiliaries as well as novel chiral ligands for 
asymmetric catalysis. 
Although amino acids and carbohydrates have often been used as chiral pool,8 terpenes, with 
their modest functionality that allows convenient structural manipulations, have rather found 
their utilities as chiral auxiliaries.3 Among natural monoterpenes, pinene derivatives have 
become famous in the 80s because of their development as chiral boron reagents. 
  
1.2 Pinene-Based Boron Reagents 
The first real potential of pinene in asymmetric synthesis appeared in 1961,9 when H. C. 
Brown realised the first asymmetric hydroboration of cis-2-butene with 
diisopinocampheylborane, Ipc2BH 2, prepared from (+)-α-pinene 1 and borane in nearly a 
complete stereoselective way (Scheme 1). 
Scheme 1. First asymmetric hydroboration of cis-2-butene with Ipc2BH 
 
 
Half a century later, α-pinene and borane have become an inseparable couple, a powerful 
combination, allowing a wide range of reactions to become enantioselective (Chart 1).2,10    
B-Ipc-9-BBN and Ipc2BCl made asymmetric reduction easy (acetophenone-type ketones 
were reduced in up to 98% ee). Ipc2BAllyl and Ipc2BCrotyl made asymmetric allyl- and 
crotylboration readily available for asymmetric synthesis (up to 93% ee). The ring-opening 
reaction of meso-epoxides with Ipc2BI provided a convenient route to enantiomerically pure 
halohydrins (up to 99% ee). Ipc2BOTf has been utilised by Paterson11 for asymmetric 
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enolboration reactions. Finally, Matteson12 developed asymmetric homologation reactions 
using pinanediol boronates. 
Chart 1. Use of α-pinene and borane in asymmetric reactions 
 
  
Although pinene derivatives have a long history of asymmetric induction as chiral auxiliaries 
(vide supra), their application in asymmetric catalysis is rather undeveloped. 
 
1.3 Pinene in Asymmetric Catalysis 
Whereas camphor-derived ligands have been widely used,13 the corresponding ligands based 
on pinene have been only rarely explored. There are mainly two types of pinene ligands: 
those in which the coordination units are pendent to the chiral pinene moiety and those in 
which the pinene is annulated with a pyridine ring increasing the rigidity of the whole 
structure.  
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1.3.1 Pendent Pinene Moiety 
Phosphine type ligands 5 and 8 developed by Helmchen14 and Knochel15 have shown high 
level of enantioselectivity in both palladium-catalysed allylic alkylations14 of cyclic substrate 
6 (up to 99% ee) (Scheme 2) and rhodium-catalysed hydrogenation of methyl 
acetamidocinnamate 9 (84% ee) (Scheme 3).15 Pinene-derived bipyridines 11a-b, 
terpyridines 12a-b and phenanthrolines 13a-b developed by Chelucci16 exhibited low-to-
moderate enantioselectivity in the palladium-catalysed allylic alkylation of 1,3-diphenyl-2-
propenyl acetate 14 with dimethyl malonate (up to 50% ee) (Scheme 4).  
 
Scheme 2. β-Phosphinocarboxylic acid used in Pd-catalysed asymmetric allylic alkylation 
 
 
Scheme 3. Diphosphine used in Rh-catalysed hydrogenation 
PPh2
PPh2
NHAc
CO2Me
Ph NHAc
CO2Me
Ph
*
Rh(COD)2BF4 (2 mol%)
8 (2 mol%), H2 (1 bar)
PhMe:MeOH (10:1), rt
Ligand: 89 10
>99% yield, 84% ee  
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Scheme 4. Bipyridines-, terpyridines- and phenanthrolines-pinene derivatives for the asymmetric Pd-
catalysed allylic alkylation 
 
 
The poor results obtained by Chelucci in his attempt to use pendent pinene ligands (vide 
supra) can be explained by a loose character of the chiral motif which is also relatively far 
away from the coordinating centres. A more rigid backbone would have the noticeable 
advantage in reducing the conformational flexibility of the catalysts, which would therefore 
diminish the number of competing diastereoisomeric pathways. 
 
1.3.2 Pinene Fused to Pyridine Ring 
The first ligands containing a rigid pinene-pyridine type framework were reported in 1992 by 
von Zelewsky et al.17 The chiral bipyridines 17 and 19 (Scheme 5) were the first two 
members of the big CHIRAGEN (CHIRAlity GENerators) ligands family developed by von 
Zelewsky.18,19 The pinene-bipyridine core was constructed in only two steps from the 
commercially available monoterpene (–)-α-pinene 1. For the formation of the [5,6]-
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pinenebipyridine 17 (Scheme 5-a), (–)-α-pinene 1 was photochemically oxidised by singlet 
oxygen into (+)-pinocarvone 16, followed by a Kröhnke annulation with 2-
acetylpyridinepyridinium iodide with an overall yield of 55%. 
Scheme 5. Formation of the first rigid pinene-pyridine type framework 
UV, O2, TPP
DMAP, Ac2O,
CH2Cl2, rt
O
(-)-1 (+)-16
N
O
N
I
NH4OAc, formamide, 100 °C N N
17
SeO2, tBuOOH
CH2Cl2, 35 °C
(-)-1 18
N
O
N
I
NH4OAc, formamide, 70 °C N N
19
O
a-
b-
 
 
In the case of formation of [4,5]-pinenebipyridine 19 (Scheme 5-b), (–)-α-pinene 1 was first 
transformed into myrtenal 18 by allylic oxidation using selenium dioxide in the presence of 
tert-butyl hydroperoxide, followed by the key Kröhnke annulation with 2-
acetylpyridinepyridinium iodide (75% overall yield).  
The unfused pyridine ring originates from the Kröhnke salt used in the annulation step; it is 
therefore very easy to introduce other functionalities. Furthermore, deprotonation of 17 and 
19 with LDA is fully regiospecific at the benzylic position on the pinene moiety which allows 
further modification of the structure via nucleophilic substitutions of a wide variety of 
electrophiles. NOE experiments have also shown that the substitution is completely 
stereoselective,17 introducing the electrophilic moiety from the sterically less hindered side.  
 
As described before, the fused pinene-pyridine framework is not only easy to build (2 steps 
synthesis) but it is also the rigid and extremely modular architecture that makes it suitable for 
incorporating into the chiral backbone of ligands designed for asymmetric catalysis.  
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Although [4,5]-pinenebipyridines (such as 19) have been successfully applied in asymmetric 
catalysis,20 we have decided to focus our attention on the use of [5,6]-pinene(bi)pyridine 
frameworks since any substitutions at the benzylic position will generate a new stereogenic 
centre closer to the coordinating units, in comparison to their [4,5]-counterparts. 
 
1.3.2.1 [5,6]-Pinenebipyridines in Asymmetric Catalysis 
2,2’-Bipyridine and its derivatives have received considerable attention over the last decade 
due to their remarkable chemistry.21 Unlike many other common ligands such as 
cyclopentadienyls and phosphines, they are extremely stable in both aqueous solution and to 
atmospheric oxygen, which simplifies both their preparation and long-term storage. 
[5,6]-pinenebipyridines appeared as asymmetric ligands as early as in 1998, when von 
Zelewsky reported the use of the bipyridyl alcohols for the enantioselective addition of 
diethylzinc to benzaldehyde.22 The ligands 20a-g were easily prepared from the fused pinene-
bipyridine 17 (vide supra) by simple deprotonation with LDA and consecutive reaction with 
a variety of ketones (Scheme 6).  
Scheme 6. Formation of the bipyridyl alcohols 20a-g 
N N
17
1. LDA, THF, -40 °C
2. R1COR2
3. H2O
N N
20a R1=R2=Me
20b R1=R2=Ph
20c R1=Ph, R2=Me
20d R1=Me, R2=Ph
20e R1=1-Naph, R2=Me
20f R1=2-Naph, R2=Me
20g R1=Me, R2=2-Naph
R1
OH
R2
 
 
Ligands 20a-g were tested in asymmetric addition of diethylzinc to benzaldehyde providing 
quantitative yield and reasonably high enantioselectivity (Scheme 7 and Table 1). Although 
the configuration of the stereogenic centre at the hydroxyl group does not seem to be a 
prerequisite for high enantioselectivity (entries 1&2), it definitively has a big influence 
regarding the selectivity of the reaction since the pairs of ligands 20c/20d (entries 3&4) and 
20f/20g (entries 6&7) exhibit very different enantioselectivity. 
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Scheme 7. Enantioselective addition of diethylzinc to benzaldehyde 
O Et2Zn (2 eq)
20 (5 mol%)
toluene, rt
21
OH
22  
Table 1. Enantioselective addition of diethylzinc to benzaldehyde with 20a-g (Scheme 7)22 
Entry Ligand Yield (%) ee (%) 
1 20a 100 73 
2 20b 100 79 
3 20c 100 78 
4 20d 100 52 
5 20e 99 86 
6 20f 100 82 
7 20g 99 47 
 
Inspired by the von Zelewsky’s bipyridines, Chelucci reported a set of [5,6]-pinene-
bipyridines 23a-f (Scheme 8)23 for the enantioselective palladium-catalysed allylic alkylation 
of 1,3-diphenyl-2-propenyl acetate 14 with dimethyl malonate.  
Scheme 8. Bipyridines for the enantioselective Pd-catalysed allylic alkylation 
 
 
All the catalysts showed good reactivity (yields are above 65%). In terms of 
enantioselectivity, the group at the benzylic position seems to have a big influence. No 
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substituent (ligand 23a) or too sterically demanding substituents (ligands 23e and 23f) 
resulted in poor enantioselectivity. At the same time, methyl, iso-propyl and benzyl groups 
exhibit good to high enantioselectivity (74%, 79% and 89% ee, respectively). 
Later, our group reported on the use of C2-symmetrical [5,6]-pinene-bipyridines 24a-c in the 
asymmetric cyclopropanation of styrene (Scheme 9).24 The copper catalysts were generated 
in situ. All the catalysts gave similar ratio of diastereoisomers 26a and 26b. However, as 
previously described, the enantioselectivity was clearly dependent on the substituent at the 
benzylic position. iso-Propyl group proved too bulky, resulting in a drop of enantioselectivity 
in both products. 
Scheme 9. Asymmetric cyclopropanation of styrene using 24a-c 
 
 
Since our group is also interested in organocatalysis, terpene-derived bipyridines were 
oxidised into novel chiral N-oxides 27a-d which proved to be efficient organocatalysts for the 
asymmetric allylation of benzaldehyde 21 with allyl trichlorosilane 28 (up to 97% ee) 
(Scheme 10).25 Once again, the unsubstituted catalyst (27a) led to lower enantioselectivity in 
comparison with its alkylated counterparts.  
Scheme 10. Enantioselective allylation of benzaldehyde using 27a-d 
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1.3.2.2 [5,6]-Pinenemonopyridines in Asymmetric Catalysis 
For a long time, ligands with C2-symmetric structural architecture dominated the field of 
asymmetric catalysis. More recently, nonsymmetrical ligands have received considerable 
attention. By modifying the Kröhnke salt structure, Chelucci advanced the field of 
unsymmetrical [5,6]-pinenemonopyridines by developing a wide range of N,O-, N,S- and 
N,P-ligands. 26-28 
 
N,O-Ligands 
Monopyridine N,O-ligands 30a-d were the first set of pinene-pyridine nonsymmetrical 
ligands investigated by Chelucci.26 Their synthesis was relatively short (4 steps), although the 
phenolic hydroxyl group had to be introduced in methoxy form to prevent possible 
complications during the alkylation step employing LDA. Catalytic activity of ligands 30a-d 
was then examined in the enantioselective addition of diethylzinc to benzaldehyde (Scheme 
11). However, the results were inferior to those obtained with von Zelewsky’s bipyridyl 
alcohols.22 
Scheme 11. N,O-ligands 30a-d for the enantioselective addition of Et2Zn to benzaldehyde 
N
R
HO O
N
MeO
I(+)-1
30a: R=H, 95% yield, 44% ee
30b: R=i -Pr,98% yield, 49% ee
30c: R=Bu, 94% yield, 61% ee
30d: R=Bn, 95% yield, 52% ee
O Et2Zn (2 eq)
30 (5 mol%)
toluene, rt
21
OH
22
LDA, R-I
31
 
 
N,S-Ligands 
As a further extension of the series, Chelucci investigated in detail pinene-derived N,S-
ligands. A wide range of N,S-ligands were generated by systematically modifying the alkyl 
chain at the benzylic position and also varying the type of the sulfur donor and its position in 
the molecule (Chart 2).27 The synthesis of the ligands followed the traditional pattern 
(between two and three steps) involving the classical Kröhnke annulation and alkylation 
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sequence. Surprisingly, the introduction of the SPh group in the benzylic position was not as 
selective as usual, leading to the formation of two diastereoisomers 32a:32b in a 3:1 ratio in 
favour of the expected isomer (SPh up).27a  
All the N,S-ligands were tested in the enantioselective palladium-catalysed allylic alkylation 
of 1,3-diphenyl-2-propenyl acetate 14 with dimethyl malonate (Scheme 12), which produced 
rather contrasting results (Table 2). When the coordinating thioether group is directly bonded 
to the stereogenic benzylic centre (entries 1&2), high level of enantioselectivity are obtained 
(up to 83% ee).27a As stated previously, it is the configuration at the benzylic position which 
controls the configuration of the product (entries 1&2). Interestingly, when the thioether 
group is placed on the phenyl ring,27b both the reactivity and the enantioselectivity drop 
significantly (entries 1&3). The size of the alkyl group in the ligand 34a has a dramatic effect 
on the outcome of the reaction (entries 4&5). The presence of a bulky iso-propyl group (34b) 
results in complete deactivation of the catalyst, however the presence of the long chain n-
butyl (34c) leads to a slight improvement of the enantioselectivity (from 20% to 32% ee). It is 
also interesting to note that when the sulfur atom is incorporated into an aromatic ring (ligand 
36),27c the palladium complex with 36 becomes completely inactive (entry 6). 
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Chart 2. N,S-ligands family 
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Scheme 12. Enantioselective Pd-catalysed allylic alkylation using the N,S-ligands family 
Ph Ph
OAc
Ph Ph
MeO2C CO2Me
*
CH2(CO2Me)2 (3 eq), BSA (3 eq)
[Pd(η3-C3H5)Cl]2 (2.5 mol%),
L* (10 mol%)
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Table 2. Enantioselective Pd-catalysed allylic alkylation using the N,S-ligands family (Scheme 12)27 
Entry Ligand Yield (%) ee (%) 
1 32a 90 83 (R) 
2 32b 85 78 (S) 
3 34a 54 20 (S) 
4 34b 0 N.D. 
5 34c 61 32 (R) 
6 36 0 N.D. 
N.D. = Not determined 
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N,P-Ligands 
A vast number of nonsymmetrical N,P-ligands have been reported over the past decade, 
however relatively few examples contained pyridine as a coordinating unit. Chelucci28 and 
our group29 reported independently the use of [5,6]-pinenemonopyridine-phosphine in 
asymmetric catalysis. Chelucci’s strategy to synthesise the N,P-ligand (+)-41a was based on 
the key nickel-catalysed coupling of the triflate 40 with diphenylphosphine (Scheme 13). The 
manipulations of the hydroxyl group make the synthesis of (+)-41a relatively long with poor 
overall yield (around 4%). Our group employed a different approach. A nucleophilic aromatic 
substitution of the fluoro derivative 44 was utilised as the key step for the introduction of the 
diphenylphosphine unit (Scheme 14), making the synthesis two steps shorter than the 
sequence used by Chelucci, with an improved overall yield (31%).   
Scheme 13. Chelucci’s synthesis of N,P-ligand (+)-41a 
 
Scheme 14. Approach of our group for the synthesis of N,P-ligand (–)-41b 
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Our group’s continued interest in organocatalysis recently led to development of a series of 
very active nucleophilic catalysts based on [5,6]-pinenemonopyridine.30 N-Oxide 45 
exhibited a very high level of enantioselectivity in the allylation of benzaldehyde with allyl 
trichlorosilane (up to 96% ee) (Scheme 15). 
Scheme 15. Allylation of benzaldehyde with (+)-METHOX 45 
O
45 (10 mol%)
MeCN, -40 °C
21
OH
29
N
O
+
SiCl3
28
OMe
OMe
OMe
>95% yield, 96% ee
45  
 
1.4 Summary 
The [5,6]-pinenemonopyridine framework seems to have all the characteristics required for 
an efficient chiral backbone of ligands designed for both asymmetric metal- and organo-
catalysis. The catalysts are very easy to build (2 steps via Kröhnke annulation), the pinene 
moiety fused to the pyridine ring makes all the structures extremely rigid; furthermore, the 
modular character of these structures provides an opportunity for fine-tuning the steric 
arrangement.  
However, it is important to note that the influence of the substitution pattern at the benzylic 
position on the enantioselective outcome of the catalysed reaction is not easy to predict. 
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2 Metal-Catalysed Asymmetric Reactions 
2.1 Introduction 
Over the last 30 years, transition metal catalysis has become an indispensable tool in modern 
organic synthesis31 due to high enantioselectivities, reactivity and flexibility of protocols. The 
importance of transition metal-based catalysis is illustrated by the Nobel Prize award to 
William S. Knowles and Ryoji Noyori for their work on “chirally catalysed hydrogenation 
reactions” and to Barry K. Sharpless for the development of “transition metal catalysed 
oxidation reactions” in 2001.32 There are, however, a number of transformations for which no 
practical level of enantioselectivity is obtained, requiring the development of novel catalytic 
systems.  
The Baeyer-Villiger oxidation (rearrangement) allows the conversion of ketones (cyclic) into 
the corresponding esters (lactones).33 Interestingly, it was only in 1994, more than a century 
after the reaction discovery, that the first asymmetric Baeyer-Villiger oxidation was 
reported.34,35 Although an enormous effort was made over the last decade (a wide range of 
metals have been screened), the level of enantioselectivity remains unsatisfactory (≤87% ee). 
In this chapter, the development of the asymmetric metal-catalysed Baeyer-Villiger oxidation 
will be discussed.  
Second part of this chapter deals with asymmetric hydrogenation. Whereas the 
enantioselective hydrogenation of functionalised olefins with both rhodium and ruthenium 
has a long history,31 “largely unfunctionalised alkenes”36 have been examined only recently. 
Pfaltz and co-workers have developed complexes37 of phosphine-oxazolines with iridium 
which have been used successfully in the asymmetric hydrogenation of arylalkenes. 
However, the iridium-catalysed asymmetric hydrogenation is still highly substrate dependent, 
and the development of new efficient chiral ligands that tolerate a broader range of substrates 
remains a challenge. In this chapter, the asymmetric iridium-catalysed hydrogenation of 
unfunctionalised olefins will be reviewed. 
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2.2 Baeyer-Villiger Oxidation (BVO) 
The Baeyer-Villiger conversion of aldehydes and ketones into the corresponding esters by 
insertion of an oxygen atom into the C-C bond33 (Figure 1) is an established, regioselective 
and stereospecific synthetic tool.38 
Figure 1. Baeyer-Villiger oxidation 
O
Baeyer-Villiger
Oxidation O
O
 
The generally accepted two-step mechanism proposed by Criegee39 in 1948 was confirmed a 
few years later with isotopic labelling experiments40 and kinetic studies. As shown in 
Scheme 16, the stepwise process consists of an initial reversible nucleophilic attack of the 
peroxy acid on the carbonyl moiety of the ketone (step a). This step is followed by the 
rearrangement of the tetrahedral intermediate, the Criegee adduct. Subsequent irreversible 
migration of one of the two substituents and a concomitant cleavage of the O-O bond in a 
concerted manner leads to ester and acid (step b). 
Scheme 16. BVO mechanism 
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Doering and Speers41 established that the rearrangement is regioselective with migration of 
the group that is best able to stabilise the developing positive charge, i.e., a tert-butyl 
substituent is more prone to migrate than a methyl group. Although this rule dictates the 
behaviour of most of the ketones, there are other electronic and steric effects which can affect 
the migration step. In the case of polycyclic systems, in particular, steric effects proved to be 
important. For instance, Baeyer-Villiger rearrangement of camphor remained a mystery in the 
1950’s as the methylene group rather than the tertiary bridgehead carbon atom was found to 
migrate preferentially (Scheme 17). Murray, Johnson, Pederson and Ott42 proposed to take 
into account the steric effect generated by the two methyl groups at the camphor bridge 
inducing the attack of the peracid in an endo-fashion. Migration of the bridgehead carbon 
would therefore lead to a boat-like lactone which is much less favourable than the migration 
of the methylene group affording a chair-like lactone (Scheme 18). 
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Scheme 17. Camphor mystery 
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Scheme 18. endo attack ruling the regioselectivity 
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Migration of the substituents is not only regioselective (as discussed above) but also proceeds 
with retention of configuration,43 making the Baeyer-Villiger oxidation particularly attractive 
for stereospecific synthesis.  
The choice of oxidant is primordial for several reasons, as it acts both as a nucleophile and a 
leaving group. A reactivity order of oxidants has been established. Peroxy acids, and 
especially m-CPBA, are the most efficient oxidants, followed by alkyl peroxides. The use of 
molecular oxygen as the terminal oxidant in the presence of sacrificial aldehyde44 is a greener 
and safer alternative to the highly reactive and potentially explosive peracids. Finally, 
hydrogen peroxide, which is not reactive enough to promote the BVO, can only be used in 
the presence of carboxylic acids to form peracids in situ45 or in combination with 
catalysts.38c,e-f This is where metal catalysts can play an important role in the development of 
the asymmetric Baeyer-Villiger Oxidation38e-f, 46 through selection of appropriate chiral 
ligands. 
 
2.2.1 Metal-Catalysed Baeyer-Villiger Oxidation 
Participation of metals can influence the BVO in several ways. Metals can be used as Lewis 
acids to activate the carbonyl group of the substrate towards the nucleophilic addition of the 
peroxy species. They also can increase the nucleophilicity of the peroxy species through 
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coordination. Finally, metals can facilitate in situ formation of peroxy acids from a sacrificial 
aldehyde and molecular oxygen.  
 
2.2.1.1 Lewis Acids Activation 
The use of Lewis acids to accelerate BVO through the activation of the ketone was pioneered 
by Noyori and co-workers in 1982.47 A wide range of cyclic ketones were oxidised into the 
corresponding lactones in moderate to good yields using bis(trimethylsilyl) peroxide as an 
oxidant and a catalytic amount of trimethylsilyl trifluoromethanesulfonate as a Lewis acid. It 
is also interesting to note that the oxidation occurred specifically at the carbonyl 
functionality, while carbon-carbon double bonds were not affected. Takai et al.48 reported 
similar results using bis(trimethylsilyl) peroxide as an oxidant and Lewis acids such as SnCl4 
or BF3.Et2O. An ingenious fluorous biphasic protocol using tin 
bis(perfluoroalkanesulfonyl)amide as catalyst49 and hydrogen peroxide as an oxidant allowed 
BVO to proceed with excellent yield and selectivity with further advantage of a full recovery 
of the catalyst without any loss of activity.  
2.2.1.2 Activation of Hydrogen Peroxide 
The first report of transition metal catalysed Baeyer-Villiger oxidation is due to Mares and 
co-workers,50 who reported in 1978 the use of peroxomolybdenum complex 46 (Chart 3) as 
catalysts and 90% H2O2 as an oxidant. Cycloalkanones were oxidised into the corresponding 
lactones in 10-83% yield. They proposed that the carbonyl group of the ketone inserts into the 
molybdenum-oxygen bond of the peroxo species to form metallo-ozonide 47 (Chart 3). This 
work has been re-investigated by Campestrini and Di Furia,51 who proposed that complex 46 
only serves as a Lewis acid catalyst, with hydrogen peroxide as an effective oxidant. 
Chart 3. Molybdenum catalyst - 1978 
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Rhenium was also employed to activate hydrogen peroxide. Methyltrioxorhenium (MTO) 
was used as a catalyst in BVO52 of cyclobutanone with hydrogen peroxide via a reactive 
peroxy intermediate 48 (Scheme 19).  
Scheme 19. MTO as H2O2 activator 
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Another suitable catalyst for the activation of hydrogen peroxide was found through the use 
of platinum complexes. Strukul53 reported that cationic platinum diphosphine complexes of 
the type [(P-P)Pt(CF3)(CH2Cl2)]+, such as 49, catalysed BVO of cyclic ketones with H2O2. 
Detailed studies revealed that the transformation involved coordination of the ketone to a 
vacant coordination site on the platinum complex, followed by a nucleophilic attack of free 
hydrogen peroxide on the attached carbonyl group (Scheme 20). 
Scheme 20. Mechanism of BVO with Pt catalyst 
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2.2.1.3 Dioxygen as Oxidant – The Mukaiyama System 
In 1991 Mukaiyama and co-workers54 described the use of sacrificial aldehydes for the 
aerobic BVO of ketones such as cyclohexanone 50 in the presence of nickel(II) complexes as 
catalysts (Scheme 21).  
Scheme 21. Mukaiyama system for the BVO 
O
O2 (1 atm),
isovaleraldehyde (3 eq)
Ni(dpm)2 (1 mol%)
O
O
93% yield
50 51
 
Mechanistic aspects of this catalysis remained largely unknown. However, in 1992, 
Murahashi et al.55 used iron(III) in the presence of benzaldehyde and molecular oxygen to 
oxidise a wide range of ketones to the corresponding lactones or esters. 4-Acyloxy β-lactams 
were also synthesised using the same protocol (Scheme 22). A mechanistic interpretation of 
the Fe2O3-catalysed oxidation was proposed by Murahashi. The catalyst is suggested to be 
involved in the autoxidation of benzaldehyde with molecular oxygen to produce peroxy 
benzoic acid in situ required for BVO. However, since the Mukaiyama system has also been 
employed successfully for the asymmetric BVO, it seems that the metal may also play an 
important role in the oxygen transfer step, although its exact nature is still unclear. 
Scheme 22. Murahashi’s conditions 
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2.2.2 Asymmetric BVO 
2.2.2.1 Enzymatic BVO 
For many years, the only way of carrying enantioselective Baeyer-Villiger oxidation was 
with the use of microorganisms.56 Enzymes that catalyse BVO mostly bear a FAD prosthetic 
group and use NADPH as the reducing agent (Scheme 23). Reduced FAD-H2 reacts with 
oxygen to give 4a-hydroperoxyflavin 52, which reacts with a carbonyl compound to give the 
corresponding Criegee intermediate 53. Presumably, the Criegee adduct is further converted 
into the cyclic peroxy intermediate 54 before allowing the rearrangement to take place 
(Scheme 23). 
Scheme 23. Enzymatic BVO 
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Recently, asymmetric BVO catalysed by an enzyme-mimicking bisflavin 98 was reported 
(Scheme 24).57 
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Scheme 24. Organocatalyst bisflavin 
 
 
2.2.2.2 Chemical Asymmetric BVO 
Despite the long history of the Baeyer-Villiger oxidation, it is only recently that its 
asymmetric version was reported. In 1994, Bolm34 and Strukul35 published independently the 
first enantioselective kinetic resolution of racemic 2-substituted-cyclohexanones (Scheme 
25). Bolm et al. used a modified copper catalyst (S,S)-56 under classical Mukaiyama 
conditions (molecular oxygen and sacrificial aldehyde) to afford the corresponding optically 
active lactone in 41% yield with up to 69% ee (Scheme 25a).  
Strukul et al. achieved their highest enantiomeric excess (58%) with 2-(n-
pentyl)cyclopentanone as substrate and BINAP-2-vanillin platinum complex 57 as catalyst 
(Scheme 25b). Six-membered cyclic ketone, 2-methylcyclohexanone, was converted under 
identical conditions into the corresponding (S)-lactone with 45% ee. The catalytically active 
cationic complex is formed when complex 57 is treated with a strong acid, such as HClO4. 
Under these conditions, phenolic oxygen is protonated leading to cleavage of the coordinate 
Pt-vanillin bond. The non-coordinating anion [ClO4]- leaves a vacant coordination site on the 
metal, thus rendering it catalytically active. 
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Scheme 25. First chemical asymmetric BVO 
 
Besides the oxidation of racemic ketones, oxidation of prochiral 3-substituted-cyclobutanones 
to optically active γ-butyrolactones is an important aspect in the study of asymmetric BVO. 
In 1996, Lopp58 was the first to report on oxidation of prochiral cyclobutanone 58 to afford 
(R)-59 (40% ee) using (i-PrO)4Ti, (+)-diethyl tartrate, and tert-butyl hydroperoxide, a system 
originally developed by Sharpless for epoxidation of allylic alcohols (Scheme 26). 
Scheme 26. Asymmetric Ti-catalysed BVO 
 
Bolm59 extended the scope of his copper(II) catalyst (S,S)-56 to the oxidation of prochiral 
cyclobutanones (Scheme 27). However, the achieved enantioselectivity remained moderate 
(up to 47% ee), only Kelly’s tricyclic ketone 60 afforded the corresponding lactone with high 
enantioselectivity (91% ee). 
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Scheme 27. Asymmetric Cu-catalysed BVO of prochiral cyclobutanones 
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Bolm60 also developed  zirconium-BINOL-BIPOL complex 61 which in combination with 
tert-butyl hydroperoxide (TBHP) proved to be effective in the asymmetric oxidation of 
bicyclic and monosubstituted cyclobutanones (Scheme 28). However, complex 61 had to be 
used in stoichiometric equivalent. High enantioselectivity was achieved with bicyclic 
structures (up to 84% ee), while the monosubstituted cyclobutanones exhibited only moderate 
selectivity (up to 44% ee).  
Scheme 28. Asymmetric Zr-mediated BVO of cyclobutanones 
 
Kotsuki61 reported oxidation of cyclobutanones with O2, using a complex generated from 
Et2Zn and a chiral amino alcohol but the reaction required high catalyst loading and the 
enantioselectivities remained moderate (≤39% ee) (Scheme 29). 
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Scheme 29. Asymmetric Zn-mediated BVO 
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Bolm improved his BINOL system by replacing Zr(IV) with Mg(II): using cumene 
hydroperoxide and 50 mol% catalyst loading, he obtained a range of lactones in 52-65% ee 
(Scheme 30-a).62 A combination of the Lewis-acidic Me2AlCl and BINOL or vaulted 
BINOL (VANOL) as chiral ligands resulted in further improvement in enantioselectivity 
(37-84% ee) and lowering of the catalyst loading to 20 mol% (Scheme 30-b).63 
Scheme 30. Binaphthol-based system 
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Katsuki successfully applied three different metal salen complexes and a palladium 
phosphino-pyridine complex in the asymmetric BVO. The cationic cobalt(III) (salen) 
complex 62 was reported to be an efficient catalyst (up to 78% ee) for the asymmetric BVO 
of 3-substituted cyclobutanones using hydrogen peroxide as a terminal oxidant (Scheme 
31).64 The efficiency of this cobalt catalyst was attributed to its cis-β-structure, which had 
two vicinal coordination sites that became vacant during the catalysis. Interestingly, by 
replacing cobalt with zirconium in the salen complex, Katsuki65 produced catalyst 63 which 
is responsible for the best enantioselectivity so far (up to 87% ee). Further modifications, 
including various metal sources (such as 65), did not improve the enantioselectivity of the 
reaction.66 The Pd(II) complex with the phosphinopyridine ligand 64 gave lactones in 
60-80% ee.67 
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Scheme 31. Katsuki’s catalysts 
 
 
2.2.2.3 Other Approaches 
Sugimura68 introduced a diastereotopic differentiating peracid oxidation of ketals prepared 
from prochiral ketones with a chiral C2-symmetrical diol in the presence of tin tetrachloride. 
High level of enantioselectivity were achieved (up to 89% ee) when the reaction was 
performed at low temperature (-100°C) (Scheme 32-a).  
Seebach et al. 69 developed a chiral, nonracemic oxidant which was employed under base 
catalysis. The readily accessible TADDOL-derived hydroperoxide 66 oxidised 
bicyclooctanone in 50% ee (Scheme 32-b). 
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Uemura70 reported the use of chiral diselenide 67 in combination with ytterbium triflate and 
hydrogen peroxide which produced γ-butyrolactones with low enantioselectivity (up to 19% 
ee) (Scheme 32-c). 
Scheme 32. Other approaches 
 
 
2.2.3 BVO Summary 
Although the Baeyer-Villiger oxidation was discovered more than a century ago, its 
asymmetric version has only been recently investigated. Even so, many chiral catalytic 
systems based on different metals (Cu, Pt, Ti, Zr, Zn, Mg, Al, Co, Pd, Hf) have been tested, 
only moderate to good enantioselectivity (up to 87% ee) was usually obtained with the very 
reactive 3-substituted cyclobutanones.  
Chapter 2. Metal-Catalysed Asymmetric Reactions 27 
 
2.3 Hydrogenation of Unfunctionalised Alkenes 
In the mid 1960s, the discovery by Wilkinson of the hydrogenation catalyst, RhCl(PPh3)3,71 
opened the door for developing asymmetric hydrogenation of olefins catalysed by rhodium 
complexes with a chiral phosphine ligand. The enantioselective efficacy of the chiral ligands 
has often been evaluated by hydrogenation of methyl acetamidocinnamate 9. Figure 2 
illustrates typical examples of phosphorus-based chiral ligands, with which Rh(I) catalyst 
selectively afforded (S)-amino acid derivative 10.31,72 In the mid 1980s, the discovery of 
BINAP-Ru(II) complexes72 significantly expanded the scope of olefinic substrates for 
asymmetric hydrogenation (Figure 3). Nevertheless, there are still many classes of substrates 
that these catalysts cannot handle.  
Figure 2. Asymmetric hydrogenation of 9 using chiral phosphine-Rh(I) complexes  
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Figure 3. Asymmetric hydrogenation of functionalised olefins catalysed BINAP-Ru complexes 
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Unfunctionalised olefins are particularly difficult substrates because, in general, a polar group 
adjacent to the C=C bond, capable of coordinating to the rhodium or ruthenium centre, is 
required for high catalyst activity and enantioselectivity. There are very few examples of 
highly enantioselective hydrogenation of olefins lacking such a polar group.73 Among them, 
titanocene and zirconocene complexes (Chart 4),74 developed by Buchwald, have shown 
high level of reactivity and enantioselectivity in the hydrogenation of various 
unfunctionalised tri- and tetrasubstituted arylalkenes. However, the complexes are extremely 
air-sensitive and relatively difficult to prepare. The major breakthrough in the asymmetric 
hydrogenation of unfunctionalised olefins came with the recent development of relatively air 
and moisture tolerant cationic iridium complexes, with chiral N,P-ligands and weakly 
coordinating counter ions. 
Chart 4. Buchwald’s titanocene and zirconocene complexes 
 
Chapter 2. Metal-Catalysed Asymmetric Reactions 29 
 
2.3.1 Iridium-Catalysed Enantioselective Hydrogenation of Olefins 
Early work on iridium catalysis was reported by Crabtree in 1977.75 The 
[Ir(pyridine)(PCy3)(COD)]PF6 complex 69 (often referred to as Crabtree’s catalyst) catalysed 
hydrogenation of a range of unfunctionalised olefins with good turnover frequency (TOF) (up 
to 4000 h-1, see Table 3). This is remarkable considering that tetrasubstituted alkenes are very 
difficult to hydrogenate due to their steric hindrance. The disadvantage of this catalyst is a 
competitive degradation leading to inactive dimer or trimer in the presence of H2. This 
explains why low conversions were reported in the case of tri- and tetrasubstituted alkenes 
even though very high initial TOFs were observed. 
Table 3. Hydrogenation of unsubstituted alkenes with Crabtree’s catalyst 69 
 
Alkene Conversion (%) Max TOF (h-1) 
 
100 8300 
 
100 4500 
 
35 3800 
 
<40 4000 
 
2.3.1.1 Phosphine-Oxazoline Type Ligands 
Inspired by Crabtree’s catalyst, Pfaltz et al in 199876 reported on the first asymmetric 
iridium-catalysed hydrogenation of alkenes using iridium complexes derived from chiral N,P-
phosphinooxazolines 70a-g (PHOX ligands,37a Chart 3). The preliminary results obtained by 
Pfaltz and co-workers were very promising (up to 97% ee for trisubstituted alkenes, see 
Table 4). However, deactivation of the catalyst, similar to the Crabtree’s system, was 
observed in the case of the iridium-PHOX complexes 70a-d (catalysts having PF6- as 
counterion). Interestingly, replacement of PF6- with the bulky and extremely weakly 
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coordinating anion BArF- (tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) allowed the 
cationic iridium complexes to be more stable towards deactivation and full reduction of 
various alkenes were routinely obtained with catalyst loading lower than 1 mol%. Recent 
kinetic study of catalysts with different counterions77 (Figure 4) showed that the catalytic 
activity of the complexes 70f strongly depends on the anion and increases in the order 
CF3SO3- < BF4- << PF6- < [B(C6F5)4]- < BArF- < [Al{OC(CF3)3}4]-. These early results 
influenced the development of the future catalysts in two ways. First, (E)-1,2-diphenyl-1-
propene 78 has become the model substrate for all new ligands. Relatively ineffective 
catalysts for the hydrogenation of (E)-1,2-diphenyl-1-propene 78 are usually not investigated 
further. That will prove to be unfortunate if those catalysts would have been more suitable for 
more difficult substrates. Second, and more important, all the chiral catalysts reported in the 
literature, contain BArF- as the counterion.  
Figure 4. Influence of the counterion on the reaction rate of hydrogenation of 78 with 70f 
 
Extensive modifications of the privileged PHOX ligands were realised by Pfaltz and others 
(Chart 5). The influence of the size of the coordinating sphere around the iridium centre and 
the electronic density of the phosphorous atom on the enantioselectivity was first examined. 
The phenyl ring linking the oxazoline unit to the phosphine moiety plays a central role in this 
structure. As an alternative arrangement, other linkers were examined. A series of iridium 
complexes based on pyrrole-derived phosphinooxazolines (71)78 was developed and showed 
a clear improvement of the enantioselectivity (particularly for the less sterically-demanding 
(E)- and (Z)-2-(4-methoxyphenyl)-2-butene 79 and 80). Interestingly, when a planar 
ferrocenyl unit (72) was introduced instead of the classical phenyl ring,79 a slight decrease of 
enantioselectivity was observed. Gilbertson80 developed iridium complexes of proline-
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derived phosphine–oxazoline ligands (73), which afforded good enantioselectivity for 
trisubstituted alkenes but tetra- and disubstituted alkenes, such as 82 and 83, were 
hydrogenated with poor enantioselectivity (6% ee and 38% ee, respectively). Andersson 
reported on a new iridium catalyst based on 2-aza-norbornane-oxazoline ligand (77)81 which 
afforded high level of enantioselectivity with trisubstituted olefins such as 79 (up to 99% ee).  
Zhang developed electron-rich phospholane-oxazoline catalysts,82 whose iridium complexes 
(74) proved to be particularly efficient for the asymmetric hydrogenation of β-
methylcinammic esters (85) (up to 99% ee). Although there is no sensible rationale behind 
the ligand modifications, it is worth to note that the environment (both electronic and steric) 
around the phosphorous atom clearly plays an important role in the selectivity of 
hydrogenation. 
Several groups investigated the influence of the oxazoline ring on the enantioselectivity of 
the hydrogenation reaction. Zhang developed a new class of conformationally rigid 
phosphine-oxazolines (75)83 which showed to be highly enantioselective ligands for iridium-
catalysed asymmetric hydrogenation of both (E)-1,2-diphenyl-1-propene 78 and of β-
methylcinammic esters 85 (up to 99% ee). Pfaltz et al replaced the oxazoline ring with an 
imidazoline ring (76),84 the extra nitrogen atom providing a handle for tuning the electronic 
and conformational properties of the ligand by the appropriate choice of the R2 group. The 
results were rather similar to those obtained with the PHOX catalysts family (70) but with a 
slight increase in enantioselectivity for unhindered alkenes, such as 79. 
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Chart 5. Chiral iridium-phosphine-oxazoline type catalysts used for the enantioselective 
hydrogenation of unfunctionalised alkenes 
 
N
O
Ar2P
RIr
+
(COD)
X-
70a Ar=Ph R=i-Pr X=PF6
70b Ar=Ph R=t-Bu X=PF6
70c Ar=o-Tol R=i-Pr X=PF6
70d Ar=o-Tol R=t-Bu X=PF6
70e Ar=Ph R=i-Pr X=BArF
70f Ar=o-Tol R=t-Bu X=BArF
70g Ar=Ph R=CH2t-Bu X=BArF
N
N
O
Ar2P
RIr
+
(COD)
BArF-
71a Ar=Ph R=i-Pr
71b Ar=Ph R=t-Bu
71c Ar=o-Tol R=t-Bu
71d Ar=Cy R=t-Bu
N
N
Ar2P
R1Ir
+
(COD)
BArF-
76a Ar=Ph R1=i-Pr R2=i-Pr
76b Ar=Ph R1=i-Pr R2=Cy
76c Ar=Ph R1=i-Pr R2=Bn
76d Ar=Ph R1=i-Pr R2=Ph
76e Ar=Ph R1=t-Bu R2=Ph
76f Ar=Ph R1=t-Bu R2=p-MeO-C6H4
76g Ar=Ph R1=t-Bu R2=p-CF3-C6H4
76h Ar=Ph R1=t-Bu R2=p-Tol
76i Ar=o-Tol R1=t-Bu R2=Ph
76j Ar=o-Tol R1=t-Bu R2=Bn
R2
N
O
R
+Ir
(COD)
BArF-
74a R=i-Pr
74b R=t-Bu
74c R=Ph
74d R=Bn
74e R=i-Bu
P
H
tBuN
N
O
Ar2P
RIr
+
(COD)
BArF-
73a Ar=Ph R=i-Pr
73b Ar=Ph R=t-Bu
73c Ar=o-Tol R=t-Bu
73d Ar=2-Et-C6H4 R=t-Bu
73e Ar=2.3-Me2-C6H3 R=t-Bu
73f Ar=2,4-Me2-C6H3 R=t-Bu
Ir+
(COD)
BArF-
75a R=t-Bu Ar=Ph
75b R=CHPh2 Ar=Ph
75c R=3,5-t-Bu2Ph Ar=Ph
75d R=ad Ar=Ph
75e R=t-Bu Ar=Cy
N
O
R
Ar2P
BArF-
N
Ir+
(COD)
Ar2P
O
Ph
N
Ph
Ir+
(COD)
BArF-
Fe
Ph2P N
O
R
72a R=Me
72b R=i-Pr
72c R=t-Bu
72d R=Ph
72e R=Bn
7076 7178 7279
7380 7482
7583 7684 77
81
  
For the catalysts synthesis, see the highlighted reference. 
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Table 4. Hydrogenation of various alkenes using iridium-phosphine-oxazoline type catalysts (Chart 5) 
alkene alkane
Ir* (0.02-2 mol%), H2 (50 bar)
CH2Cl2, rt  
Alkene 
Iridium complex (conversion %, ee %) 
7076 7178 7279 7380 7482 7583 7684 7781 
Ph
Ph
78 
f 
>99 
97 
c 
>99 
99 
a 
>99 
90 
d 
>99 
92 
c 
>99 
95 
e 
>99 
99 
i 
>99 
94 
 
>99 
98 
MeO 79 
f 
>99 
61 
d 
>99 
75 
- 
d 
>99 
76 
- - 
j 
>99 
90 
 
>99 
99 
MeO 80 
f 
97 
42 
d 
>99 
70 
- 
d 
97 
56 
- - 
i 
>99 
88 
- 
MeO 81 
- 
c 
>99 
92 
a 
95 
89 
d 
>99 
64 
- - 
i 
>99 
91 
 
>99 
95 
MeO 82 
g 
>99 
81 
- - 
d 
>52 
6 
- - - - 
MeO 83 
- - 
a 
>99 
22 
d 
>99 
38 
- - 
j 
>99 
52 
- 
OH
84 
d 
95 
96 
- 
a 
>99 
99 
d 
>99 
94 
- - - - 
CO2Et
85 
d 
96 
84 
c 
>99 
92 
a 
>99 
82 
d 
>99 
88 
c 
>99 
98 
d 
>99 
99 
- 
 
>99 
90 
 
2.3.1.2 Other N,P-Ligands 
Although the original Crabtree’s catalyst contained pyridine and tricyclohexylphosphine as 
nitrogen and phosphorous donors, respectively, very few other chiral N,P-ligands are based 
on a phosphine-pyridine structure. In 2003, Knochel85 reported on iridium complexes of 
pyridine-phosphines derived from camphor (86) and pinene (87) which were employed as 
catalysts in the hydrogenation of methyl α-acetamidocinnamate 9 with encouraging 
enantioselectivities (up to 97% ee). Pfaltz developed two new pyridine- and quinoline-
phosphine ligands 88 and 89.86 Both classes of ligands were readily prepared using either 
ethyl picolinate or 2-vinylquinoline. However, the results were rather disappointing for the 
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hydrogenation of (E)-1,2-diphenyl-1-propene 78 (<90% ee) and the ligands were not 
investigated further.  
Li and co-workers recently reported the use of QUINAP-iridium complex in the asymmetric 
hydrogenation of a range of unfunctionalised olefins in moderate (33% ee) to high 
enantioselectivity (95% ee).87  
Other types of nitrogen-containing heterocycles were also used for the development of novel 
N,P-ligands. For instance, Andersson developed chiral bidentate phosphine-thiazoles88 (91) 
which were successfully applied as ligands in the homogeneous iridium-catalyzed 
asymmetric hydrogenation of aryl alkenes and aryl alkene esters. It was found that a six-
membered ring backbone of the rigid ligand structure was preferred over seven- or five-
membered rings. It was shown that the substitution pattern of the ligands had a major effect 
on the stereochemical outcome of the reactions. Excellent enantioselectivity was obtained for 
typical substrates. Pfaltz developed an analogue of his PHOX ligands by replacing the 
oxazoline ring with a benzoxazine motif89 (5-membered ring replaced by a 6-membered 
ring). However, their iridium complexes (92) catalysed the hydrogenation of trisubstituted 
alkenes with lower enantioselectivity than the corresponding PHOX ligands.  
Ellman90 in 2004 reported on a new class of P,N-ligands. A variety of sterically and 
electronically differing chiral sulfinyl imine ligands (93) were synthesised and successfully 
applied in the asymmetric iridium-catalysed hydrogenation (up to 94% ee). 
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Chart 6. Chiral iridium catalysts used for the enantioselective hydrogenation of unfunctionalised 
alkenes 
 
 
For the catalysts synthesis, see the highlighted reference. 
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Table 5. Hydrogenation of various alkenes using iridium catalysts (Chart 6) 
alkene alkane
Ir* (0.02-2 mol%), H2 (50 bar)
CH2Cl2, rt  
Alkene 
Iridium complex (conversion %, ee %) 
8685 8785 8886 8986 9087 9188 9289 9390 
Ph
Ph
78 
a 
>99 
95 
a 
26 
80 
a 
93 
88 
b 
92 
45 
c 
>99 
95 
 
>99 
99 
 
>99 
78 
a 
>99 
94 
MeO 79 
- - - - - >99 99 
>99 
37 - 
MeO 80 
- - - - - - - - 
MeO 81 
- - - - - 
>99 
93 - - 
MeO 82 
- - - - - - 63 10 - 
MeO 83 
- - - - - - 
>99 
9 - 
OH
84 
- - - - - 
 
>99 
99 
 
13 
77 
a 
>99 
70 
CO2Et
85 
- - - - 
c 
>99 
98 
 
>99 
98 
 
95 
75 
a 
>99 
65 
 
2.3.1.3 Phosphinite Ligands 
Continuous development of new ligands for broadening the substrate scope led Pfaltz and co-
workers to investigate the use of phosphinite-oxazolines for the enantioselective iridium-
catalysed hydrogenation of unfunctionalised olefins. The SimplePHOX catalysts family 94 
(Chart 7 & Table 6),91 readily available from α-hydroxyisobutyric acid and a range of 
various amino alcohols, was the first generation of a new promising class of ligands for broad 
application in asymmetric hydrogenations of unfunctionalised alkenes. Trisubstituted alkenes, 
such as 78-81, allylic alcohol 84 and β-methylcinammic esters 85 were reduced in high 
enantioselectivity (<90% ee), even disubstituted alkene 83 was hydrogenated with good 
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enantioselectivity (78% ee). Pfaltz extended his phosphinite ligands family by developing a 
more conformationally rigid type of phosphinite-oxazolines based on serine methyl ester92 
(95) and threonine methyl ester93 (96) whose iridium complexes induced high 
enantioselectivity with a wide range of alkenes (alkene 79 was hydrogenated with perfect 
enantioselectivity (99% ee)). Ligand 96 was found to be generally more selective than its 
counterpart 95.  
Since phosphinites were clearly more selective and, in particular, tolerated a broader range of 
substrates, other groups started to develop new types of phosphinite ligands. For instance, 
Andersson reported on phosphinite-oxazole iridium complexes (97),94 which not only could 
reduce a wide range of olefins but also produced high enantioselectivity (Table 6). The 
success of these catalysts for enantioselective hydrogenation of substituted styrenes could be 
rationalised in terms of the selectivity model shown in Figure 5. The enantiofacial selectivity 
is primarily based on discrimination between a larger and a smaller germinal substituent. This 
also explained why tetrasubstituted alkene 82 afforded racemic product in only 46% 
conversion. 
Figure 5. Calculated structure of the couple catalyst-substrate (Left). Selectivity model (Right).  
 
 
Zhou95 and Pfaltz96 reported independently the use of a new class of phosphinite-catalysts (98 
and 99, respectively). Interestingly, the nitrogen donor atom comes from the pyridine ring 
which makes 98 and 99 closer to the Crabtree’s catalyst structure than the other ligands 
previously reported. The 5- or 6-membered rings containing the phosphorous coordinating 
unit are fused to the pyridine ring, increasing the overall rigidity of the ligands. However, 
these chiral ligands were obtained by resolution of the racemic pyridyl alcohols using 
preparative chiral HPLC, which makes their large-scale preparation rather difficult. The 
observed enantioselectivity was clearly dependent on the ligand structure. Introduction of a 
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substituent into the 2-position of the pyridine ring strongly increased the ee of the products. 
Enantioselectivities increased substantially when the P-phenyl groups were replaced by 
ortho-tolyl groups. In general, 5-membered ring derivatives exhibited higher 
enantioselectivities. Even a very difficult tetrasubstituted alkene 82 was hydrogenated in 
good enantioselectivity (up to 64% ee). 
Chart 7. Chiral iridium-phosphinite type catalysts used for the enantioselective hydrogenation of 
unfunctionalised alkenes 
 
BArF-
95a R1=ferrocenyl R2=i-Pr
95b R1=ferrocenyl R2=i-Bu
95c R1=ferrocenyl R2=Bn
95d R1=3,5-t-Bu2C6H3 R2=i-Bu
95e R1=3,5-t-Bu2C6H3 R2=Bn
95f R1=naphthyl R2=i-Bu
95g R1=biphenyl-4-yl R2=i-Bu
95h R1=Ph R2=i-Pr
95i R1=Ph R2=Bn
95j R1=t-Bu R2=Bn
N O
R1
O
R2R2
Ph2P
Ir+
(COD)
BArF-
96a R1=Ph R2=Bn Ar=Ph
96b R1=Ph R2=Bn Ar=Ph
96c R1=Ph R2=Bn Ar=o-Tol
96d R1=Ph R2=Me Ar=Ph
96e R1=3,5-Me2C6H3 R2=Bn Ar=Ph
96f R1=3,5-t-Bu2C6H3 R2=Bn Ar=Ph
N O
R1
O
R2R2
Ar2P
Ir+
(COD)
*
BArF-
94a R1=t-Bu Ar=Ph
94b R1=t-Bu Ar=o-Tol
94c R1=i-Pr Ar=Ph
94d R1=i-Pr Ar=o-Tol
O
N
R1
O
Ar2P
Ir+
(COD)
BArF-
97a Ar=Ph
97b Ar=o-Tol
97c Ar=3,5-Me2Ph
N O
O
Ar2P
Ir+
(COD)
Ph
Ir+
(COD)
BArF-
N
R
O
Ph2P
n
98a R=H
98b R=Cl
98c R=Ph
Ir+
(COD)
BArF-
N
R
O
Ar2P
n
n=1 or 2
R=H, Me, Ph
Ar=Ph, o-Tol, Cy, t-Bu
9491 9592 9693
9794 9895 9996
 
For the catalysts synthesis, see the highlighted reference. 
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Table 6. Hydrogenation of various alkenes using iridium-phosphinite type catalysts (Chart 7) 
alkene alkane
Ir* (0.02-2 mol%), H2 (50 bar)
CH2Cl2, rt  
Alkene 
Iridium complex (conversion %, ee %) 
9491 9592 9693 9794 9895 9996 
Ph
Ph
78 
b 
>99 
98 
e 
>99 
98 
a 
>99 
99 
b 
>99 
99 
c 
>99 
99 
 
>99 
99 
MeO 79 
b 
>99 
91 
c 
>99 
96 
f 
>99 
99 
b 
>99 
96 
- 
 
>99 
99 
MeO 80 
b 
>99 
89 
a 
>99 
85 
e 
>99 
92 
- - 
 
>99 
98 
MeO 81 
b 
>99 
95 
a 
>99 
85 
b 
95 
85 
b 
>99 
94 
- 
 
>99 
92 
MeO 82 
- - - 
b 
>46 
0 
- 
 
>99 
64 
MeO 83 
b 
>99 
78 
e 
>99 
88 
a 
>99 
89 
b 
>99 
97 
- 
 
>99 
80 
OH
84 
b 
>99 
97 
- - 
b 
95 
98 
c 
>99 
86 
- 
CO2Et
85 
b 
>99 
94 
b 
>99 
90 
b 
>99 
85 
b 
>99 
93 
c 
>99 
88 
 
>99 
99 
 
2.3.1.4 C,N-Ligands 
N-heterocyclic carbenes (NHCs) emerged as useful ligand framework in organometallic 
chemistry. Their powerful σ-donating and weak π-accepting properties result in the metal 
centres to be more electron rich compared to the corresponding phosphine complexes. Thus, 
complexes containing carbene based ligands tend to be more active in oxidative addition 
reactions and more thermostable than their phosphine analogues which make them attractive 
alternatives.     
Therefore, it is not surprising that chiral iridium catalysts based on heterocyclic carbenes 
were explored in the asymmetric hydrogenation of alkenes (Chart 8 & Table 7). Burgess97 
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reported a series of chiral NHCs-oxazolines whose iridium complexes (100) showed high 
activity and selectivity in the enantioselective hydrogenation of various arylalkenes (up to 
98% ee). Andersson developed an imidazole analogue98 (101) of his chiral phosphine-
thiazole ligand (91). The catalyst exhibited good level of enantioselectivity (up to 90% ee) 
but remained less efficient than its phosphine analogue. Finally, Bolm99 reported the use of 
iridium catalysts based on planar chiral NHCs 102 and 103 for the enantioselective 
hydrogenation of arylalkenes, although the results were disappointing (from 15 to 82% ee). 
However, it is pertinent to note that the phosphine-NHC iridium complex 103 was much 
more efficient than the NHC-oxazoline iridium complex 102. 
Chart 8. Chiral iridium catalysts based on NHCs used for the enantioselective hydrogenation of 
unfunctionalised alkenes 
 
BArF-
100a R=Ph
100b R=CHPh2
100c R=t-Bu
100d R=ad
Ar=2,6-i-PrC6H3
N O
R
N
N
Ar
Ir+
(COD)
N
O
tBu
N
N
Me
Ir+
(COD)
PPh2N
N
Ar
Ir+
(COD)
BArF-BArF
-
BArF-
N SN
Ir+
(COD)
Ph
N
Ph
10097 10198
10299a 10399b  
For the catalysts synthesis, see the highlighted reference. 
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Table 7. Hydrogenation of various alkenes using iridium catalysts based on NHCs (Chart 8) 
alkene alkane
Ir* (0.02-2 mol%), H2 (50 bar)
CH2Cl2, rt  
Alkene 
Iridium complex (conversion %, ee %) 
10097 10198 10299a 10399b 
Ph
Ph
78 
d 
>99 
98 
 
>99 
90 
 
76 
15 
 
89 
82 
MeO 79 
d 
>99 
91 
 
>99 
79 
- 
 
>99 
37 
MeO 80 
d 
>99 
78 
- - 
 
>99 
79 
MeO 81 
- - - - 
MeO 82 
- - - - 
MeO 83 
d 
91 
31 
- - 
 
>99 
79 
OH
84 
d 
>99 
93 
 
>99 
80 
- - 
CO2Et
85 
- >99 
63 
- >99 53 
 
2.3.1.5 Substrate Scope 
Although the asymmetric iridium-catalysed hydrogenation of arylalkenes has been 
extensively studied over the past decade (vide supra), other types of substrates only recently 
became the focus of attention. In 2006, Pfaltz reported the use of his champion pyridine-
phosphinite iridium catalysts 99 for the enantioselective hydrogenation of a series of 
substituted furans (Chart 9).96 High enantioselectivities were obtained, particularly when 
electron-rich (t-Bu)2P phosphine was used. 
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Chart 9. Hydrogenation of furans and benzofurans 
O O O
O
CO2Et
O
CO2Et
84% yield, 78% ee 93% yield, 98% ee >99% yield, 92% ee
>99% yield, 93% ee 47% yield, 99% ee
Ir+
(COD)
BArF-
N
R
O
Ar2P
n
99
 
Recently, Andersson significantly broadened the substrates scope in the enantioselective 
iridium-catalysed hydrogenation to vinylsilanes,100 fluorinated olefins101 and enol 
phosphinates102 (Scheme 33).  
Scheme 33. Hydrogenation of vinylsilanes, fluorinated olefins and enol phosphinates 
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2.3.2 Mechanistic Considerations 
The mechanism of olefin hydrogenation using Crabtree’s catalyst and chiral analogues has 
been studied over several years.75 The earliest mechanistic study in this area was carried out 
by Crabtree and co-workers, who employed NMR spectroscopy to detect olefin dihydride 
intermediate 104 which was formed during hydrogenation of cyclooctadiene using 
[Ir(pyridine)(PCy3)COD]PF6 in dichloromethane at 0 °C (Scheme 34).75 
Scheme 34. Crabtree’s olefin dihydride intermediate 
 
 
In a complementary study, Pfaltz and co-workers have recently demonstrated, by combining 
experimental and computational data, that the stereoselectivity of formation of the isolated 
dihydride complexes 106c and 106d was controlled by a combination of electronic (addition 
of hydride trans to the Ir-N bond) and steric effects (presence of the bulky i-Pr group on the 
PHOX complex) (Scheme 35).103 
The reaction of the [(PHOX)Ir(COD)]+ complex 70e with dihydrogen was studied by NMR 
spectroscopy. A single [(PHOX)Ir(H)2(COD)]+ isomer (105c) was formed as the primary 
product at -40 °C in THF. Subsequent reaction with H2 at -40 to 0 °C led to a mixture of two 
diastereoisomeric [(PHOX)Ir(H)2(solvent)2]+ complexes 106c and 106d with a concomitant 
loss of cyclooctane. The stereochemistry of the three hydride complexes was assigned from 
the NMR data. The structures and energies of the observed hydride complexes and the 
possible stereoisomers were analysed by using density functional theory calculations. The 
substantial energy differences (up to 39 kcal/mol) between the various stereoisomers 
demonstrated a strong influence of the nature of the chiral ligand. Consequently, 
computational studies of the potential reaction pathways should be based on the full catalyst 
and substrate structures rather than simple model systems. 
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The rest of the mechanism remains unclear. Burgress, Hall and co-workers104 proposed an 
IrIII/IrV cycle (Figure 6) based on DFT (density functional theory) calculation which 
reproduced the correct selectivity order for three different substrates. On the other hand, Chen 
and Dietiker105 reported an experimental investigation on the hydrogenation of styrene with 
70e in the gas phase by means of electrospray ionisation tandem mass spectroscopy, which 
suggests an IrI/IrIII catalytic cycle (Figure 7). 
Taking into account the available computational and experimental data, it is still too early to 
draw definitive conclusions regarding the mechanism of iridium-catalysed hydrogenation of 
alkenes.  
Scheme 35. Hydrogenation of 70e 
70e
105a 105b 105c 105d 
106a 106b 106c 106d 
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Figure 6. IrIII/IrV catalytic cycle 
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Figure 7. IrI/IrIII catalytic cycle 
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2.3.3 Summary of Iridium-Catalysed Hydrogenation 
After the discovery in 1977 of the Crabtree’s catalyst, allowing the hydrogenation of tetra-
substituted olefins with high TOFs, iridium catalysts with chiral P,N- and C,N-ligands 
emerged as a new class of highly efficient catalysts for asymmetric hydrogenation, which are 
largely complementary to rhodium- and ruthenium-diphosphine catalysts. A variety of 
unfunctionalised arylalkenes, allylic alcohols and α,β-unsaturated carboxylic esters can now 
be hydrogenated with excellent enantioselectivity. Chiral pyridine-phosphinites seem to be 
the most efficient class of ligands reported to date. However, iridium-catalysed asymmetric 
hydrogenation remains highly substrate dependent and the development of novel chiral 
ligands with an extended scope seems to be the key factor for further improvement. 
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3 Synthesis and Application of Pinene-Derivative 
Pyridines I 
3.1 Introduction 
Of the thousands of chiral ligands developed to-date, a relatively small number stands out 
because of their broad applicability. These “privileged ligands”106 (Chart 10) allow high 
levels of enantiocontrol in many different metal-catalysed reactions. A survey of their 
structures reveals an obvious common point. They all possess C2 symmetry. 
Chart 10. Examples of privileged ligands 
X
X
X=OH BINOL
BINAPX=PPh2
O
N N
O
tButBu
Bis(oxazoline)
NN
OH HO
R R
RR
HH
Salen Complexes  
 
The concept of utilising C2-symmetric ligands was first reported by Dang and Kagan in 1971 
with the synthesis of the famous C2-symmetric diphosphine DIOP for the asymmetric 
rhodium-catalysed hydrogenation.107 The reason for choosing a C2-symmetric ligand with 
two equivalent phosphorous atoms was to reduce the number of possible isomeric metal 
complexes, as well as the number of different substrate-catalyst arrangements and reactions 
pathways. This design principle had a marked influence on the course of research in 
asymmetric catalysis, and many diphosphine ligands introduced subsequently were patterned 
after DIOP (Chart 11). 
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Chart 11. Examples of chiral C2-symmetric diphosphine ligands 
P
P
MeO
OMe
(R,R)-DIPAMP
O
O
PPh2
PPh2
(S,S)-DIOP
PPh2
PPh2
(R,R)-CHIRAPHOS
P
P
(S,S)-Me-DUPHOS
PPh2
PPh2
(R)-BINAP  
Although the concept of C2 symmetry has been very successful, there is no fundamental 
reason why C2-symmetric ligands should necessarily be superior to their nonsymmetrical 
counterparts. In fact, the ligands can induce asymmetry not only through their steric factors 
but also by generating electronic differentiation on the metal centre through the presence of 
different donor atoms. In the family of heterodentate ligands, the most important and widely 
used are those containing phosphorous and nitrogen as their donor atoms. Chiral P,N-ligands 
have already proved to be very efficient in a variety of asymmetric transformations such as 
palladium-catalysed allylic substitution, copper-catalysed 1,4-addition to enones and iridium-
catalysed hydrogenation.108 
 
In this chapter, synthesis of novel P,N-ligands based on pinene will be described. Their 
application for a rather undeveloped asymmetric palladium-catalysed Baeyer-Villiger 
oxidation of cyclobutanones will also be discussed. With an attempt to extend the scope of 
these novel ligands, their iridium complexes were prepared and tested in the asymmetric 
hydrogenation of olefins and imines. 
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3.2 Synthesis of the First Generation of P,N-Ligands 
3.2.1 Target Ligands 
The target P,N-ligands 109-110 contain a rigid pyridine-pinene fused framework and a chiral 
phosphine moiety appended to the pinene ring (Chart 12). Importantly for the method 
development and catalyst screening, the ligand structure is modular. On one hand, the steric 
properties of the pyridine ring can be tuned by varying substitution at position 2. On the other 
hand, the electronic properties of the ligand can be easily modified through alterations to the 
phosphine unit.   
Chart 12. Target P,N-ligands – First generation 
N
PPh2
108
N
PPh2
110
N
O
109
PPh2
N R
107
 
 
3.2.2 Chiral Pyridine-Phosphine 108 
The general synthetic route to the preparation of the chiral pyridine moiety derived from α-
pinene (+)-1 was based on the Kröhnke annulation109 shown in Scheme 36. Commercially 
available α-pinene (+)-1 was first converted to pinocarvone (–)-16 in 96% yield by ene 
reaction with singlet oxygen 1O2.110 The reaction of pinocarvone (–)-16 with the pyridinium 
salt 112 derived from acetophenone 111 (Kröhnke annulation) furnished the desired chiral 
pinene-pyridine (+)-113 as a result of Michael addition and ring closure in one-pot. 
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Scheme 36. Synthetic route to chiral pyridine based on α-pinene 
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The benzylic CH2 group of chiral pyridine (+)-113 is reasonably acidic.17 As a result, various 
substituents can be selectively introduced at this position by one-pot deprotonation with 
strong organic bases, such as LDA or n-butyl lithium, followed by treatment with appropriate 
electrophiles. Therefore, we attempted introduction of the phosphine unit by the use of 
diphenylphosphine chloride (Scheme 37). However, the desired P,N-ligand 108 was not 
obtained. 
Scheme 37. Attempted introduction of phosphine unit with ClPPh2 
 
Another strategy was then investigated (Scheme 38). A very stable pyridine-phosphine oxide 
(–)-114 was successfully synthesised by taking advantage of the high electrophilicity of 
diphenylphosphinic chloride. However, all attempts to reduce the phosphine oxide (–)-114 
with trichlorosilane in boiling toluene111a or xylene111b failed. An adapted protocol developed 
by Spencer et al.111c using triphenylphosphine as an “oxygen trap” was also tried but without 
any success. The diphenylphosphine oxide (–)-114 was either extremely stable and the 
reduction did not occur at all or the targeted diphenylphosphine 108 was too sensitive and 
suffered reoxidation in the presence of traces of oxygen.  
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Scheme 38. Attempts to reduce the phosphine oxide (–)-114 
 
Protection of trivalent phosphorous with borane has recently proved to be a valuable 
synthetic tool for the preparation of air-sensitive chiral phosphine ligands.112 Borane-
protected phosphines can resist not only a wide range of reaction conditions but they are also 
air stable, allowing classical column chromatography for purification and long time storage. 
The borane-protected diphenylphosphine-pyridine (–)-115 was successfully prepared in 35% 
yield by classical deprotonation of the pyridine (+)-113 with n-BuLi at -40 °C, followed by 
reaction with the freshly prepared ClPPh2.BH3 as electrophile (chlorodiphenylphosphine was 
added to a solution of borane in THF (1M) and stirred for 30 min) (Scheme 39).  
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Scheme 39. Formation of the P,N-ligand 108 via its borane-protected form 
N
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1) n-BuLi, THF, -40 °C
2) ClPPh2.BH3, rt
N
(-)-115
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BH3
Et2NH
50 °C
35%
99%
N
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Deprotection of (–)-115 to afford the desired P,N-ligand 108 was accomplished in 
quantitative yield following standard protocol. The borane-protected diphenylphosphine-
pyridine (–)-115 was heated at 50 °C in the presence of a large excess of distilled 
diethylamine;113 the reaction was monitored by TLC. 
A 31P-NMR study was carried out to determine stability of the freshly deprotected pyridine-
phosphine 108. To ensure classical anaerobic reaction conditions, the deuterated chloroform 
used for the study was degassed beforehand and the NMR tube was kept under an argon 
atmosphere between each measurement. The results from investigation into the oxidative 
stability of 108 are shown in Figure 8.  
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Figure 8. 31P-NMR study 
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A 31P-NMR spectrum was recorded before deprotection of (–)-115 (Figure 8-1) and showed a 
broad singlet with a chemical shift (26.11 ppm) typical for phosphine-borane adducts. 
Immediately after deprotection of (–)-115, the 31P-NMR exhibited only one singlet at -5.28 
ppm (Figure 8-2), representative for diphenylphosphine compounds, showing clearly the 
quantitative formation of the pure desired chiral pyridine-phosphine 108. Finally, the 31P 
NMR experiments were carried out every 2 h to check the stability of 108. After only 20 h 
(Figure 8-3), the pyridine-phosphine 108 was fully oxidised into (–)-114 (singlet at 33.73 
ppm).  
These results clearly demonstrate that the pyridine-phosphine 108 is extremely sensitive to 
oxygen traces. It is therefore imperative to carry out the complexation step immediately after 
deprotection. 
 
3.2.3 Chiral Pyridine-Phosphinite 109 
Synthesis of the chiral pyridine-phosphinite 109 is outlined in Scheme 40. Pyridine (+)-113 
was first N-oxidised with meta-chloroperoxybenzoic acid and then treated with acetic 
anhydride to undergo a Boekelheide rearrangement,114 furnishing alcohols 117a and 117b as 
N
P
Ph
Ph
(-)-115
BH3
N
P
Ph
Ph
108
N
P O
Ph
Ph
(-)-114
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a 3:1 diastereoisomeric mixture in a reasonable yield (53% yield over two steps). Instead of 
separating the two diastereoisomers, it was considered more advantageous to correct the 
diastereoselectivity by an oxidation/reduction sequence. First, 117 was oxidised using Jones’ 
reagent and the resulting ketone (+)-118 was then reduced with sodium borohydride. The 
hydride is expected to be delivered from the bottom face since the dimethyl bridge of the 
pinene moiety partially blocks the upper face. Alcohol (+)-117b was obtained nearly 
diastereoisomerically pure (94:6) with the expected configuration. The structure of the 
alcohol (+)-117b was confirmed by NOE experiment (see Figure 9): when the benzylic 
proton was irradiated (7-H, 4.88 ppm), a clear enhancement appeared at 1.50 ppm and 2.50-
2.60 ppm, corresponding to the CH2 bridge (9-H and 9-H’). 
Figure 9. NOE experiment on the alcohol (+)-117b 
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The alcohol (+)-117b was deprotonated with n-BuLi, then treated with diphenylphosphine 
chloride and the reaction was finally quenched with a solution of borane in THF to afford the 
desired air stable chiral borane-protected pyridine-phosphinite (+)-119 in 41% yield. 
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Scheme 40. Synthesis of the chiral borane-protected pyridine-phosphinite (+)-119 
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It is interesting to note that 119’, diastereoisomer of (+)-119, is easily accessible via standard 
Mitsunobu115 inversion of configuration of the alcohol (+)-117b. Alcohol (+)-117b was first 
transformed into a p-nitrobenzoic ester under classical conditions116 (use of p-nitrobenzoic 
acid, DIAD and PPh3 in THF) in moderate yield (52%) due to difficulties associated with the 
separation of the desired ester from the unreacted alcohol. The ester derivative was then 
hydrolysed with potassium carbonate in methanol in high yield (93%) to afford the alcohol 
117a with the opposite configuration, as confirmed by the NMR shift of the α-proton of the 
hydroxyl group and NOE experiment (Figure 10): when the benzylic proton was irradiated 
(7-H, 4.97 ppm), a clear enhancement appeared at 0.70 ppm and 2.53 ppm, corresponding to 
the endo methyl (12-H) and 8-H, respectively. 
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Figure 10. NOE experiment on the alcohol 117a 
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3.2.4 Chiral Pyridine-Phosphine 110 
In order to vary the steric properties of the pyridine moiety, synthesis of pinene-pyridine 
unsubstituted at position 2 was required. This was accomplished from the pinene-pyridone 
intermediate (+)-121 via the synthetic route outlined in Scheme 41. (+)-α-Pinene (+)-1 was 
oxidised into pinocarvone (–)-16 in quantitative yield (as described previously), which was 
followed by Kröhnke annulation with salt 120 (generated from ethyl-α-bromoacetate and 
pyridine) to afford the desired pyridone (+)-121 in moderate yield (33%) due to difficulties 
associated with the isolation of the pure product. First, we attempted to convert pyridone 
(+)-121 directly into 2-chloropyridine 123 using standard protocols, such as treatment with 
phosphoryl chloride117 or phenyl dichlorophosphate, but without success. Pyridone (+)-121 
was therefore transformed into the triflate derivative (+)-122 in a quantitative yield using 
triflic anhydride. Surprisingly, (+)-122 proved to be extremely resistant toward the 
displacement of the triflate group by a chlorine anion to give the desired 2-chloropyridine 
123. Both the use of lithium chloride in boiling DMF118 and tetrabutylammonium chloride in 
CH2Cl2119 were ineffective. Finally, treatment of the triflate (+)-122 with pyridinium chloride 
in N-methyl-2-pyrrolidone (NMP) under microwave irradiation at 250 ºC for 15 min allowed 
formation of the 2-chloropyridine 123 (36%). Chloride 123 was quantitatively reduced 
(>95%) into the desired unsubstituted pyridine (+)-124 with a mixture of 10% Pd/C and 
formic acid in boiling DMF. Since the reduction of 2-chloropyridine 123 by Pd/C and formic 
acid proved to be efficient, the same conditions were applied to triflate (+)-122, however it 
was not successful. 
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Scheme 41. Synthesis of the chiral pinene-pyridine (+)-124 
 
Convinced that triflate (+)-122 was a useful substrate for homogeneous palladium catalysis, 
we decided to investigate its reactivity further (Table 8). The use of a mixture of 
palladium(II) acetate, potassium fluoride and polymethylhydrosiloxane (PMHS) was reported 
to dehalogenate a wide range of chloropyridines.120 We decided to try those conditions, using 
triflate (+)-122 as substrate (entry 1). To our delight, the desired pyridine (+)-124 was 
obtained with 50% conversion. Encouraged by the latter result, we replaced PMHS by a more 
classical hydrogen donor such as formic acid. However, no reaction occurred in boiling THF 
(entry 2). On the other hand, the simple change of solvent, from THF to the higher boiling 
DMF (entry 3), allowed the formation of the desired pyridine (+)-124 (50% conversion) 
accompanied by the formation of pyridone (+)-121 (30% conversion). The addition of 1,1’-
bis(diphenylphosphino)ferrocene (dppf) (4 mol%) as a ligand for palladium(II) acetate (2 
mol%) (entry 4) allowed complete conversion and isolation in reasonable yield (65%) of the 
desired unsubstituted pyridine (+)-124. 
Scheme 42. Investigation of the transformation of triflate (+)-122 into the pyridine (+)-124 
N OTf
'Pd'
N
(+)-122 (+)-124  
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Table 8. Investigation of the transformation of triflate (+)-122 into the pyridine (+)-124 (Scheme 42) 
entry Reagents Solvent, T 
Conv. of 
(+)-124a 
Conv. of 
(+)-121a 
1 Pd(OAc)2 – 5mol% 
KF – 2equiv 
PMHS – 4equiv 
THF, rt 50% - 
2 Pd(OAc)2 – 5mol% 
HCO2H – 2equiv 
THF, reflux - - 
3 Pd(OAc)2 – 5mol% 
HCO2H – 2equiv 
DMF, reflux 50% 30% 
4 Pd(OAc)2 – 2mol% 
dppf – 4mol% 
HCO2H – 2equiv 
Et3N – 3equiv 
DMF, 60°C 100% - 
aDetermined by 1H-NMR. 
Finally, the introduction of the borane-protected diphenylphosphine unit was accomplished as 
described previously. Chiral pyridine (+)-124 was deprotonated with n-BuLi at -40 °C, 
followed by reaction with the freshly prepared ClPPh2.BH3 to afford the desired borane-
protected pyridine-phosphine (+)-125 in a reasonable yield (42%) (Scheme 43). 
Scheme 43. Formation of the borane-protected pyridine-phosphine (+)-125 
 
 
3.3 Preliminary Results for the Baeyer-Villiger Oxidation 
Our preliminary investigation focused on the Baeyer-Villiger oxidation of prochiral 3-
phenylcyclobutanone 128a with urea-hydrogen peroxide (UHP) catalysed by a complex of 
palladium(II) chelated to the first generation of terpene-derived P,N-ligands (Scheme 44). 
The results were rather disappointing as none of the catalysts allowed the formation of the 
desired phenyl-γ-butyrolactone 129a. We assumed that the lack of reactivity observed was 
due to the presence of BH3.Et2NH adduct, resulting from the deprotection step, which reduces 
palladium(II) into palladium(0), preventing the reaction to proceed further. This assumption 
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is in agreement with the experimental observation of immediate formation of a black 
precipitate after addition of the palladium(II) precatalyst to the freshly deprotected ligand 
solution in THF. In fact, formation of black palladium as a result to complexation of 
palladium(II) with borane-deprotected phosphines has already been reported in the 
literature.121 After numerous unsuccessful attempts to purify the free phosphine from the 
BH3.Et2NH adduct, we decided to develop a second generation of P,N-ligands which would 
not require any borane-protection. 
Scheme 44. BVO of cyclobutanone 128a with UHP catalysed by Pd(II)-P,N-ligand complexes 
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3.4 Synthesis of the Second Generation of P,N-Ligands 
3.4.1 Target Ligands 
The new generation of P,N-ligands (Chart 13) was designed based on the idea that 
triarylphosphines are usually more stable than their diaryl analogues. Our experience of the 
Kröhnke annulation allows us to prepare a variety of chiral 2-arylpyridines, which can serve 
as points of entry for the phosphine unit. The chiral environment can be controlled by placing 
various alkyl groups at the “benzylic” position of the pinene fragment. 
Chart 13. Targeted 2nd generation of P,N-ligands 
N
(+)-41a
N
(-)-41c
N
(+)-41b
Ph2P Ph2P Ph2P
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3.4.2 Ligand Synthesis 
Chiral pyridine-phosphines 41a-c were prepared as shown in Scheme 45. Pinocarvone (–)-16 
reacted with pyridinium salt 43 derived from 2-fluoroacetophenone 42 to afford the desired 
chiral fluoro-pyridine (+)-44a via Kröhnke annulation in good yield (67%). Deprotonation of 
(+)-44a at the benzylic position with n-BuLi at -40 °C, followed by alkylation with either 
MeI or i-PrI gave (+)-44b and (+)-44c, respectively. Finally, aromatic nucleophilic 
substitution of 44a-c with diphenylphosphine anion122 (generated in situ from HPPh2, t-
BuOK and 18-crown-6) led to the formation of the desired chiral pyridine-phosphines 41a-c 
in 42%, 50% and 52% yield, respectively.  
Scheme 45. Synthesis of chiral pyridine-phosphines 41a-c 
 
While the synthesis of (+)-41a was straightforward, the preparation of (+)-41b and (–)-41c 
was complicated by the difficulties associated with isolation of the pure product from the 
crude mixture. Since phosphines (+)-41b and (–)-41c could not be fully separated from the 
unreacted respective fluorides (+)-44b and (+)-44c and traces of Ph2PH, the crude mixture 
was oxidized (H2O2, Me2CO, rt, 10 min) to convert the phosphines into the corresponding 
phosphine oxides, which were then readily separated from the fluorides (+)-44b and (+)-44c 
by column chromatography. However, the phosphine oxides were still contaminated by 
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Ph2P(O)H, generated from Ph2PH. Therefore, the mixture was treated with KOH in ethanol 
(reflux, 4 h), which generated the water-soluble Ph2PO2K,123 whose separation from the 
respective phosphine oxides was carried out by partitioning between the aqueous and organic 
phase. The pure phosphine oxides were then reduced with Cl3SiH (Et3N, toluene, reflux, 24 
h) to afford the respective phosphines (+)-41b and (–)-41c. The yields (50 and 52%, 
respectively) correspond to the overall procedure. 
 
3.5 Application of Triarylphosphine Ligands in Baeyer-Villiger 
Oxidation 
The results employing the second generation of ligands are shown in Scheme 46. The pre-
catalysts for the oxidation were generated in situ from (PhCN)2PdCl2 and the respective 
ligand (41a-c) in THF at room temperature. Each of the resulting complexes was then treated 
with AgSbF6 and the insoluble AgCl was removed by filtration. The solution of the catalyst 
thus generated, i.e., (Ligand)Pd(SbF6)2, was used in the individual oxidation reactions.  
 
Compounds 41a-c, being triarylphosphines, are relatively more stable than the 
diarylphosphines 108-110 and do not require borane protection. As a result, they were 
expected to achieve higher level of reactivity compared to the first generation of ligands. We 
were therefore pleased to note that full conversion of γ-butyrolactone 129a was achieved with 
all three ligands of the second generation. Furthermore, it is clear from Scheme 46 that the 
bulk of the ligand plays a dramatic role in the enantiocontrol of the reaction. In the absence of 
a substituent at the benzylic position (ligand 41a), the resulting γ-butyrolactone 127a was 
nearly racemic (4% ee). The enantioselectivity of the reaction was slightly improved (17% 
ee) when a methyl group was incorporated into the ligand (ligand 41b). Finally, replacement 
of the methyl group by a bulkier isopropyl substituent (ligand 41c) significantly increased the 
enantioselectivity (64% ee).  
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Scheme 46. BVO of cyclobutanone 128a with UHP catalysed by Pd(II)-P,N-ligand complexes  
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3.5.1 Solvent Effect 
Employing our most efficient ligand, the isopropyl-substituted phosphino-pyridine 41c, we 
investigated the effect of the solvent on the reactivity and enantioselectivity of the BVO 
(Scheme 47). The results obtained are shown in Table 9. In short, replacing THF with other 
solvent proved to be detrimental to enantioselectivity. In non-coordinating solvents, such as 
toluene (entry 1), the reaction did not occur. Dichloromethane (entry 2) gave full conversion 
but with moderate enantioselectivity. Finally coordinating solvent, such as acetonitrile and 
THF (entries 3 & 4), gave full conversion, THF exhibiting the highest enantioselectivity 
(64% ee). 
Scheme 47. Solvent effect 
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Table 9. Solvent screening (Scheme 47) 
Entry Solvent Conversion (%)a ee (%)a 
1 Toluene No N.D. 
2 DCM Full 36 (S) 
3 CH3CN 98 46 (S) 
4 THF Full 64 (S) 
aDetermined by chiral GC (Supelco α-DEX); N.D.=Not determined. 
 
3.5.2 Low Temperature Experiments 
In an attempt to increase enantioselectivity of the oxidation, we have investigated the reaction 
in THF at low temperatures (Scheme 48). Lowering the temperature had a beneficial effect 
on the enantioselectivity (Table 10). A considerable increase of enantioselectivity (to 81% 
ee) was observed when the reaction was carried out at -40 °C (entry 2). However, below that 
temperature (entry 3), the reactivity was dramatically reduced due to precipitation of the 
catalyst from the solution. 
Scheme 48. Low temperature experiments 
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Table 10. Low temperature experiments (Scheme 48) 
Entry Temperature (°C) Conversion (%)a ee (%)a 
1 RT Full 64 (S) 
2 -40 Full 81 (S) 
3 -80 11b N.D. 
aDetermined by chiral GC (Supelco α-DEX). bAfter 4 days of reaction. N.D.=Not determined. 
 
3.5.3 Substrate Scope 
With the aim of establishing the scope of the BVO, the required cyclobutanones 128a-j were 
synthesised in two steps via cyclisation of dichloro ketene (generated in situ from 
Chapter 3. Synthesis and Application of Pinene-Derivative Pyridines I 63 
 
trichloroacetyl chloride, Zn-Cu couple, and POCl3) and the vinyl derivative 126a-j, followed 
by reduction of the resulting dichloro ketones 127a-j with zinc in acetic acid (Scheme 49).124 
Most of the cyclobutanones 128a-j were obtained in good yields. However, we failed to 
prepare p-methoxy-phenylcyclobutanone due to the polymerisation of the starting p-methoxy 
styrene under the reaction conditions. It is interesting to note that Imada57 reported the use of 
p-methoxy-phenylcyclobutanone for his BVO study. However, after contacting Imada, it 
appeared that p-methoxy-phenylcyclobutanone was obtained in very poor yield (0.1%) and 
large scale distillation was necessary to purify it (100 mol scale reaction). 
Scheme 49. Synthesis of 3-substituted cyclobutanones 128a-j 
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The reactivity of cyclobutanones 128a-j was then investigated under the optimised conditions 
(THF, –40 °C, (–)-41c as ligand) (Scheme 50). The results are shown in Table 11. All γ-
butyrolactones 129a-j were obtained in high yield. Variation of the substitution pattern in the 
4-position of the cyclobutanone (128b-j) led to reduction in enantioselectivity to 70-75% ee 
for the aromatics with electron-withdrawing or neutral groups 128b-g (entries 2-7) and to 
58% ee for the p-methoxybenzyl derivative 128h (entry 8). Asymmetric induction observed 
for the cyclohexyl derivative 128i was in the midrange (entry 9), whereas n-octyl-
cyclobutanone 128j leaned toward the lower end of the spectrum (entry 10). 
Scheme 50. Substrate investigation 
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Table 11. Substrate investigation (Scheme 50) 
entry Ketone  R Yield (%) 129 % eea 
1 128a C6H5 97 81 (S)b 
2 128b 4-Me-C6H5 93 75 (S)b 
3 128c 4-F-C6H5 96 72 (+)b 
4 128d 4-Cl-C6H5 94 73 (S)b 
5 128e 4-Br-C6H5 95 76 (+)c 
6 128f 2-Br-C6H5 92 70 (+)c 
7 128g 2-Naphth 83 71 (+)c 
8 128h 4-MeO-C6H4CH2 91 58 (R)d,e 
9 128i Cyclohexyl 89 65 (–)c 
10 128j n-Octyl 83 55 (R)c 
aThe absolute configuration was established from the optical rotation (measured in CHCl3) by comparison with 
the literature data (see the Experimental). Lactones 129a, 129b, and 129d were (S)-configured; the configuration 
of 129c and 129e-g is assumed to be (S) in analogy with the rest of the series. bDetermined by chiral GC. 
cDetermined by chiral HPLC (Chiralpak IB) after conversion into the corresponding hydroxy benzylamide 
derivative.64 dDetermined by optical rotation.125 eNote the change in the substituent priorities in the Cahn-Ingold-
Prelog system.  
 
Our study indicates that the enantioselectivity of the oxidation is not only dependent on the 
steric size of the alkyl group in the benzylic position of the P,N-ligand but also on the nature 
of the substituent in the cyclobutanone ring.  
 
3.5.4 Mode of Action 
Based on our experimental data, we can tentatively rationalise the high selectivity of the 
ligand (–)-41c. P,N-chelation of palladium by ligand (–)-41c and treatment with AgSbF6 
generates the palladium complex 130 with two vacant coordination sites (Scheme 51). 
Subsequent coordination of the carbonyl group and hydrogen peroxide (131) can be assumed 
to activate the keto group towards intramolecular nucleophilic attack of the peroxide moiety, 
generating the Criegee adduct 132. Finally, the C-C bond antiperiplanar to the O-O bond 
migrates to give the lactone and regenerates the active palladium species 130.  
Chapter 3. Synthesis and Application of Pinene-Derivative Pyridines I 65 
 
Scheme 51. Possible mechanism of Pd(II)-catalysed BVO of cyclobutanone 
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However, it is important to note that several factors have to be controlled along the catalytic 
cycle to reach high enantioselectivity. First, depending on the nature of the coordination, two 
intermediates 131a and 131b can be generated (Scheme 52). The electronic asymmetry of the 
P,N-ligand will presumably determines the mode of coordination. The oxygen atom of 
hydrogen peroxide, being electronically richer than the oxygen atom of the carbonyl group, is 
expected to coordinate trans to the phosphine moiety, leading to 131a as favoured 
intermediate.  
Scheme 52. Electronic control 
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Once the intramolecular nucleophilic attack has occurred, the spacial arrangement of the 
Criegee intermediate 132 and its subsequent rearrangement is supposed to be dictated by the 
chiral environment generated by the ligand. As shown in Figure 11, the presence of the i-
propyl group at the benzylic position of the ligand 41c, relatively close to the metal centre, 
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can influence the configuration of the Criegee adduct 132c and therefore the absolute 
configuration of the product.   
Figure 11. Possible mode of action 
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3.6 Application of the New P,N-Ligands in the Iridium-Catalysed 
Hydrogenation 
With the aim of extending the scope of application of our chiral P,N-ligands family, the 
asymmetric iridium-catalysed hydrogenation of unfunctionalised olefins was investigated.  
 
3.6.1 Iridium Catalysts Synthesis 
The ligands 109 and 41a-c were complexed to iridium metal according to the standard 
protocol. The pyridine-phosphines were first refluxed in CH2Cl2 in the presence of 
[Ir(COD)Cl]2 dimer, and subsequently treated with NaBArF to afford the air and moisture 
stable chiral iridium complexes 133a-d (Scheme 53). All iridium catalysts were easily 
purified by flash column chromatography and isolated in moderate yield (≤ 58%). However, 
we failed to prepare catalysts based on pyridine-phosphines 108 and 110.  
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Scheme 53. Iridium catalysts preparation 
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The single crystal X-ray structure of the cationic iridium complex (+)-133b is shown in 
Figure 12.126 Single-crystals of complex (+)-133b were obtained from a mixture of hexane 
and diethyl ether (1:1) at low temperature (0 °C). The structure is depicted without the BArF 
anion. Hydrogen atoms were also omitted for clarity. 
Figure 12. X-ray structure of iridium complex (+)-133b 
 
 
3.6.2 Application of Iridium Catalysts 
3.6.2.1 Hydrogenation of trans-α-Methylstilbene 78  
Iridium complexes 133a-d were first evaluated as catalysts for asymmetric hydrogenation of 
the unfunctionalised trans-α-methylstilbene 78 under 10 bar hydrogen pressure (Scheme 54). 
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The reactions were performed at room temperature over two days with 2 mol% catalyst 
loading. The results are shown in Table 12. Structure of the catalyst proved to have a great 
influence on the reactivity and enantioselectivity of the reaction.  
Scheme 54. Hydrogenation of trans-α-methylstilbene 78 
 
Table 12. Hydrogenation of trans-α-methylstilbene 78 (see Scheme 54 for exp. cond.) 
Entry Catalyst Conversion (%)a % eeb 
1 99 99 99 
2 133e 11 41 (R)c 
3 133a 30 12 (S)c 
4 133a 50 80 (S)d 
5 133b 96 21 (R)d 
6 133c 7 N.D. 
7 133d No conversion N.D. 
aDetermined by 1H NMR. bDetermined by chiral HPLC (OJ-H, 0.5 mL.min-1, 99:1 (Hexane:iPrOH)). cReaction 
carried out with 0.5 mol% catalyst loading under 30 bar hydrogen pressure.127 dAbsolute configurations were 
assigned by comparison of the HPLC retention times with literature values.81 N.D.=Not determined.  
 
Chart 14. Reported catalyst analogues to 133a 
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Iridium catalyst 133a resembles the tertahydroquinoline-based phosphinite-iridium complex 
99 recently developed by Pfaltz and co-workers (Chart 14). Since catalyst 99 (entry 1) 
exhibited high reactivity (99% conversion) and enantioselectivity (99% ee),96 complex 133a 
was expected to be an effective catalyst for hydrogenation. However, the results were clearly 
not comparable. Catalyst 133a showed only moderate reactivity (50% conversion) and good 
enantioselectivity (80% ee). Andersson reported recently the synthesis of complex 133a and 
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its diastereoisomer 133e (Chart 14) and their application in asymmetric hydrogenation of 
olefins.127 The hydrogenation was performed under 30 bar hydrogen pressure and 0.5 mol% 
catalyst loading. First, 133e (entry 2 and 3) proved to be less effective but more selective than 
133a. But more interestingly, 133a seemed to be a more reactive and selective catalyst (entry 
3 and 4) under our experimental conditions (10 bar of hydrogen pressure with 2 mol% 
catalyst loading), clearly showing that slight modifications of the catalyst structure or of the 
reaction conditions can have a big influence on the outcome of the hydrogenation.  
The second generation of catalysts 133b-d also exhibited a high dependence on the catalyst 
structure. Complex 133b showed high reactivity (entry 5); however, its benzylic substituted 
analogues 133c-d did not prove to be effective catalysts (entry 6 and 7). 
 
3.6.2.2 Hydrogenation of Ethyl trans-β-Methylcinnamate 85 
Iridium complexes 133a-d were then tested as catalysts for asymmetric hydrogenation of 
ethyl trans-β-methylcinnamate 85 under 10 bar hydrogen pressure and 2 mol% catalyst 
loading (Scheme 55).  The results are shown in Table 13. 
Scheme 55. Hydrogenation of Ethyl trans-β-methylcinnamate 85 
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Table 13. Hydrogenation of ethyl trans-β-methylcinnamate 85 (see Scheme 55 for exp. cond.) 
Entry Catalyst Conversion (%)a e.e. (%)b 
1 133e 10 16 (S)c 
2 133a 15 9 (S)c 
3 133a 15 N.D. 
4 133b >99 20 (S)d 
5 133c >99 83 (S)d 
6 133d >99 57 (S)d 
aDetermined by 1H NMR. bDetermined by chiral HPLC (IB, 0.75 mL.min-1, 99:1 (Hexane:iPrOH)). cReaction 
carried out with 0.5 mol% catalyst loading under 30 bar hydrogen pressure.127 dAbsolute configuration obtained 
from optical rotation and comparison with literature data.128 N.D.=Not determined. 
 
Iridium catalysts based on the chiral pyridine-phosphinite (133a and 133e) showed very low 
reactivity (entries 1-3). However, the second generation of iridium catalysts 133b-d were 
more suitable for this type of substrate. High level of reactivity was achieved for the three 
catalysts (full conversion) and the enantioselectivity was clearly controlled by the steric 
hindrance generated by the alkyl groups in the benzylic position of the ligand (entries 4-6). 
The enantiomeric excess varied from 20% (ligand with no substituent 41a, entry 4) to 83% 
(methyl-substituted ligand 41b, entry 5). Unfortunately, the i-propyl substituted ligand 41c 
did not improve the enantioselectivity (57% ee, entry 6). 
 
3.6.2.3 Hydrogenation of Arylimine 136 
Although, iridium-catalysed hydrogenation of unfunctionalised olefins has been extensively 
studied over the last decade, the iridium-catalysed hydrogenation of imines was only scarcely 
evaluated.129 We therefore decided to apply our chiral iridium catalysts 133a-d for the 
asymmetric hydrogenation of arylimine 136 under 10 bar hydrogen pressure (Scheme 56). 
Arylimine 136 is sterically very similar to trans-α-methylstilbene 78. It is therefore not 
surprising that comparable results were obtained (Table 14).  Iridium complex 133a 
exhibited the best results of the whole catalysts family (entry 1) with full conversion and 
moderate enantioselectivity (48% ee).  Reactivity of the second generation of catalysts   
133b-d was, as previously observed, very sensitive to the steric bulk of the substituent at the 
benzylic position in the ligand. Complex 133b with unsubstituted ligand afforded full 
conversion into the hydrogenated product but as a racemate (entry 2), whereas the reactivity 
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quickly diminished for the substituted analogues (Me, 31% conversion, entry 3. i-Pr, 6% 
conversion, entry 4).  
Scheme 56. Hydrogenation of arylimine 136 
 
Table 14. Hydrogenation of arylimine 136 (see Scheme 56 for exp. cond.) 
Entry Catalyst Conversion (%)a e.e. (%)b 
1 133a >99 48 (S)c 
2 133b >99 0c 
3 133c 31 32 (S)c 
4 133d 6 N.D. 
aDetermined by 1H NMR. bDetermined by chiral HPLC (IB, 0.75 mL.min-1, 99:1 (Hexane:iPrOH)). cAbsolute 
configurations were assigned by comparison of the HPLC retention times with literature values.130 N.D.=Not 
determined. 
 
3.7 Summary 
Two generations of chiral P,N-ligands have been developed. The first generation, containing 
chiral phosphine moiety, had to be synthesised via borane protection due to their high oxygen 
sensitivity. The second generation was based on the more stable triarylphosphines. The chiral 
environment was then controlled by the size of the alkyl substituent in the benzylic position 
of the pyridine fragment. 
Chiral pyridine-phosphines of the second generation can act as efficient P,N-ligands for the 
enantioselective palladium(II)-catalysed Baeyer-Villiger oxidation of prochiral 3-substituted 
cyclobutanones to furnish chiral γ-butyrolactones in up to 81% ee. As well as the ligand 
structure, the enantioselectivity of the oxidation is dependent on the reaction temperature, 
solvent and the substrate structure. High enantioselectivity was observed for cyclobutanones 
with aromatic substituent, the optimal conditions were identifies as –40 °C in THF. 
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Complexes of the developed ligands with iridium can also promote asymmetric 
hydrogenation of olefins and imines. Hydrogenation has been shown to be very sensitive to 
the ligand structure, the experimental conditions, as well as to the olefin structure. Chiral 
pyridine-phosphines of second generation have proved to be particularly suitable for the 
enantioselective hydrogenation of ethyl trans-β-methylcinnamate in up to 83% ee.  
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4 Organocatalysis – Activation of Silicon with Lewis 
Bases 
4.1 Introduction 
Due to some drawbacks inherent to transition metals such as their cost, toxicity and the 
difficulty to remove their traces from the desired product, pharmaceutical companies try to 
avoid metal-based catalysts. Recently, considerable attention has become focused on the 
development of metal-free asymmetric protocols promoted by simple chiral small molecules. 
Over the past five years, organocatalysis has undergone an exponential development. Many 
enantioselective transformations can now be catalysed without metal.6,7  
Transition metal complexes translate chirality from the ligands coordinated to the metal 
centre to the newly formed stereogenic atom or group of atoms via organised transition states, 
resulting from a strong association between the metal centre and the reactants. 
Organocatalytic mechanisms often take advantage of weaker interactions such as hydrogen-
bonding and arene-arene interactions, as well as covalent interactions to activate and bring 
substrates together in an organised fashion as required for asymmetric induction. A wide 
array of organic molecules ranging from natural product derived organic bases to synthetic 
Brønsted acids has been employed as organocatalysts.6,7  
The enantioselective metal-free Lewis base catalysis131 of reactions mediated by silicon 
reagents has been pioneered by the groups of Denmark and Kobayashi, as well as our own 
group, and represents a powerful tool in asymmetric catalysis.132 In this chapter, 
organocatalytic allylation based on the activation of allyltrichlorosilane with chiral Lewis 
bases catalysts will be reviewed. 
 
4.2 Activation of Silicon Reagents 
One of the most striking differences between carbon and silicon is the ability of the latter to 
expand its coordination shell. Strong Lewis bases such as DMF and HMPA are capable of 
generating neutral hypervalent silanes that possess enhanced nucleophilicity at the peripheral 
groups (X) (a consequence of the changes in the electron distribution caused by the formation 
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of hypervalent bonds) (Figure 13) and an increase of the positive charge on silicon, thus 
providing opportunities for the development of new reactions via double activation 
(nucleophilic and electrophilic).133 This enhanced polarisation of hypervalent silicon species 
is the central point to the development of enantioselective organocatalytic transformations 
employing silicon reagents such as allylation of aromatic aldehydes with allyltrichlorosilane.  
Figure 13. Formation of hypervalent silicon species 
 
 
4.3 Allylation of Carbonyl Groups 
Asymmetric allylation of carbonyl compounds is a useful synthetic method to prepare 
optically active secondary homoallylic alcohols. It has been employed as a key-step in the 
synthesis of numerous natural products.134 The most common strategies to accomplish 
stereoselective introduction of an allyl group is the use of allylic organometallic reagents in 
which the metal is ligated by chiral modifiers. Excellent results have been obtained with 
chirally modified allylic borane or allylic titanium reagents,135 but they required a 
stoichiometric amount of chiral controller group or chiral ligand. 
More recently, allylic stannanes and allylic silanes extended the field toward catalytic 
processes.132a Allylation can be divided into three categories that reflect the stereochemical 
outcome of the reaction:136 
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Type 1: reactions wherein the syn/anti (Scheme 57) ratio reflects the (E/Z) ratio of the 
starting allylmetal; 
Type 2: reactions wherein the product is predominantly syn, independent of the geometry of 
the allylmetal; 
Type 3: reactions wherein the product is predominantly anti, independent of the geometry of 
the allylmetal. 
Scheme 57. Allylation reaction 
 
The type 1 includes the addition of allylic trichlorosilanes catalysed by chiral Lewis bases, 
the type 2 reflects the addition of allylmetals (Si, Sn, B) catalysed by chiral Lewis acids and 
the type 3 relates more to the addition of allylmetals (Cr, Zn, In) generated in situ from the 
corresponding allylic halides catalysed by chelating ligands. In this review we only 
concentrate on the type 1 transformations. 
 
4.3.1 Generality Concerning Lewis Base-Promoted Allylation 
The allylation of aldehydes with allyltrialkyl silanes in the presence of chiral Lewis acids 
(Sakurai-Hosomi reaction) (type 2) made a considerable impact on asymmetric synthesis.137 
The complementary activation with chiral Lewis bases is less common but offers high 
diastereo- and enantiocontrol that can be explained by a different reaction mechanism 
compared to the one operating in the Lewis acids activation. 
The Lewis base (LB) first coordinates to the silicon atom (Scheme 58). The resulting 
complex possesses a highly electrophilic silicon atom allowing coordination and therefore 
activation of the aldehyde. The enhanced nucleophilicity of the allyl fragment (due to the 
hypervalency of the silicon species) permits reaction with the activated aldehyde through a 
closed chair-like transition structure. Finally, the dissociation of the LB from the product 
completes the catalytic cycle.  
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Scheme 58. Lewis base-promoted allylation mechanism 
LB
(Lewis Base)
SiCl3R1
R2
SiCl3R1
R2
LB
R
O
H
O
SiCl3
R1
LB
R2
H
R
R
O
SiCl3
LB
R2 R1
H20R
OH
R2 R1
 
LB-activation of allyltrichlorosilane was pioneered by Kobayashi138 by the use of 
dimethylformamide. However, the first asymmetric allylation reaction was carried out by 
Denmark, in 1994, by employing a chiral phosphoramide (R,R)-138 as a chiral Lewis base 
promoter (Scheme 59 & Table 15).139 Using either a stoichiometric amount or 10 mol % of  
the activator (R,R)-138, addition of allyltrichlorosilane 139 to benzaldehyde provided the 
homoallylic alcohol with modest enantioselectivity (from 53 to 66% ee) in good chemical 
yield (entries 1 & 4). However, it is important to note that the geometry of C=C double bond 
in the starting allylsilanes is completely transferred into the product anti/syn ratio (entries 2 
and 3).  
Scheme 59. Addition of allylic trichlorosilanes to benzaldehyde promoted by (R,R)-138 
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Table 15. Addition of allylic trichlorosilanes to benzaldehyde promoted by (R,R)-138 (Scheme 59) 
entry Silane (R,R)-138 (equiv) Yield (%) anti/syn ee (%) 
1 139 1.0 80 - 60 (R) 
2 (E)-140 1.0 68 98/2 66 (R,R) 
3 (Z)-140 1.0 72 2/98 60 (R,S) 
4 139 0.1 40 - 53 (R) 
Since then, three major categories of chiral Lewis basic activators of allyl trichlorosilanes and 
related reagents dominated the field: phosphoramides, formamides, and more recently N-
oxides. 
 
4.3.2 Chiral Phosphoramide-Catalysed Allylation Reaction 
In 1996, Iseki reported an improvement in enantioselectivity when phosphoramides derived 
from (S)-proline (143-145) were employed (Scheme 60).140 The results are detailed in Table 
16. The loading of the chiral Lewis base had a considerable influence on the conversions. A 
reduction in loading from 1 equivalent to 10 mol% of the Lewis base dramatically slowed 
down the reaction (entries 1 & 4). On the other hand, the enantioselectivity of the allylation 
seemed to be controlled by the configuration of the phosphorus atom and the substituents on 
the nitrogen (entries 1-3).  
 
Scheme 60. Addition of allylic trichlorosilanes to benzaldehyde promoted by 143-145 
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Table 16. Addition of allylic trichlorosilanes to benzaldehyde promoted by 143-145 (Scheme 60) 
entry LB* Loading (equiv) Time (h) Yield (%) ee (%) 
1 143 1.0 6 74 71 (R) 
2 144 1.0 6 5 29 (R) 
3 145 1.0 6 84 85 (S) 
4 143 0.1 168 67 85 (R) 
 
Extensive mechanistic study carried out by Denmark revealed that the reaction was second 
order in phosphoramide catalyst.141 This led to the design of bisphosphoramides 146a-c with 
varying tether length (Scheme 61).142 The results are shown in Table 17. The optimal length 
of the spacer between the two phosphoramide units was found to be five carbon atoms (entry 
2). Catalyst 146b allowed high reactivity (85% yield) and enantioselectivity (87% ee). The 
addition of crotylsilanes catalysed by 146b again was found to be highly diastereoselective 
(entries 4 & 5), the enantioselectivity remaining very high (up to 94% ee). Under optimised 
conditions, N,N-diisopropylethylamine was employed as an additive. Hünig’s base was 
reported to dramatically enhance the reactivity of the allylation reaction and it was postulated 
that the additive could increase the rate of catalyst turnover by facilitating cleavage of the 
catalyst-silicon bond.143 
 
Scheme 61. Addition of allylic trichlorosilanes to benzaldehyde promoted by bisphosphoramides 148 
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Table 17. Addition of allylic trichlorosilanes to benzaldehyde promoted by bisphosphoramides 148 
              (Scheme 61) 
 entry LB* Silane Yield (%) anti/syn ee (%) 
1 148a 139 54 - 18 (S) 
2 148b 139 85 - 87 (S) 
3 148c 139 58 - 67 (S) 
4 148b (E)-140 57 99/1 80 (S,S) 
5 148b (Z)-140 89 1/99 94 (S,R) 
 
4.3.3 Chiral Formamide-Catalysed Allylation Reaction 
Following on the original observation by Kobayashi that DMF (as solvent) promoted the 
allylation of aldehydes with allyltrichlorosilane; Iseki introduced a “chiral version” of DMF 
(Scheme 62).144 The results are shown in Table 18. In the presence of one equivalent of 
chiral formamide (S,S)-149 (entry 1), allylation of cyclohexanecarboxaldehyde with 
allyltrichlorosilane after 7 days at -78 °C afforded the corresponding homoallylic alcohol in 
good yield (81%) and reasonable ee (68%). However, if the chiral promoter was used in 
substoichiometric amount (entry 2), both reactivity and enantioselectivity dropped. 
According to the mechanistic insight reported by Denmark, coordination of two molecules of 
the Lewis base to the silicon atom is probably needed. Use of hexamethyl phosphoramide 
(HMPA) (1.0 equiv) as an additive was therefore found to be beneficial for the 
enantioselectivity (entry 3 & 4). Unfortunately, HMPA also catalysed non-chiral background 
reaction leading to poor enantioselectivity when aromatic aldehydes were used (entry 5). The 
addition of crotylsilanes to cyclohexylcarboxaldehyde catalysed by (S,S)-149 was again 
found to be highly diastereoselective (entries 6 & 7). 
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Scheme 62. Addition of allylic trichlorosilanes to aldehydes promoted by chiral formamide (S,S)-149 
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Table 18. Addition of allylic trichlorosilanes to aldehydes promoted by chiral formamide (S,S)-149  
              (Scheme 62) 
entry LB* (equiv) R Silane HMPA (equiv) anti/syn Yield (%) ee (%) 
1 1.0 Cy 139 - - 81 68 (R) 
2 0.1 Cy 139 - - 12 32 (S) 
3 1.0 Cy 139 1.0 - 89 96 (R) 
4 0.2 Cy 139 1.0 - 34 94 (R) 
5 0.2 Ph 139 1.0 - 94 8 (R) 
6 0.4 Cy (E)-140 2.0 99/1 92 98 (S,R) 
7 0.4 Cy (Z)-140 2.0 5/95 34 3 (R,R) 
 
4.3.4 Chiral Pyridine-N-Oxide-Catalysed Allylation Reaction 
Pyridine-N-oxides were shown to be highly effective Lewis base catalysts for the allylation of 
aromatic aldehydes with allyltrichlorosilane. In 1998, Nakajima reported on the use of 
bisquinoline-N,N’-dioxide (S)-150 as a chiral promoter for this reaction (Scheme 63).143 High 
level of reactivity and enantioselectivity were obtained (Table 19). The allylation reaction 
was very fast even at -78 °C (85% yield in 6 h) with only 10 mol % of the axially chiral 
catalyst 150 (entry 1).  
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Scheme 63. Addition of allyltrichlorosilane to benzaldehyde promoted by chiral N-oxides 150-151 
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Table 19. Addition of allyltrichlorosilane to benzaldehyde promoted by chiral N-oxides 150-151 
               (Scheme 63) 
entry LB* (mol%) Solvent T (°C) Time (h) Yield (%) ee (%) 
1 150 (10) CH2Cl2 -78 6 85 88 (R) 
2 151 (1) CH3CN -45 0.25 96 94 (S) 
3 151 (0.1) CH3CN -45 2.5 96 94 (S) 
4 151 (0.01) CH3CN -45 12 68 94 (S) 
In 2002, Hayashi described a very reactive bis-N-oxide 151.145 Homoallylic alcohols were 
obtained in high yield and enantioselectivity (up to 94% ee) even with as low as 0.01 mol % 
catalyst loading (entry 2-4). The enantioselectivity was found highly dependent on the 
electronic nature of the aromatic aldehyde, suggesting participation of π-π interactions. 
Electron-rich aldehydes afforded enantiomeric excess up to 94% whereas electron-poor 
aldehydes gave only 56% ee.  
Prior to Hayashi’s report, Malkov and Kočovský developed bipyridine- N,N’-dioxide 152 
derived from β-pinene (Scheme 64).146 Although 152 afforded the homoallylic alcohol in low 
yield (18%) and modest enantiomeric excess (41% ee), the corresponding monoxide 
PINDOX 153a was more reactive and enantioselective (78% yield, 90% ee). Me2PINDOX 
153b, combining both central an axial chirality, showed even higher enantioselectivity (up to 
98% ee). Mechanistic analysis suggested that while the N-oxide unit activates the 
trichlorosilyl functionality, the role of other nitrogen atom in stabilising the closed, chair-like 
transition state was less clear. As a further extension of this family of catalysts, Malkov and 
Kočovský reported new bipyridine-N-monoxides derived from α-pinene (Scheme 64). Due to 
extreme steric hindrance, iso-PINDOX 154 showed a reduction in the reaction rate; however, 
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a high level of enantioselectivity was still obtained (96% ee).146 Interestingly, monopyridine 
N-oxide METHOX 45,30b lacking the second pyridine ring, still allowed formation of the 
homoallylic alcohol in high yield (95%) and enantioselectivity (96% ee), suggesting that 
coordination to nitrogen in 153 and 154 may not play an important role. Instead, arene-arene 
interactions between the catalyst and the substrate have been suggested to account for the 
high reactivity and selectivity. 
 
Scheme 64. Addition of allyltrichlorosilane to benzaldehyde promoted by chiral N-oxides 45 and  
152-154 
 
Malkov and Kočovský have also reported that quinoline-N-oxide QUINOX 155 catalysed the 
enantioselective allylation of aromatic and heteroaromatic aldehydes (Scheme 65).147 The 
results are shown in Table 20. Although all the homoallylic alcohols were obtained in 
reasonable yields, their enantiopurity strongly depended on their electronic character; 
electron poor aldehydes exhibiting high level of enantioselectivity (entries 5 & 6) compared 
to electron rich aldehydes (entries 2-4). This effect was attributed to the enhanced π-π 
interactions between the catalyst and the incoming electron poor aldehyde.147 
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Scheme 65. Addition of allyltrichlorosilane to aromatic aldehydes promoted by QUINOX 155 
 
Table 20. Addition of allyltrichlorosilane to aromatic aldehydes promoted by QUINOX 155 
               (Scheme 65) 
entry Ar Yield (%) ee (%) 
1 Ph 60 87 (R) 
2 4-MeO-C6H4 70 16 (R) 
3 2-Furyl 68 5 (R) 
4 2-Thiophenyl 59 6 (R) 
5 4-NO2-C6H4 73 89 (R) 
6 4-CF3-C6H4 85 96 (R) 
 
Terpyridine tri-N-oxides have also been reported to catalyse the allylation of aromatic 
aldehydes with allyltrichlorosilane. Kwong and co-workers developed a series of terpene 
derived terpyridine tri-N-oxides 157a-d which proved to be effective catalysts for the 
allylation of electron poor aldehyde (up to 86% ee) (Scheme 66, Table 21).148  
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Scheme 66. Addition of allyltrichlorosilane to aromatic aldehydes promoted by 156-157a-d 
 
Table 21. Addition of allyltrichlorosilane to aromatic aldehydes promoted by 156-157a-d 
                     (Scheme 66) 
entry LB* Ar Yield (%) ee (%) 
1 156 Ph 85 34 (R) 
2 157a Ph 89 74 (R) 
3 157b Ph 97 64 (R) 
4 157c Ph 87 67 (R) 
5 157d Ph 85 44 (R) 
6 157a 4-MeO-C6H4 94 65 (R) 
7 157a 4-CF3-C6H4 91 86 (R) 
Snapper et al. have reported that chiral-at-nitrogen N-oxides can also be effective 
organocatalysts for the allylation of aromatic aldehydes (360HScheme 67).148F149    
Scheme 67. Addition of allyltrichlorosilane to aromatic aldehydes promoted by 158 
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Chiral N-oxides derived from proline and (R)-α-methylbenzylamine 158 proved to be an 
efficient activator for the enantioselective allylation of a variety of aromatic aldehydes with 
allyltrichlorosilane at room temperature (361HTable 22). Electron rich and electron poor 
substrates gave rise to appreciable levels of asymmetric induction; the highest enantiopurity 
was observed with electron rich 3,4-dimethoxybenzaldehyde (92% ee, entry 4).  
Table 22. Addition of allyltrichlorosilane to aromatic aldehydes promoted by 158 ( 362HScheme 67) 
Entry Ar Yield (%) ee (%) 
1 Ph 82 87 (R) 
2 4-MeO-C6H4 81 88 (R) 
3 4-Cl-C6H4 74 85 (R) 
4 3,4-(MeO)2-C6H3 73 92 (R) 
 
4.4 30BSummary 
Chiral Lewis bases, such as phosphoramides, formamides and N-oxides, were found to be 
effective organocatalysts for the enantioselective allylation of aromatic aldehydes with allyl 
trichlorosilane. The good diastereoselectivity observed for the Lewis base-catalysed 
crotylation is dictated by a closed chair-like transition state. 
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5 10BSynthesis and Application of Pinene-Derivative 
Pyridine II 
5.1 31BIntroduction 
Since chiral pyridine N-oxides were found to be effective organocatalysts for the 
enantioselective allylation of aromatic aldehydes with allyltrichlorosilane, we decided to 
develop novel pyridine N-oxides derived from α-pinene. Their design was based on the 
privileged pinene-pyridine fused structure which already allowed creating a successful chiral 
environment for metal-based catalysis (363HFigure 14). 
Figure 14. Novel pyridine N-oxides design 
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5.2 32BChiral Pyridine-Dimethylamine-N,N’-bisoxide 
5.2.1 63BSynthesis 
The synthetic strategy for preparation of the chiral bis-N-oxide (–)-162 from alcohol (+)-117b 
is shown in 364HScheme 68. Initially, we attempted to convert alcohol (+)-117b (for the synthesis, 
see chapter 3) into azide (+)-159 via one-pot mesylation of the hydroxyl functionality and 
subsequent displacement with azide anion,149F150 however without success. One of the possible 
explanations is that the approach of the azide anion may be impeded by the bulky pinene 
moiety. Eventually, alcohol (+)-117b was successfully transformed into azide (+)-159 (80% 
yield) with inversion of configuration via a Mitsunobu-like reaction using 
diphenylphosphorylazide (DPPA). 150F151 The structure of azide (+)-159 was confirmed by NOE 
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experiment ( 365HFigure 15). When the benzylic proton was irradiated (7-H, 4.91 ppm), a clear 
enhancement appeared at 0.70 ppm and 2.44 ppm corresponding to endo-methyl group (12-
H) and 8-H, respectively. Hydrogenation of azide (+)-159 over Pd/C was not very efficient 
(35%), whereas reduction with lithium aluminium hydride afforded the desired amine (+)-160 
in 98% yield.  
Scheme 68. Formation of the chiral bis-N-oxide (–)-162 
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Figure 15. NOE experiment on the azide (+)-159 
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Dimethylation of amine (+)-160 via a classical reductive amination protocol (e.g. 
paraformaldehyde, sodium borohydride and TFA in THF151F152) resulted only in low conversion 
to the desired dimethylamine (–)-161. However, the Eschweiler-Clarke methylation152F153 of 
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amine (+)-160 (using formaldehyde in formic acid) was more successful, leading to 
dimethylamine (−)-161 in high yield (87%). Dimethylamine (–)-161 was finally treated with 
mCPBA to give the desired bis-N-oxide (–)-162 in moderate yield (62%). 
 
5.2.2 64BAllylation of Benzaldehyde Catalysed by (–)-162 
Bis-N-oxide (–)-162 was tested as catalyst in the model asymmetric allylation of 
benzaldehyde with allyltrichlorosilane (366HScheme 69). Unfortunately, even at room 
temperature, the conversion remained very low (20% yield). Due to the lack of flexibility, 
bis-N-oxide (–)-162 may encounter some difficulties to coordinate to the silicon atom, 
resulting in a poor activation of allyl trichlorosilane.  
Scheme 69. Allylation of benzaldehyde catalysed by the bis-N-oxide (–)-162 
SiCl3 +
Ph
O
Ph
OH
139 141CH2Cl2, i-Pr2NEtrt
(-)-162 (20 mol%)
N
(-)-162
N O O
20% yield, 11% ee
 
 
5.3 33BChiral Pinene-Bipyridine-N,N’-dioxides 
The mechanistic study carried out by Denmark indicated that the allylation reaction was 
second order in phosphoramide catalyst367H141 which led to the design of bisphosphoramides 
148a-c with varying tether length (see chapter 4).368H142 Therefore, we decided to develop a 
series of chiral bipyridine-N,N’-dioxides with varying spacers (369HChart 15). 
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Chart 15. Targeted chiral bipyridine-N,N’-dioxides 
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5.3.1 65BSynthesis of the Bipyridine-N,N’-dioxides 167a-b 
Chiral bipyridine-N,N’-dioxides 167a-b were synthesised as shown in 370HScheme 70. The 
desired substituted-2-pyridine-acetophenones 164a-c were obtained in high yield by Suzuki-
Miyaura coupling between 2-bromopyridine and the substituted acetylphenylboronic acid 
163a-c.153F154 Substituted acetophenones 164a-c were then heated in pyridine with iodine to 
afford the corresponding Kröhnke salts 165a-c. The desired salts 165a-b were obtained in 
high yield, whereas the pyridinium salt 168 was formed (as a result of intramolecular 
nucleophilic substitution) instead of 165c (371HScheme 71). Subsequent Kröhnke annulation of 
the pyridinium salts 165a-b with pinocarvone (–)-16 afforded bipyridines 166a-b in moderate 
yields (22% and 36% yield, respectively). Bipyridines 166a-b were finally treated with 
mCPBA to give the desired chiral pinene-bipyridine-N,N’-dioxides 167a-b in reasonable 
yield. 
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Scheme 70. Synthesis of the chiral bipyridine-N,N’-dioxides 167a-b 
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Scheme 71. Formation of the pyridinium salt 168 
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5.3.2 66BPreliminary Results for the Allylation of Benzaldehyde 
Chiral bipyridine-N,N’-dioxides 167a-b were tested in the enantioselective allylation of 
benzaldehyde with allyltrichlorosilane (372HScheme 72). The results are shown in 373HTable 23. 
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Bipyridine-N,N’-dioxides 167a-b catalysed formation of homoallylic alcohol 141 in high 
yield (entries 1 and 2), however, enantioselectivity in both cases was very low (3% and 12% 
ee, respectively, entries 1 and 2). It was not surprising to find that para-substituted catalyst  
(–)-167a led to a racemic alcohol, since the bidentate coordination to silicon seems 
improbable. On the other hand, bis-N-oxide (–)-167b appears to have enough flexibility to 
chelate silicon, leading to a slight increase in enantioselectivity. 
Scheme 72. Allylation of benzaldehyde catalysed by the bipyridine-N,N’-dioxides 167a-b 
 
Table 23. Allylation of benzaldehyde catalysed by the bipyridine-N,N’-dioxides 167a-b (374HScheme 72) 
entry LB* Yield (%) ee (%)a 
1 (–)-167a 84 3 (R)b 
2 (–)-167b 83 12 (R)b 
aDetermined by chiral HPLC (IB, 0.75 mL.min-1, hexane/2-propanol, 97.5:2.5). 
bAbsolute configuration obtained from the HPLC retention times and comparison 
with literature data. 154F155 
 
5.3.3 67BSynthesis of Bipyridine-N,N’-dioxides 170a-b 
In an attempt to improve the enantioselectivity of the allylation reaction, we decided to tune 
the promising bis-N-oxide (–)-167b by substituting the benzylic position of the pyridine ring 
with various alkyl groups.  
Chiral bipyridine-N,N’-dioxides 170a-b were prepared as shown in 375HScheme 73. 
Deprotonation of the bipyridine (+)-166b in the benzylic position with n-BuLi at -40 °C, 
followed by alkylation with either MeI or i-PrI gave (+)-169a and (–)-169b, respectively. 
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Subsequent treatment with mCPBA finally afforded the desired chiral bipyridine-N,N’-
dioxides 170a-b in moderate yield. 
Scheme 73. Formation of the bipyridine-N,N’-dioxides 170a-b 
 
 
5.3.4 68BEnantioselective Allylation of Benzaldehyde 
The results obtained employing bis-N-oxides (–)-170a and (–)-170b are shown in 376HTable 24 
below. Again, both compounds showed good reactivity but the enantioselectivity was 
negligible (entries 1 and 2). We can only assume that the presence of the alkyl groups 
impedes the chelation of silicon by the two N-oxide functionalities. 
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Scheme 74. Allylation of benzaldehyde catalysed by the bipyridine-N,N’-dioxides 170a-b 
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Table 24. Allylation of benzaldehyde catalysed by the bipyridine-N,N’-dioxides 170a-b (377HScheme 74) 
entry LB* Yield (%) ee (%)a 
1 (–)-170a 87 2 (R) 
2 (–)-170b 85 3 (R) 
aDetermined by chiral HPLC (IB, 0.75 mL.min-1, hexane/2-propanol, 97.5:2.5). 
bAbsolute configuration obtained from the HPLC retention times and comparison 
with literature data.378H155  
 
 
5.4 34BSummary 
Novel bis-N-oxide compounds 167a-b and 170a-b were synthesised from α-pinene and a 
range of 2-pyridine-acetophenones 164a-c by employing Kröhnke annulation reaction as the 
key cyclisation step. Although poor enantioselectivity was achieved (up to 12% ee), high 
reactivity of the prepared catalysts is, however, promising. Better tuning of the chiral 
environment may lead to an improvement of the enantioselectivity. 
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6 11BExperimental 
 
6.1 35BGeneral Methods 
All reactions were carried out under an inert atmosphere in oven-dried glassware unless 
otherwise stated. Room temperature refers to ambient room temperature (20-22 °C); 0 °C 
refers to an ice slush bath. Heated experiments were conducted using thermostatically 
controlled oil baths. Reactions were monitored by Thin Layer Chromatography (TLC) using 
aluminium backed silica gel 60 (F254) plates, visualised using UV254nm and potassium 
permanganate, PMA, Drangendorf and ninhydrin dips as appropriate. Flash chromatography 
was carried out routinely using 60Å silica gel (Fischer) as the stationary phase unless 
otherwise stated. Melting points were determined on a Kofler block and are uncorrected. 
Optical rotations were recorded in CHCl3 at 20 °C unless otherwise indicated with an error of 
<±0.1. The [α]D values are given in 10-1 deg.cm2.g-1. The NMR spectra were recorded on a 
Bruker Spectrospin 400 (400 MHz) spectrometer. Chemical shifts are reported in δ units, 
parts per million (ppm) downfield from TMS. Coupling constants (J) are measured in Hertz 
(Hz) and are unadjusted; therefore, due to limits in resolution, in some cases there are small 
differences (<1 Hz) in the measured J value of the same coupling constant determined from 
different signals. Splitting patterns are designed as follows: s – singlet, d – doublet, t – triplet, 
dd – doublet of doublets, dt – doublet of triplets, td – triplet of doublets, ddd – doublet of 
doublet of doublets, tt – triplet of triplets, sp – septet, m – multiplet, br – broad. Various 2D 
techniques and DEPT experiments were used to establish the structures and to assign the 
signals. The IR spectra were recorded on a JASCO FT-IR spectrophotometer for a thin film 
between NaCl plates, or as a KBr disc. The mass spectra (EI and/or CI) were measured on a 
Joel JMS700 spectrometer. Enantiomeric excess was determined by chiral GC analysis (using 
a Hewlett Packard 6890 Series GC system, Hewlett Packard 3395 integrator and Supelco α-
DEXTM 120 fused capillary column 30 m × 0.25 mm × 0.25 μm film thickness) or by chiral 
HPLC analysis (using a Hewlett Packard Agilent 1100 Series quaternary pump, vacuum 
degasser, diode array detector, manual injector and Hewlett Packard ChemStation and a 
Diacel Chiracel IB or OJ-H 0.46 cm × 25 cm column) as stated. The chiral GC and HPLC 
methods were calibrated with the corresponding racemic mixtures. Autoclave reactions were 
accomplished in a stainless steel autoclave manufactured by HEL Ltd. 
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6.2 36BMaterials 
All solvents were of reagent grade and were dried and distilled under argon or nitrogen 
immediately before use as follows: tetrahydrofuran, diethyl ether and toluene from 
sodium/benzophenone, dichloromethane from calcium hydride. Petroleum ether refers to the 
fraction boiling in the range 40-60°C. Methanol and ethanol were distilled over magnesium 
turnings and stored over molecular sieves. Triethylamine was distilled immediately before 
use from calcium hydride. Yields are given for isolated products showing one spot on a TLC 
plate and with no impurities detectable in the NMR spectrum. The identity of the products 
prepared by different methods was checked by comparison of their NMR spectra and TLC 
behaviour. (R)-(+)-α-Pinene was purchased from Aldrich with a 98% ee.  
 
6.3 37BSynthesis and Application of Pinene-Derivative P,N-Ligands  
6.3.1 69BSynthesis of the First Generation of Ligands 
(1R,5R)-(–)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptan-3-one (–)-16 
O
C10H14O
Mol. Wt.: 150.22
8
8'
1
7
5
4
96 2
3
 
(R)-(+)-α-Pinene 1 (7.5 g, 55 mmol, 1.0 equiv), acetic anhydride (6.24 mL, 66 mmol, 1.2 
equiv), pyridine (2.20 mL, 27 mmol, 0.5 equiv), TPP (catalytic amount) and DMAP (catalytic 
amount) were introduced into a UV reactor with CH2Cl2 (100 mL). A stream of oxygen was 
bubbled through the latter solution accompanied by UV irradiation (546 nm). The solution 
was stirred at room temperature until completion of the reaction, as determined by TLC 
(hexane / ethyl acetate: 95:5), typically 20 h. The reaction mixture was then diluted with 
CH2Cl2 (60 mL). The organic layer was successively washed with a saturated aqueous 
solution of NaHCO3 (60 mL), 10% aqueous solution of HCl (2 × 40 mL), 0.5M aqueous 
solution of CuSO4 (40 mL), brine (40 mL) and finally dried over MgSO4. The solvent was 
then removed under vacuum to afford pure pinocarvone (–)-16 as a purple oil (7.92 g, 96%): 
1H NMR (400 MHz, CDCl3) δ 0.76 (s, 3H, 8-H), 1.25 (d, J = 10.3 Hz, 1H, 7a-H), 1.32 (s, 
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3H, 8’-H), 2.16 (tt, J = 6.2, 3.0 Hz, 1H, 5-H), 2.48 (m, 1H, 7b-H), 2.58-2.68 (m, 2H, 4-H), 
2.72 (t, J = 6.2 Hz, 1H, 1-H), 4.97 (d, J = 1.7 Hz, 1H, 9a-H), 5.92 (d, J = 1.7 Hz, 1H, 9b-H); 
13C NMR (100 MHz, CDCl3) δ 21.4 (CH3-8), 25.9 (CH3-8’), 32.3 (CH2-7), 38.4 (CH-5), 40.7 
(C-6), 42.4 (CH2-4), 48.1 (CH-1), 117.3 (CH2-9), 149.0 (C-2), 199.8 (C=O-3) in agreement 
with the literature data.379H110 
 
1-(2-Oxo-2-phenylethyl)pyridinium iodide 112 
N
O
I
1
4
8
7
5
6
6' 2'
3'5'
4'
2
3
C13H12INO
Mol. Wt.: 325.14  
A solution of acetophenone 111 (2.40 g, 20 mmol) and iodine (5.08 g, 20 mmol, 1.0 equiv) in 
pyridine (10 mL) was refluxed overnight. The reaction mixture was cooled to room 
temperature, inducing the precipitation of a solid which was filtered off and washed with 
diethyl eher (3×20 mL). The remaining solid was then stirred overnight in diethyl ether (50 
mL). After filtration, the brown solid 112 was isolated (5.21 g, 80%): 1H NMR (400 MHz, 
d6-DMSO) δ 6.51 (s, 2H, 1–H), 7.67 (t, J = 7.6 Hz, 2H, 5–H, 7–H), 7.80 (t, J = 7.5 Hz, 1H, 
6–H), 8.05-8.09 (m, 2H, 4–H, 8–H), 8.29 (dd, J = 7.8, 6.7 Hz, 2H, 3’–H, 5’–H), 8.75 (tt, J = 
7.8, 1.3 Hz, 1H, 4’–H), 9.01 (dd, J = 6.7, 1.3 Hz, 2H, 2’–H, 6’–H) in agreement with the 
literature data.380H30a  
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(8S,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-113 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
C18H19N
Mol. Wt.: 249,35  
A solution of pinocarvone (–)-16 (1.05 g, 7.0 mmol, 1.0 equiv) with the Kröhnke salt 112 
(2.28 g, 7.0 mmol, 1.0 equiv) and ammonium acetate (9.25 g) in acetic acid (12 mL) was 
refluxed for 6 h. The mixture was then diluted with water (25 mL), made neutral by addition 
of an aqueous solution of sodium hydroxide (2M) and extracted with ethyl acetate (3×50 
mL). The organic phase was successively washed with water (3×50 mL) and brine (50 mL) 
and dried over MgSO4. The solvent was removed under vacuum to afford pure (+)-113 as a 
brown solid (1.10 g, 63%): 1H NMR (400 MHz, CDCl3) δ 0.69 (s, 3H, 12-H), 1.32 (d, J = 9.6 
Hz, 1H, 9-H), 1.42 (s, 3H, 13-H), 2.40 (tt, J = 5.8, 3.0 Hz, 1H, 8-H), 2.71 (dt, J = 9.6, 5.8 Hz, 
1H, 9-H’), 2.80 (t, J = 5.8 Hz, 1H, 10-H), 3.21 (d, J = 3.1 Hz, 2H, 7-H), 7.28 (d, J = 7.8 Hz, 
1H, 3-H), 7.37 (tt, J = 7.3, 1.3 Hz, 1H, 4’-H), 7.41 (d, J = 7.8 Hz, 1H, 4-H), 7.45 (td, J = 7.3, 
1.3 Hz, 2H, 3’-H, 5’-H), 7.96 (d, J = 7.2 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 
21.3 (CH3-12), 26.1 (CH3-13), 32.0 (CH2-9), 36.8 (CH2-7), 39.5 (C-11), 40.3 (CH-8), 46.3 
(CH-10), 117.2 (CH-4), 126.7 (2×CH-2’,6’), 128.2 (CH-4’), 128.6 (2×CH-3’,5’), 133.5 
(CH-3), 140.0 (C-1’), 140.3 (C-5), 154.8 (C-2), 156.8 (C-6) in accordance with the literature 
data.381H30a 
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(7R,8R,10S)-(–)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7-
yl(diphenyl)phosphine oxide (–)-114 
N
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9
P
O
C30H28NOP
Mol. Wt.: 449.52  
A 2.5M solution of n-butyllithium in hexane (0.8 mL, 2.0 mmol, 1.0 equiv) was added 
dropwise to a solution of (+)-113 (0.50 g, 2.0 mmol, 1.0 equiv) in anhydrous THF (5 mL) 
under an argon atmosphere at –40 °C. The red colour of the mixture turned darker and darker. 
The solution was stirred at that temperature for 1 h and then a solution of diphenylphosphinic 
chloride (0.40 mL, 2.0 mmol, 1.0 equiv) in THF (2 mL) was added dropwise at –40 °C. The 
solution was then gradually warmed up to room temperature and stirred overnight. The 
reaction was then quenched by addition of water (20 mL), the mixture was extracted with 
CH2Cl2 (3×20 mL), the organic solution was washed with brine (20 mL) and dried over 
MgSO4. The solvent was removed under vacuum and the residue was purified by 
chromatography on silica gel (30 g) using a mixture of petroleum ether and ethyl acetate (1:1) 
at the beginning, followed by a regular increase of the ethyl acetate ratio to pure ethyl acetate 
to give pure (–)-114 as a white solid (307 mg, 34%): mp 104-106 °C (hexane); [α]D25 –54.0 
(c 1.0, CHCl3); IR (KBr) ν 3016 (s, C-H), 1596 (m, C=Car), 1525 (m, C=Car), 1432 (m, 
C=Car), 1216 (s, P=O), 771 (s, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.63 (s, 3H, 
12-H), 1.32 (s, 3H, 13-H), 1.54 (d, J = 10.2 Hz, 1H, 9-H), 2.45 (dt, J = 10.2, 5.8 Hz, 1H, 
9-H’), 2.60-2.65 (m, 2H, 8-H, 10-H), 4.32 (dd, J2H,P = 13.9 Hz, J = 1.0 Hz, 1H, 7-H), 7.10 
(td, J = 7.2, 1.5 Hz, 2H, 3’-H, 5’-H), 7.14-7.20 (m, 4H, 4-H, 4’-H, 2’-H, 4’-H), 7.30 (td, J = 
7.4, 3.0 Hz, 2H, aromH), 7.35-7.51 (m, 5H, 3-H, aromH), 7.69-7.75 (m, 2H, aromH), 7.82-
7.89 (m, 2H, aromH); 13C NMR (100 MHz, CDCl3) δ 20.8 (CH3-12), 25.7 (CH3-13), 28.4 
(CH2-9), 41.1 (CH-8), 41.9 (C-11), 45.3 (d, J = 21 Hz, CH-7), 45.9 (CH-10), 116.9 (CH-3), 
126.0 (2×CH-2’,6’), 128.1 (d, J = 12 Hz, 2×aromCH), 128.2 (2×CH-3’,5’), 128.22 (CH-4’), 
128.5 (d, J = 12 Hz, 2× aromCH), 130.9 (d, J = 3 Hz, aromCH), 131.0 (d, J = 3 Hz, 
aromCH), 131.15 (d, J = 9 Hz, 2× aromCH), 131.85 (d, J = 9 Hz, 2× aromCH), 133.0 (d, J = 
97 Hz, C), 134.2 (CH-4), 134.6 (d, J = 97 Hz, C), 138.4 (C-1’), 141.0 (d, J = 5 Hz, C-5), 
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152.0 (d, J = 7 Hz, C-6), 153.3 (C-2); 31P NMR (162.0 MHz, CDCl3) δ 33.4 (P=O); MS (EI) 
m/z (%) 449 (M•+, 15), 248 (M•+-P(O)Ph2, 100), 206 (M•+-P(O)Ph2-C3H6, 18); HRMS (EI) 
449.1906 (C30H28NOP requires 449.1909).  
 
Borane-protected (7R,8R,10S)-(–)-2-Phenyl-7-(diphenylphosphino)-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (–)-115 
13
BH3
N
12 10
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311 5
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P
8
C30H31BNP
Mol. Wt.: 447,36  
A solution of n-buthyllithium in hexane (2.5M; 0.4 mL, 1.0 mmol, 1.0 equiv) was added 
dropwise to a solution of (+)-113 (0.25 g, 1.0 mmol, 1.0 equiv) in THF (2 mL) at –40 °C. The 
solution was stirred at that temperature for 1 h and then a solution of Ph2PCl.BH3 (3.0 mmol, 
3.0 equiv) was added dropwise at –40 °C [the Ph2PCl.BH3 solution was prepared by stirring 
for 30 min a mixture of borane in THF (1M, 3 mL, 3 mmol, 1.0 equiv) and 
chlorodiphenylphosphine (0.54 mL, 3 mmol, 1.0 equiv) in diethyl ether (2 mL) at room 
temperature]. The resulting solution was then gradually warmed up to room temperature and 
stirred overnight. A saturated aqueous solution of NH4Cl (2 mL) was then added to quench 
the reaction, the mixture was extracted with CH2Cl2 (3×20 mL) and the combined organic 
extracts were washed with brine (20 mL) and dried over MgSO4. The solvent was removed 
under vacuum and the residue was purified by chromatography on silica gel (20 g) using a 
mixture of hexane and diethyl ether (20:1) to give pure (–)-115 as a white solid (154 mg, 
35%): mp 190-192 °C (MeOH); [α]D25 –112.4 (c 1.0, CHCl3); IR (KBr) ν 3050-2950 (s, C-
H), 2397 (m, B-H), 1560 (m, C=Car), 1425 (m, C=Car), 771 (s, C-Har) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.74 (s, 3H, 12-H), 1.21 (d, J = 10.3 Hz, 1H, 9-H), 1.41 (s, 3H, 13-H), 1.54 
(s, 3H, BH3), 2.45 (dt, J = 10.3, 5.8 Hz, 1H, 9-H’), 2.66 (t, J = 5.8 Hz, 1H, 10-H), 2.77 (qd, J 
= 6.2, 2.0 Hz, 1H, 8-H), 4.43 (dd, J2H,P = 13.4 Hz, J = 2.0 Hz, 1H, 7-H), 7.19-7.23 (m, 3H, 
4-H, 3’-H, 5’-H), 7.25-7.29 (m, 3H, 4’-H, 2×aromH), 7.35-7.43 (m, 3H, 2’-H, 6’-H, aromH), 
7.47-7.57 (m, 4H, 3-H, 3×aromH), 7.68-7.73 (m, 2H, aromH), 7.83-7.88 (m, 2H, aromH); 
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13C NMR (100 MHz, CDCl3) δ 20.9 (CH3-12), 25.9 (CH3-13), 28.3 (CH2-9), 42.4 (CH-8), 
42.5 (C-11), 42.7 (d, J = 29 Hz, CH-7), 45.8 (CH-10), 117.1 (CH-3), 126.1 (2×CH-2’,6’), 
128.2 (d, J = 10 Hz, 2×aromCH), 128.33 (2×CH-3’,5’), 128.39 (CH-4’), 128.45 (d, J = 55 
Hz, C), 128.5 (d, J = 10 Hz, 2×aromCH), 130.1 (d, J = 2 Hz, aromCH), 131.0 (d, J = 2 Hz, 
aromCH), 131.7 (d, J = 55 Hz, C), 132.5 (d, J = 9 Hz, 2×aromCH), 134.2 (CH-4), 134.4 (d, J 
= 9 Hz, 2×aromCH), 138.5 (C-1’), 140.8 (d, J = 4 Hz, C-5), 153.1 (d, J = 7 Hz, C-6), 153.3 
(C-2); 31P NMR (162.0 MHz, CDCl3) δ 25.8 (m); MS (EI) m/z (%) 447 (M•+, 14), 433 (M•+-
BH3, 58), 248 (M•+-PPh2.BH3, 57), 206 (M•+- PPh2.BH3-C3H6, 100), 91 (73); HRMS (EI) 
447.2286 (C30H31BNP requires 447.2293). 
 
(8S,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-triene 1-oxide 
(+)-116 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
O
C18H19NO
Mol. Wt.: 265,35  
m-Chloroperoxybenzoic acid (70%, 0.7 g, 4 mmol, 2.0 equiv) was added portion-wise to a 
cooled (0 °C) solution of (+)-113 (0.5 g, 2 mmol, 1.0 equiv) in CH2Cl2 (20 mL). The mixture 
was then allowed to warm up to room temperature and stirred overnight. The mixture was 
washed with an aqueous solution of NaHCO3 (10%; 1×20 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the residue was purified by chromatography on silica 
gel (25 g) using ethyl acetate to remove the unreacted starting material and some by-products, 
followed by methanol to afford pure (+)-116 as a white solid (394 mg, 75%): mp 128-130 °C 
(hexane); [α]D20 +100.2 (c 0.6, CHCl3); IR (KBr) ν 3051 (m, C-H), 2938 (s, C-H), 1662 (m, 
C=Car), 1477 (s, C=Car), 1447 (m, C=Car), 1265 (s, N-O), 770 (s, C-Har) cm-1;  1H NMR 
(400 MHz, CDCl3) δ 0.73 (s, 3H, 12-H), 1.32 (d, J = 9.8 Hz, 1H, 9-H), 1.42 (s, 3H, 13-H), 
2.45 (m, 1H, 8-H), 2.69 (dt, J = 9.8, 5.7 Hz, 1H, 9-H’), 2.81 (t, J = 5.7 Hz, 1H, 10-H), 3.05-
3.24 (m, 2H, 7-H), 6.92 (d, J = 7.8 Hz, 1H, 3-H), 7.19 (d, J = 7.8 Hz, 1H, 4-H), 7.42 (t, J = 
6.9 Hz, 1H, 4’-H), 7.45 (t, J = 6.9 Hz, 2H, 3’-H, 5’-H), 7.79 (d, J = 6.9 Hz, 2H, 2’-H, 6’-H); 
13C NMR (100 MHz, CDCl3) δ 21.1 (CH3-12), 25.8 (CH3-13), 31.2 (CH2-7), 31.5 (CH2-9), 
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39.31 (CH-8), 39.32 (C-11), 46.1 (CH-10), 122.9 (CH-3), 123.7 (CH-4), 128.0 (2×CH-3’,5’), 
128.9 (CH-4’), 129.5 (2×CH-2’,6’), 133.3 (C-1’), 144.2 (C-5), 146.8 (C-2), 147.1 (C-6); MS 
(EI) m/z (%) 265 (M•+, 50), 248 (M•+-OH, 65), 206 (M•+-OH-C3H6, 100), 83 (62); HRMS 
(EI) 265.1466 (C18H19NO requires 265.1467).  
 
(8R,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7-one 
(+)-118 
N
10
5
4
3
2
6
7
8
11
12
13
13
14
14'
15'
15
16
9
O
C18H17NO
Mol. Wt.: 263,33  
A mixture of the N-oxide derivative (+)-116 (105.2 mg, 0.40 mmol) and acetic anhydride (5 
mL) was stirred at 110 °C for 2 h under argon. The reaction mixture was then cooled to room 
temperature and acetic anhydride was removed under vacuum. An aqueous solution of 
hydrochloric acid (3M, 10 mL) was added to the residue and the resulting mixture was 
refluxed for 1.5 h., then cooled to room temperature and chilled with an ice bath. The solution 
was made alkaline (pH≈12-13) by a slow addition of an aqueous solution of sodium 
hydroxide (2M). The aqueous layer was extracted with CH2Cl2 (3 × 15 mL) and the 
combined organic solutions were dried over MgSO4 and concentrated under vacuum to obtain 
a diastereoisomeric mixture of benzylic alcohol derivatives 117a and 117b (ratio 3:1) (74.2 
mg, 70%). The latter mixture of alcohols 117 (74.2 mg, 0.28 mmol, 1.0 equiv) was dissolved 
in acetone (2 mL) and Jones’ reagent (70 µL, 0.28 mmol, 1.0 equiv) was added and the 
mixture was stirred at room temperature for 30 min. The reaction was then quenched by 
addition of propan-2-ol (10 drops) and the mixture was filtered over a silica pad. The filtrate 
was then made alkaline by addition of an aqueous solution of sodium hydroxide (2M). 
CH2Cl2 (10 mL) was then added, the two layers were separated, the aqueous phase was 
extracted with CH2Cl2 (3 × 15 mL). The combined organic solutions were dried over MgSO4 
and concentrated under vacuum to give pure (+)-118 as a white solid (62 mg, 84%): mp 155-
157 °C; [α]D20 +163.7 (c 0.6, CHCl3); IR (KBr) ν 2975 (m, C-H), 1705 (s, C=O), 1585 (m, 
C=Car), 1558 (s, C=Car), 1455 (m, C=Car), 779 (m, C-Har) cm-1; 1H NMR (400 MHz, 
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CDCl3) δ 0.83 (s, 3H, 12-H), 1.62 (s, 3H, 13-H), 2.18 (dt, J = 8.2, 5.0 Hz, 1H, 9-H), 3.09-
3.13 (m, 3H, 8-H, 9-H’, 10-H), 7.41 (tt, J = 7.2, 1.3 Hz, 1H, 4’-H), 7.47 (t, J = 7.2 Hz, 2H, 
3’-H, 5’-H), 7.64 (d, J = 7.9 Hz, 1H, 3-H), 7.78 (d, J = 7.9 Hz, 1H, 4-H), 8.08 (d, J = 7.2 Hz, 
2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 22.7 (CH3-12), 26.7 (CH3-13), 39.3 
(CH2-9), 47.1 (CH-10), 52.7 (C-11), 58.2 (CH-8), 123.2 (CH-4), 127.1 (2×CH-2’,6’), 128.7 
(2×CH-3’,5’), 129.1 (CH-4’), 134.9 (CH-3), 138.5 (C-2’), 144.8 (C-5), 147.9 (C-2), 156.6 
(C-6), 199.9 (C=O); MS (CI-isobutane) m/z (%) 264 ((M+H)+, 100), HRMS (CI-isobutane) 
264.1389 (C18H18NO (M+H)+ requires 264.1388). 
 
(7S,8R,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7-ol 
(+)-117b 
N
12
13
10
8
9
7
4
311 5
6 2
OH
14
14'
15
15'
16
C18H19NO
Mol. Wt.: 265,35
13
 
Sodium borohydride (4 mg, 0.103 mmol, 1.0 equiv) was added portion-wise to a solution of 
ketone (+)-118 (27 mg, 0.103 mmol, 1.0 equiv) in ethanol (1 mL) and the reaction mixture 
was stirred at room temperature for 20 min. Water (2 mL) was then added to quench the 
remaining sodium borohydride and the aqueous layer was extracted with CH2Cl2 (3 × 5 mL). 
The combined organic layers were dried over MgSO4 and concentrated under vacuum to 
afford pure (+)-117b as a white solid (25 mg, 91%): mp 85-87 °C; [α]D20 +86.9 (c 1.5, 
CHCl3); IR (KBr) ν 3430 (s, OH), 2933 (s, C-H), 1586 (m, C=Car), 1568 (m, C=Car), 1441 
(m, C=Car), 772 (m, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.61 (s, 3H, 12-H), 1.39 (s, 
3H, 13-H), 1.50 (d, J = 9.9 Hz, 1H, 9-H), 2.44 (td, J = 5.8, 3.3 Hz, 1H, 8-H), 2.50-2.60 (m, 
1H, 9-H’), 2.74 (t, J = 5.8 Hz, 1H, 10-H), 3.42 (br s, 1H, OH), 4.88 (d, J = 3.3 Hz, 1H, 7-H), 
7.29 (d, J = 7.8 Hz, 1H, 4-H), 7.33 (t, J = 7.0 Hz, 1H, 4’-H), 7.39 (t, J = 7.0 Hz, 2H, 3’-H, 
5’-H), 7.47 (d, J = 7.8 Hz, 1H, 3-H), 7.95 (d, J = 7.0 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 
MHz, CDCl3) δ 22.0 (CH3-12), 25.7 (CH3-13), 33.0 (CH2-9), 39.5 (C-11), 45.1 (CH-8), 45.9 
(CH-10), 73.2 (CH-7), 117.8 (CH-3), 125.64 (2×CH-2’,6’), 125.69 (CH-4’), 127.7 
(2×CH-3’,5’), 132.9 (CH-4), 137.9 (C-1’), 138.4 (C-5), 153.9 (C-2), 156.9 (C-6); MS (EI) 
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m/z (%) 265 (M•+, 50), 248 (M•+-OH, 26), 206 (M•+-OH-C3H6, 50), 196 (100), 28 (39); 
HRMS (EI) 265.1469 (C18H19NO requires 265.1467). 
NOE: Irradiation on 4.88 7-H enhanced 1.50 9-H and 2.50-2.60 9-H’ 
N
9
7
OH
H
H
H
 
 
(7R,8R,10S)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7-ol 
117a 
N
12
13
10
8
9
7
4
311 5
6 2
OH
14
14'
15
15'
16
C18H19NO
Mol. Wt.: 265,35
13
 
Diisopropyl azodicarboxylate (0.62 mL, 3.12 mmol, 4 equiv) was added dropwise to a cold  
(0 ºC) solution of alcohol (+)-117b (200 mg, 0.78 mmol, 1 equiv), p-nitrobenzoic acid (520 
mg, 3.12 mmol, 4 equiv), and triphenylphosphine (820 mg, 3.12 mmol, 4 equiv) in dry THF 
(6 mL). After completion of the addition, the reaction mixture was allowed to warm to room 
temperature and was stirred overnight at that temperature. The mixture was then diluted with 
ether (10 mL) and the organic layer was washed with a saturated aqueous solution of sodium 
carbonate (2×15 mL), dried over MgSO4, and concentrated under vacuum. The crude 
material was dissolved in methanol (3 mL) and potassium carbonate (570 mg, 4.1 mmol, 10 
equiv) was added portion-wise and the reaction mixture was stirred at room temperature for 2 
h. The solvent was evaporated under reduced pressure, the residue was diluted with water (5 
mL) and made alkaline by addition of an aqueous solution of 2M sodium hydroxide. The 
aqueous layer was extracted with CH2Cl2 (3×20 mL) and the organic extract was dried over 
MgSO4, and concentrated under vacuum to provide pure alcohol 117a as a colourless oil 
(100.3 mg, 50%): 1H NMR (400 MHz, CDCl3) δ 0.70 (s, 3H, 12-H), 1.48 (s, 3H, 13-H), 1.59 
(d, J = 9.9 Hz, 1H, 9-H), 2.53 (td, J = 5.8, 3.2 Hz, 1H, 8-H), 2.64 (dt, J = 9.9, 5.8 Hz, 1H, 
9-H’), 2.83 (t, J = 5.8 Hz, 1H, 10-H), 3.51 (br s, 1H, OH), 4.97 (d, J = 3.2 Hz, 1H, 7-H), 7.35 
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(d, J = 7.8 Hz, 1H, 3-H), 7.38 (t, J = 7.4 Hz, 1H, 4’-H), 7.45 (t, J = 7.4 Hz, 2H, 3’-H, 5’-H), 
7.52 (d, J = 7.8 Hz, 1H, 4-H), 8.00 (d, J = 7.4 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, 
CDCl3) δ 21.0 (CH3-12), 26.6 (CH3-13), 29.6 (CH2-9), 44.9 (C-11), 45.5 (CH-8), 46.6 
(CH-10), 71.5 (CH-7), 118.9 (CH-4), 126.7 (2×CH-2’,6’), 128.5 (CH-4’), 128.6 
(2×CH-3’,5’), 133.8 (CH-3), 139.2 (C-1’), 139.8 (C-5), 155.0 (C-2), 157.2 (C-6); HRMS 
(EI) 265.1469 (C18H19NO requires 265.1467).  
NOE: Irradiation on 4.97 7-H enhanced 0.70 12-H and 2.53 8-H 
N
12
8
7
OH
H
H
 
 
Borane-protected (7S,8R,10S)-(+)-2-Phenyl-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7- yl diphenylphosphinite (+)-119 
N
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13
10
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9
7
4
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O
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2'
5'
3'
4'
1'
P
BH3
C30H31BNOP
Mol. Wt.: 463,36  
A solution of n-butyllithium in hexane (2.5M; 0.38 mL, 0.94 mmol, 1.0 equiv) was added 
dropwise to a solution of (+)-117b (250 mg, 0.94 mmol, 1.0 equiv) in anhydrous THF (2 mL) 
under argon at –40 °C. The solution was stirred at that temperature for 30 min and then 
allowed to gradually warm to 0 °C. Diphenylphosphine chloride (0.20 mL, 1.04 mmol, 1.1 
equiv) was then added dropwise and the reaction mixture was warmed up to room 
temperature and stirred for 3 h. A solution of borane in THF (1M, 0.94 mL, 0.94 mmol, 1.0 
equiv) was added dropwise to the latter solution and the reaction mixture was stirred 
overnight. The reaction was then quenched by addition of water (15 mL), the aqueous phase 
was extracted with CH2Cl2 (3×20 mL), and the combined organic extracts were washed with 
brine (20 mL) and dried over MgSO4. The solvent was removed under vacuum and the 
residue was purified by chromatography on a column of silica gel (13 g) using a mixture of 
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petroleum ether and AcOEt (95:5) to give pure (+)-119 (176 mg, 41%) as a white solid: mp 
117-120 °C (hexane); [α]D19 +170.5 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 0.82 (s, 
3H, 12-H), 1.42 (s, 3H, 13-H), 1.48 (d, J = 9.7 Hz, 1H, 9-H), 1.54 (br s, 3H, BH3), 2.73-2.79 
(m, 2H, 10-H, 9-H’), 2.84 (td, J = 6.4, 3.3 Hz, 1H, 8-H), 5.78 (dd, J2H,P = 10.0 Hz, J = 3.3 Hz, 
1H, 7-H), 7.33 (d, J = 7.8 Hz, 1H, 4-H), 7.35-7.49 (m, 9H, 3’-H, 5’-H, 4’-H, 6×aromH), 7.55 
(d, J = 7.8 Hz, 1H, 3-H), 7.72-7.77 (m, 2H, aromH), 7.90 (dd, J = 8.0, 1.6 Hz, 2H, 2’-H, 
6’-H), 8.02-8.07 (m, 2H, aromH); 13C NMR (100 MHz, CDCl3) δ 23.5 (CH3-12), 26.6 
(CH3-13), 35.1 (CH2-9), 40.6 (C-11), 46.6 (CH-10), 47.0 (CH-8), 80.1 (CH-7), 118.6 (CH-3), 
126.6 (2×CH-2’,6’), 128.3 (d, J = 10 Hz, 2×aromCH), 128.4 (d, J = 10 Hz, 2×aromCH), 
128.49 (CH-4’), 128.51 (2×CH-3’,5’), 131.2 (d, J = 11 Hz, 2×aromCH), 131.37 (d, J = 2 Hz, 
aromCH), 131.46 (d, J = 2 Hz, aromCH), 132.1 (d, J = 11 Hz, 2×aromCH), 133.0 (d, J = 65 
Hz, C), 133.7 (CH-4), 133.9 (d, J = 65 Hz, C), 139.1 (C-1’), 140.2 (C-5), 154.0 (d, J = 6 Hz, 
C-6), 155.0 (C-2); 31P NMR (162.0 MHz, CDCl3) δ 105.9 (m); Anal. Calcd. for 
C30H31BNOP: C, 77.76; H, 6.74; N, 3.02. Found: C, 77.30; H, 6.69; N, 3.22. 
 
1-(2-Ethoxy-2-oxoethyl)pyridinium bromide 120 
N
O
Br 1
3
6' 2'
3'5'
4'
2 O
4
C9H12BrNO2
Mol. Wt.: 246,10  
Ethyl α-bromoacetate (11.1 mL, 100 mmol, 1.0 equiv) was added dropwise to a solution of 
pyridine (7 mL, 100 mmol, 1.0 equiv) in ethyl acetate (20 mL). The reaction mixture was 
heated at 50 °C for 1 h and then cooled to room temperature. The yellow precipitate was 
filtered off and washed with ethyl acetate (20 mL) to yield pure 120 as a clear brown solid 
(23.1 g, 94%): 1H NMR (400 MHz, d6-DMSO) δ 1.24 (t, J = 7.1 Hz, 3H, 4–H), 4.22 (q, J = 
7.1 Hz, 2H, 3–H), 5.79 (s, 2H, 1–H), 8.27 (dd, J = 7.6, 6.8 Hz, 2H, 3’–H, 5’–H), 8.74 (t, J = 
7.6 Hz, 1H, 4’–H), 9.15 (d, J = 6.8 Hz, 2H, 2’–H, 6’–H) in accordance with the literature 
data.382H24 
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 (8S,10S)-(+)-11,11-Dimethyl-1-azatricyclo[7.1.1.05,6]undeca-3,5-dien-2-one (+)-121 
N
H
O
12
13
10
8
9
7
4
311 5
6 2
C12H15NO
Mol. Wt.: 189,25  
Piperidine (0.13 mL) was added dropwise to a solution of pinocarvone (–)-16 (1.30 g, 8.65 
mmol, 1.0 equiv), Kröhnke salt 120 (2.30 g, 9.34 mmol, 1.1 equiv) and ammonium acetate 
(6.40 g, 83 mmol, 9.6 equiv) in butanol (15 mL). The reaction mixture was refluxed for 2 h, 
then acetic acid (0.88 mL) was added, and the mixture was refluxed for an additional 48 h. 
The reaction mixture was then cooled to room temperature and quenched by addition of an 
aqueous solution of sodium hydroxide (2M). The mixture was extracted with ethyl acetate 
(3×20 mL), washed with brine (20 mL), dried over MgSO4, and concentrated under vacuum. 
The resulting brown oil was then purified by ion-exchange low pKa sorbent column (SCX). 
Two column volume of MeOH were used to wash impurities. A solution of ammonia in 
MeOH (2M) was then used to release the pure pyridone (+)-121 from the column, as a brown 
solid (540 mg, 33%): 1H NMR (400 MHz, CDCl3) δ 0.70 (s, 3H, 12-H), 1.24 (d, J = 9.2 Hz, 
1H, 9-H), 1.37 (s, 3H, 13-H), 2.28 (m, 1H, 8-H), 2.56 (t, J = 5.5 Hz, 1H, 10-H), 2.63 (dt, J = 
9.2, 5.5 Hz, 1H, 9-H’), 2.85-3.00 (m, 2H, 7-H), 6.32 (d, J = 8.9 Hz, 1H, 3-H), 7.14 (d, J = 8.9 
Hz, 1H, 4-H), 13.52 (br s, 1H, N-H); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH3-12), 26.0 
(CH3-13), 31.5 (CH2-7), 32.8 (CH2-9), 39.6 (CH-8), 40.3 (C-11), 44.2 (CH-10), 115.0 
(CH-3), 124.9 (C-5), 141.3 (CH-4), 142.2 (C-6), 165.4 (C=O) in accordance with the 
literature data.383H24  
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(8S,10S)-(+)-11,11-Dimethyl-1-azatricyclo[7.1.1.05,6]undeca-3,5-dien-2-yl 
trifluoromethanesulfonate (+)-122 
N O
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13
10
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9
7
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311 5
6 2
S
CF3O
O
C13H14F3NO3S
Mol. Wt.: 321,32  
Triflic anhydride (0.32 mL, 2 mmol, 2.0 equiv) was added dropwise to a solution of pyridone 
(+)-121 (194 mg, 1 mmol, 1.0 equiv) and triethylamine (0.21 mL, 1.5 mmol, 1.5 equiv) in 
CH2Cl2 at –45 ºC. The resulting mixture was stirred at this temperature for 1 h., followed by 
an additional 1 h at 0 ºC and finally allowed to reach room temperature. The reaction was 
quenched by addition of an aqueous solution of sodium carbonate (1M). The mixture was 
extracted with CH2Cl2 (3×20 mL), the organic extract was washed with brine (20 mL), dried 
over MgSO4, and concentrated under vacuum to afford the pure triflate (+)-122 (277 mg, 
86%) as a brown oil: 1H NMR (400 MHz, CDCl3) δ 0.63 (s, 3H, 12-H), 1.27 (d, J = 9.9 Hz, 
1H, 9-H), 1.41 (s, 3H, 13-H), 2.37 (tt, J = 5.8, 2.9 Hz, 1H, 8-H), 2.71 (dt, J = 9.9, 5.8 Hz, 1H, 
9-H’), 2.82 (t, J = 5.8 Hz, 1H, 10-H), 3.08 (d, J = 2.9 Hz, 2H, 7-H), 6.86 (d, J = 8.0 Hz, 1H, 
3-H), 7.36 (d, J = 8.0 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3) δ 21.2 (CH3-12), 25.8 
(CH3-13), 31.6 (CH2-9), 36.1 (CH2-7), 39.3 (C-11), 39.7 (CH-8), 45.7 (CH-10), 111.3 
(CH-3), 118.9 (q, J = 276 Hz, CF3), 137.1 (CH-4), 143.0 (C-5), 153.8 (C-6), 157.1 (C-2) in 
accordance with the literature data.384H24 
 
 (8S,10S)-2-Chloro-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-triene 123 
N Cl
12
13
10
8
9
7
4
311 5
6 2
C12H14ClN
Mol. Wt.: 207,7  
Pyridinium chloride (100 mg, 0.864 mmol, 2 equiv) was added to a solution of triflate (+)-
122 (139 mg, 0.431 mmol, 1 equiv) in N-methyl-2-pyrrolidone (2.6 mL) and the mixture was 
stirred under microwave irradiation (250 ºC) for 15 min. The resulting mixture was diluted 
with ethyl acetate (4 mL), the organic layer was washed with water (2×10 mL), dried over 
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MgSO4, and concentrated under vacuum. The resulting brownish oil was purified by column 
chromatography on silica gel (4 g) using a mixture of hexane and ethyl acetate (1:1) to give 
pure 123 (32 mg, 36%) as a colourless oil: 1H NMR (400 MHz, CDCl3) δ 0.63 (s, 3H, 12-H), 
1.27 (d, J = 9.8 Hz, 1H, 9-H), 1.40 (s, 3H, 13-H), 2.38 (m, 1H, 8-H), 2.69 (dt, J = 9.8, 5.7 Hz, 
1H, 9-H’), 2.75 (t, J = 5.7 Hz, 1H, 10-H), 3.08 (d, J = 2.1 Hz, 2H, 7-H), 7.01 (d, J = 8.9 Hz, 
1H, 3-H), 7.17 (d, J = 8.9 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3) δ 21.0 (CH3-12), 25.9 
(CH3-13), 31.9 (CH2-7), 36.2 (CH2-9), 39.3 (C-11), 39.9 (CH-8), 45.8 (CH-10), 120.5 
(CH-3), 135.7 (CH-4), 140.7 (C-5), 147.8 (C-6), 157.8 (C-2); LCMS (GSK-gold) 3.31 min – 
mass 208.1. 
 
(8S,10S)-(+)-11,11-Dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-124 
N
12
13
10
8
9
7
4
311 5
6 2
C12H15N
Mol. Wt.: 173,25  
Procedure A: from chloropyridine 
A mixture of 10% Pd/C (10 mg, 0.0077 mmol, 0.05 equiv) and 2-chloropyridine derivative 
123 (32 mg, 0.155 mmol, 1.00 equiv) in formic acid 99% (0.25 mL) and DMF (1.25 mL) was 
heated at 60 ºC for 5 h. The mixture was then cooled to room temperature, diluted with 
CH2Cl2 (4 mL) and filtered through a plug of celite. The filtrate was made alkaline by 
addition of an aqueous solution of sodium hydroxide (2M). The mixture was then extracted 
with CH2Cl2 (3×20 mL), dried over MgSO4, and concentrated under vacuum to afford the 
pure pyridine (+)-124 (25.4 mg, 95%). 
 
Procedure B: from triflate 
Formic acid 99% (38 μL, 1.00 mmol, 2.00 equiv) was added dropwise to a solution of the 
triflate derivative (+)-122 (160 mg, 0.50 mmol, 1.00 equiv), triethylamine (0.21 mL, 1.50 
mmol, 3.00 equiv), palladium(II) acetate (2.3 mg, 0.01 mmol, 0.02 equiv) and 1,1’-
bis(diphenylphosphino)ferrocene (12 mg, 0.02 mmol, 0.04 equiv) in DMF (1 mL). The 
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reaction mixture was stirred at 60 ºC for 2 h under argon, then cooled to room temperature 
and diluted with water (4 mL). The resulting mixture was extracted with ether (3×10 mL) and 
the combined organic layers were washed successively with a saturated aqueous solution of 
NaHCO3 (30 mL) and brine (30 mL), dried over Na2SO4, and evaporated. The brown residue 
was then purified by column chromatography on silica gel (4 g) using a mixture of hexane 
and ethyl acetate (9:1), to afford pure (+)-124 (55.6 mg, 65%) as a colourless oil: [α]D20 +51.8 
(c 1.0, CHCl3); IR (KBr) ν 3020 (m, C-H), 1573 (m, C=Car), 1524 (m, C=Car), 1430 (m, 
C=Car), 758 (s, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.61 (s, 3H, 12-H), 1.24 (d, J = 
9.5 Hz, 1H, 9-H), 1.37 (s, 3H, 13-H), 2.33 (tt, J = 5.8, 2.8 Hz, 1H, 8-H), 2.64 (dt, J = 9.5, 5.8 
Hz, 1H, 9-H’), 2.71 (t, J = 5.8 Hz, 1H, 10-H), 3.08 (d, J = 2.8 Hz, 2H, 7-H), 6.93 (dd, J = 7.4, 
5.0 Hz, 1H, 3-H), 7.15 (dd, J = 7.4, 1.3 Hz, 1H, 4-H), 8.31 (dd, J = 5.0, 1.4 Hz, 1H, 2-H); 13C 
NMR (100 MHz, CDCl3) δ 21.1 (CH3-12), 26.0 (CH3-13), 31.8 (CH2-9), 36.4 (CH2-7), 39.3 
(C-11), 40.1 (CH-8), 46.4 (CH-10), 120.2 (CH-3), 132.8 (CH-4), 141.7 (C-5), 146.6 (CH-2), 
156.8 (C-6); MS (CI-isobutane) m/z (%) 174 ((M+H)+, 100), 95 (11), 69 (61); HRMS 
(CI-isobutane) 174.1284 (C12H16N (M+H)+ requires 174.1283). 
 
Borane-protected (7R,8S,10S)-(+)-7-(diphenylphosphino)-11,11-Dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-125 
13
BH3
N
12 10
9
7
4
311 5
6 2
P
8
C24H27BNP
Mol. Wt.: 371.26  
A solution of n-buthyllithium in hexane (1.6M; 0.42 mL, 0.67 mmol, 1.0 equiv) was added 
dropwise to a solution of (+)-124 (120 mg, 0.67 mmol, 1.0 equiv) in THF (2 mL) at –40 °C. 
The solution was stirred at that temperature for 1 h and then a solution of Ph2PCl.BH3 (1.0 
mmol, 1.5 equiv) was added dropwise at –40 °C [the Ph2PCl.BH3 solution was prepared by 
stirring for 30 min a mixture of borane in THF (1M, 1 mL, 1.0 mmol, 1.0 equiv) and 
chlorodiphenylphosphine (0.18 mL, 1.0 mmol, 1.0 equiv) in diethyl ether (2 mL) at room 
temperature]. The resulting solution was then gradually warmed up to room temperature and 
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stirred overnight. A saturated aqueous solution of NH4Cl (2 mL) was then added to quench 
the reaction, the mixture was extracted with CH2Cl2 (3×20 mL), and the combined organic 
extracts were washed with brine (20 mL) and dried over MgSO4. The solvent was removed 
under vacuum and the residue was purified by chromatography on silica gel (20 g) using a 
mixture of hexane and ether (20:1) to give pure (+)-125 as a white solid (103 mg, 42%): 
[α]D26 +45.7 (c 1.0, CHCl3); IR (KBr) ν 3018 (m, C-H), 2389 (m, B-H), 1576 (m, C=Car), 
1525 (m, C=Car), 1432 (m, C=Car), 1213 (s, P-BH3), 758 (s, C-Har) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.69 (s, 3H, 12-H), 1.40 (s, 3H, 13-H), 1.50 (d, J = 10.3 Hz, 1H, 9-H), 2.53 
(dt, J = 10.3, 5.8 Hz, 1H, 9-H’), 2.67 (t, J = 5.8 Hz, 1H, 10-H), 2.70 (qd, J = 6.2, 2.1 Hz, 1H, 
8-H), 4.33 (dd, J2H,P = 13.8 Hz, J = 2.0 Hz, 1H, 7-H), 7.91-6.96 (m, 1H, 3-H), 7.15 (dd, J = 
7.5, 1.5 Hz, 1H, 4-H), 7.29 (td, J = 7.6, 2.0 Hz, 2H, aromH), 7.38 (td, J = 7.6, 1.4 Hz, 1H, 
aromH), 7.45-7.52 (m, 3H, 3×aromH), 7.74 (ddd, J = 10.7, 8.0, 1.2 Hz, 2H, 2×aromH), 7.92 
(ddd, J = 10.3, 7.7, 1.8 Hz, 2H, 2×aromH), 8.23 (dd, J = 4.9, 1.7 Hz, 1H, 2-H); 13C NMR 
(100 MHz, CDCl3) δ 20.7 (CH3-12), 25.8 (CH3-13), 28.4 (CH2-9), 42.0 (d, J = 10 Hz, C-11), 
42.4 (d, J = 29 Hz, CH-7), 42.7 (CH-8), 45.8 (d, J = 2 Hz, CH-10), 121.1 (CH-3), 127.8 (d, J 
= 10 Hz, 2×aromCH), 128.3 (d, J = 10 Hz, 2×aromCH), 129.3 (d, J = 53 Hz, C), 130.5 (d, J = 
2 Hz, aromCH), 130.6 (d, J = 2 Hz, aromCH), 130.9 (d, J = 55 Hz, C), 133.2 (CH-4), 133.21 
(d, J = 9 Hz, 2×aromCH), 134.2 (d, J = 9 Hz, 2×aromCH), 141.8 (d, J = 4 Hz, C-5), 146.4 (d, 
J = 2 Hz, CH-2), 153.6 (d, J = 6 Hz, C-6); 31P NMR (162.0 MHz, CDCl3) δ 26.7 (m); MS 
(EI) m/z (%) 371 (M•+, 22), 357 (M•+-BH3, 100), 172 (M•+-PPh2.BH3, 86), 130 (M•+-
PPh2•BH3-C3H6, 100); HRMS (EI) 371.1653 (C24H27BNP requires 371.1646); Anal. Calcd. 
for C24H27BNP: C, 77.64; H, 7.33; N, 3.77. Found: C, 77.74; H, 7.44; N, 3.71. 
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(7R,8R,10S)-2-Phenyl-7-(diphenylphosphino)-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene 108 
13
N
12 10
9
7
4
311 5
6 2
6'
2'
5'
3'
4'
1'
P
8
C30H28NP
Mol. Wt.: 433.52  
Borane-protected diphenylphosphine (–)-115 was dissolved in diethylamine (1-2 mL) and 
stirred for 6 h. The conversion was monitored by TLC. After completion of the reaction all 
volatiles were removed under high-vacuum at 60 °C to afford 108: 31P NMR (162.0 MHz, 
CDCl3) δ -5.28 (s). No other experimental data were recorded because of rapid oxidation of 
phosphine 108. 
 
6.3.2 70BSynthesis of the Second Generation of Ligands 
1-[2-(2’-Fluorophenyl)-2-oxoethyl]pyridinium iodide 43 
N
O
I
1
4
4'
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7 7'
8'8
9
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3
F
C13H11FINO
Mol. Wt.: 343,14  
A solution of 2’-fluoroacetophenone 42 (2.76 g, 20 mmol) and iodine (5.08 g, 20 mmol, 1.0 
equiv) in pyridine (10 mL) was refluxed overnight. The reaction mixture was cooled to room 
temperature, inducing the precipitation of a solid which was filtered off and washed with eher 
(3×20 mL). The remaining solid was then stirred overnight in diethyl ether (50 mL). After 
filtration, the salt 43 was isolated as a brown solid (5.22 g, 76%): 1H NMR (400 MHz, d4-
MeOD) δ 6.30 (s, 2H, 1–H), 7.38-7.43 (m, 2H, 5–H, 5’–H), 7.75-7.82 (m, 1H, 6–H), 8.06 
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(dd, J = 7.3, 1.7 Hz, 1H, 4’–H), 8.20-8.24 (m, 2H, 8–H, 8’–H), 8.73 (tt, J = 7.9, 1.3 Hz, 1H, 
9–H), 8.95 (dd, J = 6.5, 1.3 Hz, 2H, 7–H, 7’–H) in agreement with the literature data.385H30a  
(8S,10S)-(+)-2-(2’-Fluorophenyl)-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-
triene (+)-44a 
C18H18FN
Mol. Wt.: 267,34
N
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A solution of pinocarvone (–)-16 (1.05 g, 7.0 mmol, 1.0 equiv), the Kröhnke salt 43 (2.41 g, 
7.0 mmol, 1.0 equiv), and ammonium acetate (9.25 g) in acetic acid (12 mL) was refluxed for 
6 h. The mixture was then cooled to room temperature, diluted with water (25 mL), made 
neutral by addition of an aqueous solution of sodium hydroxide (2M), and extracted with 
ethyl acetate (3×50 mL). The organic phase was successively washed with water (3×50 mL) 
and brine (50 mL) and dried over MgSO4. The solvent was removed under vacuum to afford 
pure (+)-44a as a red oil (1.25 g, 67%): [α]D19 +68.8 (c 1.0, CHCl3); IR (NaCl) ν 2939 (s, 
C-H), 1588 (s, C=Car), 1595 (s, C=Car), 1440 (s, C=Car), 1225 (m, C-H methyl), 1108 (s, 
C-F), 752 (m, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.69 (s, 3H, 12-H), 1.32 (d, J = 
9.6 Hz, 1H, 9-H), 1.41 (s, 3H, 13-H), 2.39 (tt, J = 5.8, 2.9 Hz, 1H, 8-H), 2.71 (dt, J = 9.6, 5.8 
Hz, 1H, 9-H’), 2.79 (t, J = 5.8 Hz, 1H, 10-H), 3.18 (d, J = 2.9 Hz, 2H, 7-H), 7.12 (ddd, J = 
11.3, 8.1, 1.2 Hz, 1H, 3’-H), 7.23 (td, J = 7.9, 1.3 Hz, 1H, 5’-H), 7.25 (d, J = 7.8 Hz, 1H, 
4-H), 7.31 (m, 1H, 4’-H), 7.46 (dd, J = 7.8, 2.4 Hz, 1H, 3-H), 7.96 (td, J = 7.9, 1.9 Hz, 1H, 
6’-H); 13C NMR (100 MHz, CDCl3) δ 21.3 (CH3-12), 26.0 (CH3-13), 31.9 (CH2-9), 36.7 
(CH2-7), 39.5 (C-11), 40.2 (CH-8), 46.3 (CH-10), 116.0 (d, J = 23 Hz, CH-3’), 121.1 (d, J = 
9 Hz, CH-3), 124.4 (d, J = 4 Hz, CH-5’), 127.9 (d, J = 12 Hz, C-1’), 129.6 (d, J = 8 Hz, 
CH-4’), 130.9 (d, J = 3 Hz, CH-6’), 133.1 (CH-4), 140.7 (C-5), 150.3 (d, J = 2 Hz, C-2), 
156.9 (C-6), 160.3 (d, J = 249 Hz, C-2’); 19F NMR (376 MHz, CDCl3) δ –117.4 (s); MS (EI) 
m/z (%) 267 (M•+, 68), 252 (M•+-CH3, 52), 224 (100), 83 (38); HRMS (EI) 267.1427 
(C18H18FN requires 267.1423). 
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General Procedure for the Benzylic Alkylation of (+)-44a 
A solution of n-butyllithium in hexane (2.5M; 0.6 mL, 1.5 mmol, 1 equiv) was added 
dropwise to a solution of (+)-44a (400 mg, 1.5 mmol, 1 equiv) in anhydrous THF (2 mL) 
under argon at –40 °C. The solution was stirred at that temperature for 1 h, then the 
respective electrophile, iodomethane (0.1 mL, 1.5 mmol, 1 equiv) or 2-iodopropane (0.15 
mL, 1.5 mmol, 1 equiv) was added dropwise at –40 °C. The solution was then gradually 
warmed up to room temperature and stirred overnight. The reaction was quenched by 
addition of water (15 mL), the aqueous phase was extracted with CH2Cl2 (3×20 mL), and the 
combined organic extracts were washed with brine (20 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the residue was purified by chromatography on silica 
gel (15 g) using a mixture of petroleum ether and ethyl acetate (97:3) to give, respectively, 
pure (+)-44b as a colourless oil, or pure (+)-44c as a colourless oil.  
(7R,8S,10S)-(+)-2-(2’-Fluorophenyl)-7,11,11-trimethyl-1-azatricyclo[7.1.1.05,6]undeca-
2,4,6-triene (+)-44b 
N
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C19H20FN
Mol. Wt.: 281,37  
(+)-44b (246 mg, 59%): [α]D20 +38.4 (c 1.0, CHCl3); IR (NaCl) ν 2945 (s, C-H), 1586 (m, 
C=Car), 1488 (m, C=Car), 1437 (m, C=Car), 1206 (m, C-H methyl), 1031 (s, C-F), 754 (m, 
C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.65 (s, 3H, 12-H), 1.31 (d, J = 9.8 Hz, 1H, 
9-H), 1.38 (s, 3H, 13-H), 1.44 (d, J = 7.1 Hz, 3H, CH3C(7)), 2.13 (td, J = 5.8, 2.5 Hz, 1H, 
8-H), 2.53 (dt, J = 9.8, 5.8 Hz, 1H, 9-H’), 2.74 (t, J = 5.8 Hz, 1H, 10-H), 3.24 (qd, J = 7.1, 2.5 
Hz, 1H, 7-H), 7.09 (ddd, J = 11.5, 8.1, 1.3 Hz, 1H, 3’-H), 7.18 (d, J = 7.8 Hz, 1H, 4-H), 7.20 
(td, J = 7.6, 1.3 Hz, 1H, 5’-H), 7.24-7.29 (m, 1H, 4’-H), 7.48 (dd, J = 7.8, 2.0 Hz, 1H, 3-H), 
7.96 (td, J = 7.9, 1.9 Hz, 1H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 18.2 (CH3C(7)), 20.8 
(CH3-12), 26.2 (CH3-13), 28.5 (CH2-9), 38.8 (CH-7), 41.3 (C-11), 46.7 (CH-8), 46.9 
(CH-10), 115.9 (d, J = 23 Hz, CH-3’), 121.0 (d, J = 9 Hz, CH-3), 124.2 (d, J = 4 Hz, CH-5’), 
127.8 (d, J = 12 Hz, C-1’), 129.5 (d, J = 9 Hz, CH-4’), 130.9 (d, J = 4 Hz, CH-6’), 132.8 
(CH-4), 140.4 (C-5), 149.9 (d, J = 3 Hz, C-2), 160.4 (d, J = 249 Hz, C-2’), 160.6 (C-6); 19F 
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NMR (376 MHz, CDCl3) δ –116.9 (s); MS (EI) m/z (%) 281 (M•+, 19), 266 (M•+-CH3, 50), 
238 (62), 224 (12), 83 (100); HRMS (EI) 281.1583 (C19H20FN requires 281.1580). 
 
(7R,8S,10S)-(+)-2-(2’-Fluorophenyl)-7-isopropyl-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-44c. 
N
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Mol. Wt.: 309,42  
(+)-44c (309 mg, 67%): [α]D25 +15.8 (c 1.0, CHCl3); IR (NaCl) ν 2942 (s, C-H), 1587 (m, 
C=Car), 1483 (m, C=Car), 1432 (m, C=Car), 1213 (m, C-H methyl), 1056 (s, C-F), 752 (m, 
C-Har) cm-1;  1H NMR (400 MHz, CDCl3) δ 0.59 (s, 3H, 12-H), 0.81 (d, J = 7.0 Hz, 3H, 
CH3CH), 1.17 (d, J = 7.0 Hz, 3H, CH3’CH), 1.35 (d, J = 9.7 Hz, 1H, 9-H), 1.36 (s, 3H, 
13-H), 2.32 (td, J = 5.7, 2.0 Hz, 1H, 8-H), 2.52 (dt, J = 9.7, 5.7 Hz, 1H, 9-H’), 2.68 (t, J = 5.7 
Hz, 1H, 10-H), 2.83 (spd, J = 7.0, 4.7 Hz, 1H, (CH3)2CH), 2.93 (dd, J = 4.7, 2.0 Hz, 1H, 
7-H), 7.06 (ddd, J = 11.5, 8.1, 1.3 Hz, 1H, 3’-H), 7.17 (d, J = 7.8 Hz, 1H, 4-H), 7.18 (td, J = 
7.5, 1.4 Hz, 1H, 5’-H), 7.22-7.27 (m, 1H, 4’-H), 7.47 (dd, J = 7.8, 2.0 Hz, 1H, 3-H), 8.04 (td, 
J = 7.9, 2.0 Hz, 1H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 20.0 (CH3CH), 21.0 (CH3-12), 
22.2 (C’H3CH), 26.3 (CH3-13), 29.4 (CH2-9), 30.3 (CH3CHCH3), 41.2 (CH-8), 41.9 (C-11), 
46.5 (CH-10), 49.1 (CH-7), 116.0 (d, J = 23 Hz, CH-3’), 121.0 (d, J = 10 Hz, CH-3), 124.3 
(d, J = 4 Hz, CH-5’), 127.9 (d, J = 12 Hz, C-1’), 129.5 (d, J = 9 Hz, CH-4’), 130.9 (d, J = 3 
Hz, CH-6’), 132.9 (CH-4), 141.1 (C-5), 149.6 (d, J = 3 Hz, C-2), 159.2 (C-6), 160.5 (d, J = 
249 Hz, C-2’); 19F NMR (376 MHz, CDCl3) δ –116.9 (s); MS (EI) m/z (%) 309 (M•+, 17), 
294 (M•+-CH3, 15), 266 (M•+-CH(CH3)2, 84), 224 (100), 83 (78); HRMS (EI) 309.1897 
(C21H24FN requires 309.1893). 
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General Procedure for the Reaction of Fluoro Derivatives 44a-c with Ph2PK  
Diphenylphosphine (0.32 mL, 1.86 mmol, 2 equiv) was added to a suspension of potassium 
tert-butoxide (210 mg, 1.86 mmol, 2 equiv) and 18-crown-6 (490 mg, 1.86 mmol, 2 equiv) in 
THF (10 mL) at 0 °C and the resulting deep red solution was stirred at this temperature for 1 
h. A solution of the respective fluoro derivative 44a (250 mg, 0.93 mmol, 1 equiv), 44b (262 
mg, 0.93 mmol, 1 equiv), and 44c (287 mg, 0.93 mmol) in THF (2 mL) was then added 
dropwise and the mixture was stirred at room temperature for 48 h. Methanol (2 mL) was 
then added and the solvent was removed in vacuo to afford an oil that was purified via flash 
chromatography on silica gel (25 g) with use of petroleum ether followed by a 9:1 mixture of 
petroleum ether and ethyl acetate to give pure (+)-41a (167 mg, 42%) as a white solid. In the 
case of (+)-41b and (–)-41c, after evaporation of the solvent, the residue was dissolved in 
acetone (20 mL) and a 30% aqueous solution of hydrogene peroxide (3 mL) was added. The 
resulting mixture was stirred at room temperature for 10 min, and then partitioned between 
water and CH2Cl2. The layers were separated, the aqueous phase was extracted with CH2Cl2 
(3×10 mL), and the combined organic extracts were washed with water (20 mL) and brine 
(20 mL), dried over MgSO4, and concentrated under vacuum. The crude mixture was then 
purified via flash chromatography on silica gel (17 g) with a 1:1 mixture of petroleum ether 
and ethyl acetate, followed by pure methanol. The methanolic fraction was concentrated in 
vacuo and the residue was dissolved in ethanol (1.5 mL). Potassium hydroxide (1.3 mmol, 
56.1 mg, 1.3 equiv) was added to the latter solution and the reaction mixture was refluxed for 
4 h. The latter mixture was then cooled to room temperature and diluted with water (20 mL). 
The aqueous phase was extracted with ethyl acetate (3×20 mL) and the combined organic 
extracts were then washed with a saturated aqueous solution of NaHCO3 (3×20 mL), dried 
over MgSO4, and concentrated under vacuum. Finally, the residue was dissolved in toluene 
(10 mL), triethylamine (2.1 mL, 15 mmol, 15 equiv) and trichlorosilane (1 mL, 10 mmol, 10 
equiv) were added, and the resulting reaction mixture was refluxed for 24 h. The mixture was 
then diluted with an aqueous solution of sodium hydroxide (2M, 10 mL) and the aqueous 
phase was extracted with CH2Cl2 (3×10 mL). The combined organic extracts were washed 
with water (20 mL) and brine (20 mL) and dried over MgSO4 and concentrated under 
vacuum to afford pure (+)-41b (208 mg, 50%) and (–)-41c (230 mg, 52%), respectively.  
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(8S,10S)-(+)-2-[2’-(Diphenylphosphino)phenyl]-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-41a 
C30H28NP
Mol. Wt.: 433.52
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(+)-41a (167 mg, 42%): [α]D19 +58.5 (c 1.0, CHCl3); IR (KBr) ν 2936 (m, C-H), 1576 (m, 
C=Car), 1445 (m, C=Car), 1432 (m, C=Car), 1213 (m), 757 (s, C-Har) cm-1;  1H NMR (400 
MHz, CDCl3) δ 0.46 (s, 3H, 12-H), 1.13 (d, J = 9.4 Hz, 1H, 9-H), 1.27 (s, 3H, 13-H), 2.18 (tt, 
J = 5.7, 2.9 Hz, 1H, 8-H), 2.52 (dt, J = 9.4, 5.7 Hz, 1H, 9-H’), 2.60 (t, J = 5.7 Hz, 1H, 10-H), 
2.75 (d, J = 2.9 Hz, 2H, 7-H), 6.92 (ddd, J = 7.7, 4.1, 1.1 Hz, 1H, 3’-H), 7.02 (d, J = 7.7 Hz, 
1H, 4-H), 7.08 (d, J = 7.7 Hz, 1H, 5-H), 7.12-7.22 (m, 11H, aromH), 7.31 (td, J = 7.6, 1.3 Hz, 
1H, 5’-H), 7.51 (ddd, J = 7.6, 4.2, 1.2 Hz, 1H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 21.3 
(CH3-12), 26.0 (CH3-13), 31.7 (CH2-9), 36.0 (CH2-7), 39.4 (C-11), 40.1 (CH-8), 46.2 
(CH-10), 120.14 (d, J = 3.7 Hz, CH-3), 127.7, (CH-4’), 128.0-128.2 (6×aromCH), 128.5 
(CH-5’), 129.3 (d, J = 4 Hz, CH-6’), 132.6 (CH-4), 133.9 (d, J = 6.4 Hz, 2×aromCH), 134.1 
(d, J = 6.4 Hz, 2×aromCH), 134.2 (d, J = 30.5 Hz, CH-3’), 136.6 (d, J = 18 Hz, C-1’), 138.6 
(d, J = 11 Hz, CPAr2), 138.7 (d, J = 11 Hz, C’PAr2), 139.7 (C-5), 145.9 (d, J = 24 Hz, C-2’), 
155.6 (C-6), 155.8 (d, J = 2 Hz, C-2); 31P NMR (162.0 MHz, CDCl3) δ –9.3 (s); MS (EI) m/z 
(%) 433 (M•+, 10), 356 (M•+-C6H5, 100), 248 (M•+-PPh2, 5), 91 (12), 44 (76); HRMS (EI) 
433.1953 (C30H28NP requires 433.1959).  
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(7R,8S,10S)-(+)-2-[2’-(Diphenylphosphino)phenyl]-7,11,11-trimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-41b 
N
10
2
3
4
5
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
P
C31H30NP
Mol. Wt.: 447.55  
(+)-41b (208 mg, 50%): [α]D26 +3.4 (c 1.0, CHCl3); IR (KBr) ν 2942 (m, C-H), 1573 (m, 
C=Car), 1452 (m, C=Car), 1431 (m, C=Car), 1217 (m), 755 (s, C-Har) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.51 (s, 3H, 12-H), 0.90 (d, J = 7.0 Hz, 3H, CH3C(7)), 1.17 (d, J = 9.9 Hz, 
1H, 9-H), 1.31 (s, 3H, 13-H), 1.97 (td, J = 5.7, 2.4 Hz, 1H, 8-H), 2.41 (dt, J = 9.9, 5.7 Hz, 1H, 
9-H’), 2.63 (t, J = 5.7 Hz, 1H, 10-H), 2.90 (qd, J = 7.0, 2.4 Hz, 1H, 7-H), 6.96 (dd, J = 7.5, 
3.8 Hz, 1H, 3’-H), 7.06 (d, J = 7.7 Hz, 1H, 4-H), 7.11 (d, J = 7.7 Hz, 1H, 3-H), 7.15-7.25 (m, 
11H, aromH), 7.34 (td, J = 7.5, 1.0 Hz, 1H, 5’-H), 7.55 (ddd, J = 7.5, 4.3, 1.1 Hz, 1H, 6’-H); 
13C NMR (100 MHz, CDCl3) δ 17.7 (CH3C(7)), 20.9 (CH3-12), 26.2 (CH3-13), 28.5 (CH2-9), 
38.7 (CH-7), 41.3 (C-11), 46.8 (CH-8), 46.9 (CH-10), 120.2 (d, J = 3.0 Hz, CH-3), 127.7, 
(CH-4’), 128.0-128.2 (6×aromCH), 128.4 (CH-5’), 129.4 (d, J = 4.2 Hz, CH-6’), 132.5 (CH-
4), 133.7 (d, J = 15.1 Hz, 2×aromCH), 134.9 (d, J = 14.8 Hz, 2×aromCH), 134.4 (d, J = 21.4 
Hz, CH-3’), 136.1 (d, J = 18 Hz, C-1’), 139.0 (d, J = 11 Hz, CPAr2), 139.2 (d, J = 11 Hz, 
C’PAr2), 139.5 (C-5), 146.4 (d, J = 23 Hz, C-2’), 156.0 (d, J = 2 Hz, C-2), 159.6 (C-6); 31P 
NMR (162.0 MHz, CDCl3) δ –9.9 (s); MS (EI) m/z (%) 447 (M•+, 14), 370 (M•+-C6H5, 100); 
HRMS (EI) 447.2118 (C31H30NP requires 447.2116). 
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(7R,8S,10S)-(–)-2-[2’-(Diphenylphosphino)phenyl]-7-isopropyl-11,11-dimethyl-1- 
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (–)-41c 
N
10
2
3
4
5
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
P
C33H34NP
Mol. Wt.: 475.60  
(–)-41c (230 mg, 52%): [α]D26 –15.0 (c 1.0, CHCl3); IR (KBr) ν 2951 (m, C-H), 1571 (m, 
C=Car), 1449 (m, C=Car), 1433 (m, C=Car), 1215 (m), 752 (s, C-Har) cm-1; 1H NMR (400 
MHz, CDCl3) δ 0.49 (s, 3H, 12-H), 0.53 (d, J = 7.0 Hz, 3H, CH3CH), 0.73 (d, J = 7.0 Hz, 3H, 
CH3’CH), 1.30 (d, J = 9.9 Hz, 1H, 9-H), 1.31 (s, 3H, 13-H), 2.15-2.25 (m, 2H, 8-H, 
CH3CHCH3), 2.44 (dt, J = 9.9, 5.6 Hz, 1H, 9-H’), 2.60 (t, J = 5.6 Hz, 1H, 10-H), 2.63-2.67 
(m, 1H, 7-H), 6.99 (dd, J = 7.2, 3.8 Hz, 1H, 3’-H), 7.09 (d, J = 7.7 Hz, 1H, 4-H), 7.12 (d, J = 
7.7 Hz, 1H, 3-H), 7.14-7.26 (m, 11H, aromH), 7.33 (t, J = 7.2 Hz, 1H, 5’-H), 7.54 (dd, J = 
7.2, 4.4 Hz, 1H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 19.7 (CH3CH), 21.1 (CH3-12), 22.0 
(C’H3CH), 26.3 (CH3-13), 29.1 (CH(CH3)2), 29.5 (CH2-9), 40.4 (CH-8), 41.9 (C-11), 46.6 
(CH-10), 48.9 (CH-7), 120.4 (d, J = 3.1 Hz, CH-3), 127.7-128.2 (7×aromCH), 128.6 (CH-5’), 
129.6 (d, J = 5.0 Hz, CH-6’), 132.5 (CH-4), 133.6 (d, J = 18.8 Hz, 2×aromCH), 133.8 (d, J = 
18.8 Hz, 2×aromCH), 135.2 (d, J = 22.2 Hz, CH-3’), 135.8 (d, J = 18 Hz, C-1’), 139.0 (d, J = 
12.8 Hz, CPAr2), 139.3 (d, J = 12.6 Hz, C’PAr2), 140.3 (C-5), 147.4 (d, J = 25.7 Hz, C-2’), 
156.2 (d, J = 2.7 Hz, C-2), 158.2 (C-6); 31P NMR (162.0 MHz, CDCl3) δ –11.2 (s); MS (EI) 
m/z (%) 475 (M•+, 39), 398 (M•+-C6H5, 100), 355 (M•+-C6H5-(CH3)2CH, 32), 194 (60); 
HRMS (EI) 475.2428 (C33H34NP requires 475.2429). 
 
6.3.3 71BAsymmetric Palladium-Catalysed Baeyer-Villiger Oxidation 
Zinc-copper couple preparation 
A solution of copper sulfate (CuSO4·5H2O, 0.76 g) in water (5 mL) was added in two 
portions at 30-s intervals to a stirred mixture of zinc dust (6.5 g, 0.1 mol) in water (10 mL). 
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After 1 min the mixture was filtered through a sintered-glass Büchner funnel and the zinc–
copper couple was washed with water (2×5 mL), acetone (2×5 mL), ether (5 mL). The 
resulting dark-gray powder was dried at 100 °C under vacuum for 6 h and then stored under 
argon. 
 
General Procedure for the Formation of 2,2-Dichloro-Cyclobutanones 127a-j 
A solution of trichloroacetyl chloride (1.12 mL, 10.0 mmol, 2.0 equiv) and phosphorus 
oxychloride (0.51 mL, 5.5 mmol, 1.1 equiv) in ether (5 mL) was added dropwise to a solution 
of the vinyl derivative 126a-j (5.0 mmol, 1.0 equiv) and zinc-copper couple (0.98 g, 15.0 
mmol, 3.0 equiv) in ether (10 mL). The resulting solution was heated at 40 °C for 2 h and 
then stirred at room temperature overnight. The resulting mixture was filtered over Celite and 
the Celite was washed with ether (12 mL). Hexane (40 mL) was added to the filtrate, which 
was then gently stirred to help zinc dichloride to precipitate. The supernatant solution was 
successively washed with water (20 mL), a saturated aqueous solution of NaHCO3 (20 mL) 
and brine (20 mL), dried over Na2SO4, and concentrated under vacuum to afford pure 127a-j 
which were used directly in the next step without further purification. 
 
2,2-Dichloro-3-phenylcyclobutanone 127a 
Cl
Cl
O
C10H8Cl2O
Mol. Wt.: 215,08
2
1
3
4
1'
6'
2'
5'
3'
4'
 
127a: (1.042 g, 97%): 1H NMR (400 MHz, CDCl3) δ 3.55 (dd, J = 17.6, 10.3 Hz, 1H, 4-H), 
3.73 (dd, J = 17.6, 10.3 Hz, 1H, 4-H’), 4.26 (t, J = 10.3 Hz, 1H, 3-H), 7.33 (d, J = 7.2 Hz, 
2H, 2’-H, 6’-H), 7.40 (t, J = 7.2 Hz, 1H, 4’-H), 7.45 (t, J = 7.2 Hz, 2H, 3’-H, 5’-H); 13C 
NMR (100 MHz, CDCl3) δ 45.7 (CH2-4), 50.5 (CH-3), 89.5 (C-2), 128.0 (2×CH-2’,6’), 
128.3 (CH-4’), 128.6 (2×CH-3’,5’), 134.4 (C-1’), 191.9 (C=O-1) in agreement with the 
literature data.386H124a  
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2,2-Dichloro-3-(4’-toluyl)cyclobutanone  127b 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'
C11H10Cl2O
Mol. Wt.: 229.10  
127b: (1.040 g, 91%): 1H NMR (400 MHz, CDCl3) δ 2.33 (s, 3H, CH3), 3.41 (dd, J = 17.7, 
10.3 Hz, 1H, 4-H), 3.59 (dd, J = 17.7, 10.3 Hz, 1H, 4-H’), 4.13 (t, J = 10.3 Hz, 1H, 3-H), 
7.14 (d, J = 8.2 Hz, 2H, 3’-H, 5’-H), 7.18 (dd, J = 8.2 Hz, 2H, 2’-H, 6’-H) in agreement with 
the literature data.155F156 
 
2,2-Dichloro-3-(4’-fluorophenyl)cyclobutanone 127c 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'F
C10H7Cl2FO
Mol. Wt.: 233.07  
127c: (1.092 g, 94%): 1H NMR (400 MHz, CDCl3) δ 2.75 (dd, J = 17.7, 10.3 Hz, 1H, 4-H), 
3.55 (dd, J = 17.7, 10.3 Hz, 1H, 4-H’), 4.10 (t, J = 10.3 Hz, 1H, 3-H), 6.97 (t, J = 8.7 Hz, 2H, 
3’-H, 5’-H), 7.17 (dd, J = 8.7, 5.2 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 45.8 
(CH2-4), 49.8 (CH-3), 89.4 (C-2), 115.5 (d, J = 21.6 Hz, 2×CH-3’,5’), 129.7 (d, J = 8.2 Hz, 
2×CH-2’,6’), 130.2 (d, J = 3.3 Hz, C-1’), 162.4 (d, J = 247.4 Hz, CF-4’), 191.5 (C=O-1); 19F 
NMR (376 MHz, CDCl3) δ –113.2 (s). 
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2,2-Dichloro-3-(4’-chlorophenyl)cyclobutanone 127d 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'Cl
C10H7Cl3O
Mol. Wt.: 249.52  
127d: (1.121 g, 90%): 1H NMR (400 MHz, CDCl3) δ 3.49 (dd, J = 17.7, 10.3 Hz, 1H, 4-H), 
3.61 (dd, J = 17.7, 10.3 Hz, 1H, 4-H’), 4.14 (t, J = 10.3 Hz, 1H, 3-H), 7.18 (d, J = 8.9 Hz, 
2H, 3’-H, 5’-H), 7.34 (dd, J = 8.9 Hz, 2H, 2’-H, 6’-H) in agreement with the literature 
data.156F157 
2,2-Dichloro-3-(4’-bromophenyl)cyclobutanone 127e 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'Br
C10H7BrCl2O
Mol. Wt.: 293.97  
127e: (1.352 g, 92%): 1H NMR (400 MHz, CDCl3) δ 3.55 (dd, J = 17.6, 10.3 Hz, 1H, 4-H), 
3.67 (dd, J = 17.6, 10.3 Hz, 1H, 4-H’), 4.19 (t, J = 10.3 Hz, 1H, 3-H), 7.19 (d, J = 8.5 Hz, 
2H, 3’-H, 5’-H), 7.56 (dd, J = 8.5 Hz, 2H, 2’-H, 6’-H) in agreement with the literature 
data.157F158 
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2,2-Dichloro-3-(2’-bromophenyl)cyclobutanone 127f 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'
C10H7BrCl2O
Mol. Wt.: 293.97
Br
 
127f: (1.314 g, 94%): 1H NMR (400 MHz, CDCl3) δ 3.60 (d, J = 9.8 Hz, 2H, 4H), 4.67 (t, J 
= 9.8 Hz, 1H, 3-H), 7.13 (td, J = 7.7, 1,5 Hz, 1H, 4’-H), 7.17 (dd, J = 7.7, 1,5 Hz, 1H, 6’-H), 
7.28 (td, J = 7.7, 1.1 Hz, 1H, 5’-H), 7.58 (dd, J = 7.7, 1.1 Hz, 1H, 3’-H). Used without 
further purification. 
 
2,2-Dichloro-3-(2’-naphthyl)cyclobutanone 127g 
Cl
Cl
O
2
1
3
4
2'
1'
3'
8a'
4'
8'
4a'
7'
5'
6'
C14H10Cl2O
Mol. Wt.: 265.13  
127g (547 mg, 41%): 1H NMR (400 MHz, CDCl3) δ 3.35 (dd, J = 17.7, 10.3 Hz, 1H, 4-H), 
3.63 (dd, J = 17.7, 10.3 Hz, 1H, 4-H’), 4.17 (t, J = 10.3 Hz, 1H, 3-H), 7.33 (dd, J = 8.5, 1.8 
Hz, 1H, 3’-H), 7.37-7.45 (m, 2H, 6’-H, 7’-H), 7.63-7.67 (m, 1H, 1’-H), 7.72-7.80 (m, 3H, 4’-
H, 8’-H, 5’-H). Used without further purification. 
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2,2-Dichloro-3-(4’-methoxybenzyl)cyclobutanone 127h 
2
1
3 41'
6'
2'
5'
3'
4'MeO OCl Cl
5
C12H12Cl2O2
Mol. Wt.: 259.13  
127h (1.287 g, 99%): 1H NMR (400 MHz, CDCl3) δ 2.75 (dd, J = 14.0, 8.7 Hz, 1H, 4-H), 
3.03 (dd, J = 16.7, 8.0 Hz, 1H, 4-H’), 3.10-3.30 (m, 3H, CH2CH), 3.77 (s, 3H, CH3O), 6.86 
(d, J = 8.7 Hz, 2H, 3’-H, 5’-H), 7.15 (dd, J = 8.7, 2H, 2’-H, 6’-H). Used without further 
purification. 
 
2,2-Dichloro-3-(cyclohexyl)cyclobutanone 127i 
Cl
Cl
O
2
1
3
4
1'
6'
2'
5'
3'
4'
C10H14Cl2O
Mol. Wt.: 221.12  
127i: (1.062 g, 96%): 1H NMR (400 MHz, CDCl3) δ 0.92-1.35 (m, 5H), 1.51-1.79 (m, 5H), 
2.00-2.12 (m, 1H, 1’-H), 2.54 (q, J = 10.3 Hz, 1H, 3-H), 3.03 (dd, J = 17.4, 10.3 Hz, 1H, 
4-H), 3.13 (dd, J = 17.4, 10.3 Hz, 1H, 4-H’). Used without further purification. 
 
2,2-Dichloro-3-octylcyclobutanone 127j 
Cl
Cl
O
2
1
3
4
C12H20Cl2O
Mol. Wt.: 251.19  
127j (1.062 g, 85%): 1H NMR (400 MHz, CDCl3) δ 0.83 (t, J = 6.8 Hz, 3H, CH3CH2), 1.16-
1.46 (m, 12H, 6×CH2), 1.50-1.62 (m, 1H, CH2CH2CH), 1.80-1.90 (m, 1H, CH2CH2’CH), 
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2.78-2.87 (m, 1H, 3-H), 2.91 (dd, J = 17.1, 9.2 Hz, 1H, 4-H), 3.30 (dd, J = 17.1, 9.2 Hz, 1H, 
4-H’) in agreement with the literature data.158F159 
 
General Procedure for the Formation of Cyclobutanones 128a-j 
A mixture of dichloro ketone 127a-j (4 mmol, 1.0 equiv) and zinc dust (1.05 g, 16 mmol, 4.0 
equiv) in acetic acid (15 mL) was stirred at room temperature for 2 h and then refluxed for 5 
h. The resulting mixture was diluted with water (20 mL) and extracted with ether (2×30 mL). 
The organic phase was washed successively with a saturated solution of aqueous NaHCO3 
(3×20 mL), water (30 mL) and brine (30 mL), and dried over MgSO4 and concentrated under 
vacuum. The crude material was then purified by flash chromatography on silica gel (20 g) 
with a mixture of petroleum ether and ethyl acetate (5:1) to afford 128a-j as colourless oils. 
 
3-Phenylcyclobutanone 128a   
O
4
1
3
2
1'
6'
2'
5'
3'
4'
C10H10O
Mol. Wt.: 146,19  
128a: (503 mg, 86%): 1H NMR (400 MHz, CDCl3) δ 3.10-3.19 (m, 2H, 2-H, 4-H), 3.34-3.43 
(m, 2H, 2-H’, 4-H’), 3.57 (pent, J = 8.2 Hz, 1H, 3-H), 7.16 (t, J = 7.1 Hz, 1H, 4’-H), 7.20 (d, 
J = 7.1 Hz, 2H, 2’-H, 6’-H), 7.26 (t, J = 7.1 Hz, 2H, 3’-H, 5’-H); 13C NMR (100 MHz, 
CDCl3) δ 28.3 (CH-3), 54.6 (2×CH2-2,4), 126.4 (2×CH-2’,6’), 126.5 (CH-4’), 128.6 
(2×CH-3’,5’), 143.5 (C-1’), 206.5 (C=O-1) in agreement with the literature data.159F160  
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3-(4’-Toluyl)cyclobutanone 128b 
O
4
1
3
2
1'
6'
2'
5'
3'
4'
C11H12O
Mol. Wt.: 160.21  
128b (205 mg, 32%): IR (NaCl) ν 2922 (w, C-H), 1783 (s, C=O), 1608 (m, C=Car), 1570 (m, 
C=Car), 1515 (m, C=Car), 1161 (m), 1019 (m), 813 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 2.28 (s, 3H, CH3), 3.08-3.17 (m, 2H, 2-H, 4-H), 3.33-3.42 (m, 2H, 2-H’, 4-H’), 3.54 
(pent, J = 8.6 Hz, 1H, 3-H), 7.09 (d, J = 8.4 Hz, 2H, 3’-H, 5’-H), 7.12 (dd, J = 8.4 Hz, 2H, 
2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 20.7 (CH3), 27.7 (CH-3), 54.4 (2×CH2-2,4), 
126.1 (2×CH-2’,6’), 129.0 (2×CH-3’,5’), 135.8 (C-4’), 140.3 (C-1’), 206.5 (C=O-1); MS (EI) 
m/z (%) 160 (M•+, 12), 118 (M•+-CH2C=O, 100), 91 (M•+-C3H5C=O, 26), 83 (32); HRMS 
(EI) 160.0889 (C11H12O requires 160.0888). 
 
3-(4’-Fluorophenyl)cyclobutanone 128c   
O
4
1
3
2
1'
6'
2'
5'
3'
4'F
C10H9FO
Mol. Wt.: 164.18  
128c: (368 mg, 56%): IR (NaCl) ν 2977 (w, C-H), 1785 (s, C=O), 1604 (m, C=Car), 1511 
(m, C=Car), 1431 (m, C=Car), 1226 (s), 1103 (m, C-F), 829 (s, C-Har) cm-1; 1H NMR (400 
MHz, CDCl3) δ 3.07-3.18 (m, 2H, 2-H, 4-H), 3.35-3.47 (m, 2H, 2-H’, 4-H’), 3.58 (pent, J = 
8.3 Hz, 1H, 3-H), 6.95 (t, J = 8.6 Hz, 2H, 3’-H, 5’-H), 7.19 (dd, J = 8.6, 5.4 Hz, 2H, 2’-H, 
6’-H); 13C NMR (100 MHz, CDCl3) δ 27.5 (CH-3), 54.5 (2×CH2-2,4), 115.2 (d, J = 21.3 Hz, 
2×CH-3’,5’), 127.8 (d, J = 8.0 Hz, 2×CH-2’,6’), 139.1 (d, J = 3.1 Hz, C-1’), 161.3 (d, J = 
244.7 Hz, CF-4’), 206.0 (C=O-1); 19F NMR (376 MHz, CDCl3) δ –116.3 (s); MS (EI) m/z 
(%) 164 (M•+, 4), 122 (M•+-CH2C=O, 100), 84 (61), 49 (86); HRMS (EI) 164.0638 (C10H9FO 
requires 164.0637). 
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3-(4’-Chlorophenyl)cyclobutanone 128d 
O
4
1
3
2
1'
6'
2'
5'
3'
4'Cl
C10H9ClO
Mol. Wt.: 180.63  
128d: (332 mg, 46%): IR (NaCl) ν 2974 (w, C-H), 1786 (s, C=O), 1593 (m, C=Car), 1493 
(m, C=Car), 1092 (s, C-Cl), 1013 (m), 821 (s, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 
3.13-3.23 (m, 2H, 2-H, 4-H), 3.42-3.53 (m, 2H, 2-H’, 4-H’), 3.63 (pent, J = 8.3 Hz, 1H, 3-H), 
7.21 (d, J = 8.4 Hz, 2H, 2’-H, 6’-H), 7.29 (d, J = 8.4 Hz, 2H, 3’-H, 5’-H); 13C NMR (100 
MHz, CDCl3) δ 27.7 (CH-3), 54.5 (2×CH2-2,4), 127.7 (2×CH-3’,5’), 128.5 (2×CH-2’,6’), 
132.1 (C-4’), 141.9 (C-1), 205.8 (C=O-1) in agreement with the literature data.160F161 
 
3-(4’-Bromophenyl)cyclobutanone 128e 
O
4
1
3
2
1'
6'
2'
5'
3'4'
C10H9BrO
Mol. Wt.: 225.08
Br
 
128e (459 mg, 51%): IR (NaCl) ν 2976 (w, C-H), 1786 (s, C=O), 1589 (m, C=Car), 1489 (m, 
C=Car), 1073 (s), 1009 (m), 817 (s, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 3.16-3.25 
(m, 2H, 2-H, 4-H), 3.45-3.55 (m, 2H, 2-H’, 4-H’), 3.64 (pent, J = 8.4 Hz, 1H, 3-H), 7.17 (d, J 
= 8.3 Hz, 2H, 2’-H, 6’-H), 7.47 (d, J = 8.3 Hz, 2H, 3’-H, 5’-H); 13C NMR (100 MHz, CDCl3) 
δ 28.0 (CH-3), 54.6 (2×CH2-2,4), 120.4 (C-4’), 128.2 (2×CH-2’,6’), 131.7 (2×CH-3’,5’), 
142.5 (C-1’), 206.0 (C=O-1); MS (EI) m/z (%) 224/226 (M•+, 7/7), 183 (M•+-CH2C=O, 100), 
115 (17), 103 (M•+-CH2C=O-Br, 60), 77 (42); HRMS (EI) 223.9835 (C10H979BrO requires 
223.9837). 
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3-(2’-Bromophenyl)cyclobutanone 128f 
O
4
1
3
2
1'
6'
2'
5'
3'
4'
C10H9BrO
Mol. Wt.: 225.08
Br
 
128f (468 mg, 52%): IR (NaCl) ν 2981 (w, C-H), 1786 (s, C=O), 1590 (m, C=Car), 1566 (m, 
C=Car), 1472 (m, C=Car), 1102 (s), 1026 (s), 754 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 3.18-3.27 (m, 2H, 2-H, 4-H), 3.49-3.58 (m, 2H, 2-H’, 4-H’), 3.95 (pent, J = 8.3 Hz, 
1H, 3-H), 7.14 (ddd, J = 8.4, 6.1, 3.0 Hz, 1H, 4’-H), 7.32-7.38 (m, 2H, 5’-H, 6’-H), 7.61 (d, J 
= 8.4 Hz, 1H, 3’-H); 13C NMR (100 MHz, CDCl3) δ 28.9 (CH-3), 52.9 (2×CH2-2,4), 124.7 
(C-2’), 126.4 (CH-5’), 127.5 (CH-4’), 128.2 (CH-6’), 133.0 (CH-3’), 141.5 (C-1’), 205.9 
(C=O-1); MS (CI-Isobutane) m/z (%) 225/227 (M•+, 100/98), 183 (M•+-CH2C=O, 30), 147 
(28), 103 (M•+-CH2C=O-Br, 25); HRMS (CI-Isobutane) 224.9912 (C10H1079BrO (M+H)+ 
requires 224.9915). 
 
3-(2’-Naphthyl)cyclobutanone 128g 
O2 1
3
42'
1'
3'
8a'
4'
8'
4a'
7'
5'
6'
C14H12O
Mol. Wt.: 196.24  
128g: (60.8 mg, 15%): IR (NaCl) ν 3050 (w, Car-H), 1781 (s, C=O), 1623 (m, C=Car), 1511 
(m, C=Car), 1430 (m, C=Car), 1226 (s), 817 (s, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 
3.22-3.32 (m, 2H, 2a-H, 4a-H), 3.43-3.52 (m, 2H, 2-H’, 4-H’), 3.74 (pent, J = 8.3 Hz, 1H, 
3-H), 7.33 (dd, J = 8.5, 1.8 Hz, 1H, 3’-H), 7.37-7.45 (m, 2H, 6’-H, 7’-H), 7.64 (br s, 1H, 
1’-H), 7.72-7.80 (m, 3H, 4’-H, 8’-H, 5’-H); 13C NMR (100 MHz, CDCl3) δ 28.5 (CH-3), 
54.5 (2×CH2-2,4), 124.7 (CH-1’), 124.8 (CH-3’), 125.7 (CH-6’), 126.3 (CH-7’), 127.48 (CH-
4’), 127.54 (CH-8’), 128.5 (CH-5’), 132.1 (C-8a’), 133.2 (C-4a’), 140.7 (C-2’), 206.6 
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(C=O-1); MS (CI-Isobutane) m/z (%) 197 ((M+H)+, 95), 154 ((M+H)+-CH2C=O, 12), 85 
(72), 69 (100); HRMS (CI-isobutane) 197.0967 (C14H13O (M+H)+ requires 197.0966). 
 
3-(4’-Methoxybenzyl)cyclobutanone 128h 
2
1
3
4
1'
6'
2'
5'
3'
4'MeO O
5
C12H14O2
Mol. Wt.: 190.24  
128h: (400 mg, 43%): IR (NaCl) ν 2957 (w, Car-H), 1777 (s, C=O), 1612 (m, C=Car), 1590 
(m, C=Car), 1512 (m, C=Car), 1247 (s, C-O), 836 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 2.51-2.61 (m, 1H, 3-H), 2.62-2.71 (m, 2H, 2-H, 4-H), 2.75 (d, J = 7.5 Hz, 2H, 
CH2CH), 2.96-3.05 (m, 2H, 2-H’, 4-H’), 3.70 (s, 3H, CH3O), 6.80 (d, J = 8.6 Hz, 2H, 3’-H, 
5’-H), 7.05 (d, J = 8.6 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 24.7 (CH-3), 40.4 
(CH2CH), 51.6 (2×CH2-2,4), 54.7 (CH3), 113.5 (2×CH-3’,5’), 129.0 (2×CH-2’,6’), 131.6 
(C-1’), 157.7 (C-4’), 207.1 (C=O-1); MS (EI) m/z (%) 190 (M•+, 56), 148 (M•+-CH2C=O, 96), 
121 (M•+-C3H5C=O, 100), 77 (32);  HRMS (EI) 190.0997 (C12H14O2 requires 190.0994). 
 
3-(Cyclohexyl)cyclobutanone 128i 
O
4
1
3
2
1'
6'
2'
5'
3'
4'
C10H16O
Mol. Wt.: 152.23  
128i: (371 mg, 51%): IR (NaCl) ν 2923 (s, C-H), 2851 (s, C-H), 1786 (s, C=O), 1448 (m, 
CH2), 1108 (m) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.78-0.92 (m, 2H), 1.02-1.22 (m, 4H), 
1.54-1.74 (m, 5H), 1.90-2.03 (m, 1H, 3-H), 2.60-2.70 (m, 2H, 2-H, 4-H), 2.89-3.00 (m, 2H, 
2-H’, 4-H’); 13C NMR (100 MHz, CDCl3) δ 25.7 (2× CH2), 25.9 (CH2-4’), 29.6 (CH-3), 30.6 
(2×CH2), 43.4 (CH-1’), 50.5 (2×CH2-2,4), 207.9 (C=O-1); MS (CI-Isobutane) m/z (%) 153 
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((M+H)+, 100), 135 ((M+H)+-H2O, 15), 71 (10); HRMS (CI-Isobutane) 153.1281 (C10H17O 
(M+H)+ requires 153.1279). 
 
3-Octylcyclobutanone 128j 
O2 1
3
4
C12H22O
Mol. Wt.: 182.30  
128j: (354 mg, 46%): IR (NaCl) ν 2923 (s, C-H), 2854 (m, C-H), 1785 (s, C=O), 1461 (w), 
1380 (w), 1095 (w) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.83 (t, J = 6.8 Hz, 3H, CH3CH2), 
1.16-1.31 (m, 12H, 6×CH2), 1.48-1.56 (m, 2H, CH2CH), 2.29 (pent, J = 7.5, 1.2 Hz, 1H, 
3-H), 2.55-2.65 (m, 2H, 2-H, 4-H), 3.01-3.12 (m, 2H, 2-H’, 4-H’); 13C NMR (100 MHz, 
CDCl3) δ 13.9 (CH3CH2), 22.5 (CH2), 23.7 (CH-3), 28.1 (CH2), 29.1 (CH2), 29.3 (CH2), 29.4 
(CH2), 31.7 (CH2), 36.2 (CH2CH), 52.3 (2×CH2-2,4), 208.1 (C=O-1); MS (CI-Isobutane) m/z 
(%) 183 ((M+H)+, 100), 165 ((M+H)+-H2O, 9), 71 (18); HRMS (CI-Isobutane) 183.1747 
(C12H23O (M+H)+ requires 183.1749). 
 
General Procedure for the Formation of γ-Butyrolactones 129a-j  
A mixture of dichlorobis(benzonitrile)palladium(II) (9.5 mg, 0.025 mmol, 5.0 mol%) and 
ligand (–)-41c (13 mg, 0.0275 mmol, 5.5 mol%) in THF (2 mL) was stirred at room 
temperature for 1 h. Silver hexafluoroantimonate (17 mg, 0.05 mmol, 10 mol%) was then 
added and the reaction mixture was stirred for an additional 1 h. The mixture was then 
filtered over a Celite pad, cyclobutanone 128a-j (0.5 mmol, 1 equiv) was then added to the 
filtrate, and the solution was cooled to -40 °C. Urea-hydrogen peroxide (61 mg, 0.65 mmol, 
1.3 equiv) was then added and the mixture was stirred at -40 °C overnight. Concentration in 
vacuo, followed by flash chromatography on silica gel (15 g), using a mixture of petroleum 
ether and ethyl acetate (9:1) afforded pure γ-butyrolactones 129a-j. 
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(S)-(+)-3-Phenyl-γ-butyrolactone (S)-(+)-129a 
O
O
C10H10O2
Mol. Wt.: 162.19
3
1
2
1' 4
6'
2'
5'
3'
4'
 
(+)-129a: (78.6 mg, 97%): [α]D24 +38.4 (c 1.0, CHCl3, 81% ee), [lit.161F162 gives [α]D +46.0 (c 
0.95, CHCl3, 96% ee)]; 1H NMR (400 MHz, CDCl3) δ 2.58 (dd, J = 17.5, 8.9 Hz, 1H, 2-H), 
2.83 (dd, J = 17.5, 8.9 Hz, 1H, 2-H’), 3.70 (pent, J = 8.9 Hz, 1H, 3-H), 4.18 (dd, J = 8.9, 8.1 
Hz, 1H, 4-H), 4.57 (dd, J = 8.9, 8.1 Hz, 1H, 4-H’), 7.14 (d, J = 7.3 Hz, 2H, 2’-H, 6’-H), 7.21 
(t, J = 7.3 Hz, 1H, 4’-H), 7.28 (t, J = 7.3 Hz, 2H, 3’-H, 5’-H); 13C NMR (100 MHz, CDCl3) 
δ 35.6 (CH2-2), 41.0 (CH-3), 74.0 (CH2-4), 126.6 (2×CH-2’,6’), 127.6 (CH-4’), 129.1 
(2×CH-3’,5’), 139.3 (C-1’), 176.3 (C=O-1) in agreement with the literature data;162F163 Chiral 
GC (Supelco α-DEX), carrier gas, He (flow 2 mL.min-1), injection temp 200 °C, initial 
column temp 110 °C for 3 min, rate 1deg.min-1, final temp 220°C, tR = 56.11 min, tS = 56.58 
min.  
 
(S)-(+)-3-(4’-Toluyl)-γ-butyrolactone (S)-(+)-129b 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'
C11H12O2
Mol. Wt.: 176.21  
(+)-129b: (81.9 mg, 93%): [α]D24 +36.9 (c 1.0, CHCl3, 75% ee); 1H NMR (400 MHz, CDCl3) 
δ 2.34 (s, 3H, CH3), 2.65 (dd, J = 17.5, 8.9 Hz, 1H, 2-H), 2.90 (dd, J = 17.5, 8.9 Hz, 1H, 
2-H’), 3.75 (pent, J = 8.9 Hz, 1H, 3-H), 4.23 (dd, J = 8.9, 8.0 Hz, 1H, 4-H), 4.64 (dd, J = 8.9, 
8.0 Hz, 1H, 4-H’), 7.11 (d, J = 8.1 Hz, 2H, 3’-H, 5’-H), 7.17 (dd, J = 8.1 Hz, 2H, 2’-H, 6’-H); 
13C NMR (100 MHz, CDCl3) δ 21.0 (CH3), 35.7 (CH2-2), 40.8 (CH-3), 74.1 (CH2-4), 126.5 
(2×CH-3’,5’), 129.7 (2×CH-2’,6’), 136.3 (C-1’), 137.4 (C-4’), 176.4 (C=O-1) in agreement 
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with the literature data;163F164 Chiral GC (Supelco α-DEX), carrier gas, He (flow 2 mL.min-1), 
injection temp 200 °C, initial column temp 110 °C for 3 min, rate 1 deg.min-1, final temp 220 
°C, tR = 66.18 min, tS = 66.67 min. 
 
(+)-3-(4’-Fluorophenyl)-γ-butyrolactone (+)-129c 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'F
C10H9FO2
Mol. Wt.: 180.18  
(+)-129c: (86.5 mg, 96%): [α]D24 +29.8 (c 1.0, CHCl3, 72% ee); 1H NMR (400 MHz, CDCl3) 
δ 2.61 (dd, J = 17.5, 8.9 Hz, 1H, 2-H), 2.90 (dd, J = 17.5, 8.9 Hz, 1H, 2-H’), 3.77 (pent, J = 
8.9 Hz, 1H, 3-H), 4.21 (t, J = 8.9 Hz, 1H, 4-H), 4.64 (t, J = 8.9 Hz, 1H, 4-H’), 7.04 (t, J = 8.6 
Hz, 2H, 3’-H, 5’-H), 7.20 (dd, J = 8.6, 5.2 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) 
δ 35.6 (CH2-2), 40.2 (CH-3), 73.8 (CH2-4), 115.9 (d, J = 21.5 Hz, 2×CH-3’,5’), 128.2 (d, J = 
8.1 Hz, 2×CH-2’,6’), 135.1 (d, J = 3.2 Hz, C-1’), 161.9 (d, J = 246.4 Hz, C-4’), 176.1 
(C=O-1); 19F NMR (376 MHz, CDCl3) δ –114.5 (s) in agreement with the literature data;387H163 
Chiral GC (Supelco α-DEX), carrier gas, He (flow 2 mL.min-1), injection temp 200 °C, 
initial column temp 110 °C for 3 min, rate 1 deg.min-1, final temp 220°C, tminor = 58.06 min, 
tmajor = 58.64 min. 
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(S)-(+)-3-(4’-Chlorophenyl)-γ-butyrolactone (S)-(+)-129d 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'Cl
C10H9ClO2
Mol. Wt.: 196.63  
(+)-129d: (92.6 mg, 94%): [α]D24 +36.5 (c 1.0, CHCl3, 73% ee); 1H NMR (400 MHz, CDCl3) 
δ 2.62 (dd, J = 17.5, 8.8 Hz, 1H, 2-H), 2.93 (dd, J = 17.5, 8.8 Hz, 1H, 2-H’), 3.77 (pent, J = 
8.8 Hz, 1H, 3-H), 4.23 (dd, J = 8.8, 7.8 Hz, 1H, 4-H), 4.65 (dd, J = 8.8, 7.8 Hz, 1H, 4-H’), 
7.17 (d, J = 8.3 Hz, 2H, 2’-H, 6’-H), 7.34 (d, J = 8.3 Hz, 2H, 3’-H, 5’-H); 13C NMR (100 
MHz, CDCl3) δ 35.6 (CH2-2), 40.5 (CH-3), 73.7 (CH2-4), 128.0 (2×CH-2’,6’), 129.2 
(2×CH-3’,5’), 133.5 (C-4’), 137.9 (C-1’), 175.8 (C=O-1); in agreement with the literature 
data;388H163 Chiral GC (Supelco α-DEX), carrier gas, He (flow 2 mL.min-1), injection temp 200 
°C, initial column temp 110 °C for 3 min, rate 1 deg.min-1, final temp 220°C, tR = 81.43 min, 
tS = 81.90 min. 
 
(+)-3-(4’-Bromophenyl)-γ-butyrolactone (+)-129e 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'Br
C10H9BrO2
Mol. Wt.: 241.08  
(+)-129e: (114.5 mg, 95%): mp 60-62 °C (hexane); [α]D25 +28.6 (c 1.0, CHCl3, 76% ee); 1H 
NMR (400 MHz, CDCl3) δ 2.61 (dd, J = 17.5, 8.8 Hz, 1H, 2-H), 2.92 (dd, J = 17.5, 8.8 Hz, 
1H, 2-H’), 3.75 (pent, J = 8.8 Hz, 1H, 3-H), 4.22 (dd, J = 8.8, 7.7 Hz, 1H, 4-H), 4.65 (dd, J = 
8.8, 7.7 Hz, 1H, 4-H’), 7.11 (d, J = 8.3 Hz, 2H, 2’-H, 6’-H), 7.48 (d, J = 8.3 Hz, 2H, 3’-H, 5’-
H); 13C NMR (100 MHz, CDCl3) δ 35.5 (CH2-2), 40.5 (CH-3), 73.6 (CH2-4), 121.5 (C-4’), 
128.3 (2×CH-2’,6’), 132.1 (2×CH-3’,5’), 138.4 (C-1’), 175.8 (C=O-1); MS (EI) m/z (%) 
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240/242 (M•+, 31/32), 183 (M•+-CH2CO2, 100), 103 (M•+-CH2CO2-Br, 40); HRMS (EI) 
239.9792 (C10H979BrO2 requires 239.9786); Chiral HPLC (Chiracel IB, 0.75 mL.min-1, 
hexane/2-propanol, 92:8) tmajor = 33.4 min, tminor = 39.1 min after derivatisation into the 
hydroxyl benzylamide derivative.389H64b  
 
(+)-3-(2’-Bromophenyl)-γ-butyrolactone (+)-129f 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'
C10H9BrO2
Mol. Wt.: 241.08
Br
 
(+)-129f: (110.9 mg, 92%): mp 41-43 °C (hexane); [α]D25 +26.6 (c 1.0, CHCl3, 70% ee); 1H 
NMR (400 MHz, CDCl3) δ 2.67 (dd, J = 17.6, 8.7 Hz, 1H, 2-H), 2.98 (dd, J = 17.6, 8.7 Hz, 
1H, 2-H’), 4.23 (pent, J = 8.7 Hz, 1H, 3-H), 4.31 (dd, J = 8.7, 6.7 Hz, 1H, 4-H), 4.71 (dd, J = 
8.7, 6.7 Hz, 1H, 4-H’), 7.17 (td, J = 7.7, 1.7 Hz, 1H, 4’-H), 7.28 (dd, J = 7.7, 1.7 Hz, 1H, 
6’-H), 7.35 (td, J = 7.7, 1.2 Hz, 1H, 5’-H), 7.61 (dd, J = 7.7, 1.2 Hz, 1H, 3’-H); 13C NMR 
(100 MHz, CDCl3) δ 34.6 (CH2-2), 40.0 (CH-3), 72.8 (CH2-4), 124.3 (C-2’), 126.6 (CH-6’), 
128.2 (CH-5’), 129.1 (CH-4’), 133.4 (CH-3’), 138.6 (C-1’), 176.0 (C=O-1); MS (EI) m/z (%) 
240/242 (M•+, 29/28), 183 (M•+-CH2CO2, 100), 103 (M•+-CH2CO2-Br, 67); HRMS (EI) 
239.9787 (C10H979BrO2 requires 239.9786); Chiral HPLC (Chiracel OJ-H, 0.75 mL.min-1, 
hexane/2-propanol, 75:25) tminor = 9.1 min, tmajor = 10.4 min after derivatisation into the 
hydroxyl benzylamide derivative. 390H64b  
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(+)-3-(2’-Naphthyl)-γ-butyrolactone (+)-129g 
3
12
2'
4
1'
3'
8a'
4'
8' O
O
4a'
7'
5'
6'
C14H12O2
Mol. Wt.: 212.24  
(+)-129g: (88.1 mg, 83%): [α]D24 +43.6 (c 1.0, CHCl3, 71% ee); 1H NMR (400 MHz, CDCl3) 
δ 2.79 (dd, J = 17.5, 8.9 Hz, 1H, 2-H), 3.00 (dd, J = 17.5, 8.9 Hz, 1H, 2-H), 3.95 (pent, J = 
8.9 Hz, 1H, 3-H), 4.37 (dd, J = 8.9, 7.9 Hz, 1H, 4-H’), 4.74 (dd, J = 8.9, 7.9 Hz, 1H, 4-H’), 
7.34 (dd, J = 8.5, 1.8 Hz, 1H, 3’-H), 7.47-7.55 (m, 2H, 7’-H, 6’-H), 7.67 (br s, 1H, 1’-H), 
7.80-7.90 (m, 3H, 4’-H, 8’-H, 5’-H); 13C NMR (100 MHz, CDCl3) δ 35.6 (CH2-2), 41.1 
(CH-3), 73.9 (CH2-4), 124.4 (CH-3’), 125.4 (CH-1’), 126.2 (CH-6’), 126.6 (CH-7’), 127.60 
(CH-4’), 127.63 (CH-8’), 129.0 (CH-5’), 132.6 (C-8a’), 133.3 (C-4a’), 136.6 (C-2’), 176.4 
(C=O-1) in agreement with the literature data;391H163 Chiral HPLC (Chiracel IB, 0.75 mL.min-1, 
hexane/2-propanol, 90:10) tmajor = 31.5 min, tminor = 34.7 min after derivatisation into the 
hydroxyl benzylamide derivative. 392H64b  
 
(R)-(+)-3-(4’-Methoxybenzyl)-γ-butyrolactone (R)-(+)-129h 
3
1
4
2
1'
6'
2'
5'
3'
4'MeO
5
O
O
C12H14O3
Mol. Wt.: 206.24  
(+)-129h: (93.8 mg, 91%): [α]D23 +3.2 (c 0.5, CHCl3, 58% ee), [lit.393H125 gives [α]D +5.4 (c 6.8, 
CHCl3, 98% ee)]; 1H NMR (400 MHz, CDCl3) 2.56 (dd, J = 17.5, 8.0 Hz, 1H, 2-H), 2.57 
(dd, J = 17.5, 8.0 Hz, 1H, 2-H’), 2.70 (dd, J = 7.6, 3.3 Hz, 2H, CH2CH), 2.72-2.86 (m, 1H, 
3-H), 3.78 (s, 3H, CH3O), 4.00 (dd, J = 9.1, 6.5 Hz, 1H, 4-H), 4.30 (dd, J = 9.1, 6.5 Hz, 1H, 
4-H’), 6.84 (d, J = 8.6 Hz, 2H, 3’-H, 5’-H), 7.06 (d, J = 8.6 Hz, 2H, 2’-H, 6’-H); 13C NMR 
(100 MHz, CDCl3) δ 34.1 (CH2-2), 37.2 (CH-3), 37.9 (CH2CH), 55.2 (CH3), 72.5 (CH2-4), 
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114.0 (2×CH-3’,5’), 129.5 (2×CH-2’,6’), 130.1 (C-1’), 158.3 (C-4’), 176.8 (C=O-1) in 
agreement with the literature data. 394H64b 
 
(–)-3-Cyclohexyl-γ-butyrolactone (–)-129j 
O
O
3
1
2
1'
4
6'
2'
5'
3'4'
C10H16O2
Mol. Wt.: 168.23  
(–)-129j: (74.8 mg, 89%): [α]D24 –6.8 (c 0.5, CHCl3, 65% ee); 1H NMR (400 MHz, CDCl3) δ 
0.89-1.02 (m, 2H), 1.09-1.35 (m, 4H), 1.56-1.77 (m, 5H), 2.20 (dd, J = 16.6, 8.0 Hz, 1H, 
2-H), 2.30 (pent, J = 9.8 Hz, 1H, 3-H), 2.53 (dd, J = 16.6, 8.0 Hz, 1H, 2-H’), 3.96 (dd, J = 
8.9, 8.0 Hz, 1H, 4-H), 4.39 (dd, J = 8.9, 8.0 Hz, 1H, 4-H’); 13C NMR (100 MHz, CDCl3) δ 
25.7 (CH2), 25.8 (CH2), 26.1 (CH2), 30.4 (CH2), 31.1 (CH2), 32.7 (CH2-2), 41.3 (CH-1’), 
41.6 (CH-3), 72.1 (CH2-4), 177.3 (C=O-1); MS (EI) m/z (%) 168 (M•+, 49), 150 (21), 137 
(66), 86 (100), 83 (95); HRMS (EI) 168.1153 (C10H16O2 requires 168.1150); Chiral HPLC 
(Chiracel IB, 0.75 mL.min-1, hexane/2-propanol, 90:10) tmajor = 14.0 min, tminor = 17.5 min 
after derivatisation into the hydroxyl benzylamide derivative. 395H64b  
 
(R)-(+)-3-Octyl-γ-butyrolactone (R)-(+)-129j 
2
3
45
6
7
8
9
10
11
12
1
O
O
C12H22O2
Mol. Wt.: 198.30  
(+)-129j: (82.5 mg, 83%): [α]D24 +0.6 (c 1.0, CHCl3, 55% ee); 1H NMR (400 MHz, CDCl3) δ 
0.85 (t, J = 6.9 Hz, 3H, CH3CH2), 1.19-1.30 (m, 12H, 6×CH2), 1.40-1.48 (m, 2H, CH2CH), 
2.14 (dd, J = 16.7, 7.7 Hz, 1H, 2-H), 2.46-2.56 (m, 1H, 3-H), 2.58 (dd, J = 16.7, 8.3 Hz, 1H, 
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2-H’), 3.89 (dd, J = 8.9, 7.1 Hz, 1H, 4-H), 4.38 (dd, J = 8.9, 7.4 Hz, 1H, 4-H’); 13C NMR 
(100 MHz, CDCl3) δ 13.9 (CH3CH2), 22.5 (CH2), 27.2 (CH2), 29.0 (CH2), 29.2 (CH2), 29.3 
(CH2), 31.6 (CH2), 32.9 (CH2CH), 34.4 (CH2-2), 35.5 (CH-3), 73.3 (CH2-4), 177.2 (C=O-1) 
in agreement with literature data;396H163 Chiral HPLC (Chiracel IB, 0.75 mL.min-1, hexane/2-
propanol, 95:5) tR = 30.1 min, tS = 33.7 min after derivatisation into the hydroxyl 
benzylamide derivative. 397H64b  
 
6.3.4 72BAsymmetric Iridum-Catalysed Hydrogenation 
Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate NaBArF 
CF3
F3C
B
CF3
CF3
CF3
CF3
CF3
F3C Na
C32H12BF24Na
Mol. Wt.: 886,2
3 1
2
4
5
6
7
8
 
A mixture of magnesium turnings (1.01 g, 41.7 mmol, 6.5 equiv), sodium tetrafluoroborate 
(0.70 g, 6.4 mmol, 1.0 equiv) (previously dried at 120 °C under vacuum) and 1,2-
dibromoethane (0.49 mL, 5.7 mmol, 0.9 equiv) in ether (150 mL) was slightly heated to 
obtain a gentle reflux. A solution of 1-bromo-3,5-bis(trifluoromethyl)benzene (6.2 mL, 36 
mmol, 5.6 equiv) in ether (50 mL) was then added dropwise to keep refluxing the latter 
solution without external heating. When the addition was over, the mixture was refluxed for 
an additional 30 min and stirred overnight at room temperature. The reaction mixture was 
then poured into a solution of sodium carbonate (16 g) in water (200 mL), and the mixture 
was stirred for 30 min and then filtered. The ethereal layer was separated and the aqueous 
phase was extracted with ether (3×50 mL). The organic layers were combined, dried over 
Na2SO4, treated with charcoal (2 g), filtered, and concentrated under vacuum. The remaining 
oily solid was suspended in benzene (200 mL). The remaining water was removed by 
Dean&Stark azeotrope distillation for 2 h. The solution was then cooled down to room 
temperature and the solvent was removed by cannula filtration. The residual solid was then 
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dried overnight under vacuum to afford pure NaBArF as a tan solid (5 g, 88%): 1H NMR 
(400 MHz, d6-DMSO) δ 7.67 (m, 8H, 4-H, 6-H), 7.72 (m, 4H, 2-H); 13C NMR (100 MHz, d6-
DMSO) δ 117.4 (CH-2), 123.9 (q, J = 272.4 Hz, 2×CF3-7,8), 128.4 (q, J = 31.4 Hz, 2×C-3,5), 
134.0 (2×CH-4,6), 160.9 (q, J = 49.8 Hz, C-1); 19F NMR (376.5 MHz, d6-DMSO) δ –61.9 
(CF3). 
 
General Procedure for the Preparation of Iridium(I) Catalysts 133a-d  
[Ir(COD)Cl]2 (33.58 mg, 0.05 mmol, 0.5 equiv) and the respective P,N-ligand (0.10 mmol, 
1.0 equiv) were dissolved in CH2Cl2 (2 mL). The resulting red solution was heated at 50 °C 
until disappearance of the starting P,N-ligand (TLC monitoring). The solution was then 
cooled to room temperature and Na[BArF] (133 mg, 0.15 mmol, 1.5 equiv) was added, 
followed by water (2 mL), and the resulting mixture was stirred vigorously for 30 min. The 
two layers were separated and the aqueous layer was extracted with CH2Cl2 (2×3 mL). The 
combined organic layers were dried with MgSO4 and concentrated in vacuo. The residue was 
then purified by flash chromatography on silica gel (15 g) using a mixture of hexane and 
CH2Cl2 (1:1) to give 133a-d as orange solids. 
 
(7S,8R,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7- yl 
diphenylphosphinite-η4-(1,5-cyclooctadiene) iridium(I) tetrakis-[3,5-
bis(trifluoromethyl)phenyl]borate (+)-133a 
C70H52BF24IrNOP
Mol. Wt.: 1613.13
N
12
13
10
8
9
7
4
311 5
6 2
O
6'
2'
5'
3'
4'
1'
P
Ir+
(COD)
-BArF
 
(+)-133a (66.2 mg, 41%): mp 69-71 °C (Et2O:CH2Cl2 1:1); [α]D25 +32.3 (c 0.25, CHCl3); IR 
(KBr) ν 3020 (s, C-H), 1638 (brm, C=Car), 1279 (m), 1215 (s, P-O), 770 (s, C-Har) cm-1; 1H 
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NMR (400 MHz, CDCl3) δ 0.68 (s, 3H, 12-H), 1.46 (m, 4H, 9-H, 13-H), 1.50-1.52 (m, 2H, 
CH2(COD)), 1.66-1.76 (m, 1H, CH2(COD)), 1.80-1.90 (m, 2H, CH2(COD)), 1.91-2.12 (m, 
3H, CH2(COD)), 2.72-2.80 (m, 1H, CH(COD)), 2.82-2.94 (m, 3H, 8-H, 9-H’, 10-H), 3.00-
3.60 (m, 1H, CH(COD)), 4.27-4.35 (m, 2H, CH(COD)), 6.30 (dd, J = 8.6, 3.7 Hz, 1H, 7-H), 
7.16-7.20 (m, 2H, aromH), 7.31-7.39 (m, 5H, aromH), 7.40-7.42 (m, 7H, aromH), 7.43-7.50 
(m, 5H, aromH), 7.56-7.70 (m, 10H, aromH); 31P NMR (162.0 MHz, CDCl3) δ 99.2 (s); MS 
(FAB) m/z (%) 750 (M•+, 100), 642 (M•+-COD, 28), 462 (48); HRMS (FAB) 750.2498 
(C38H40NOPIr requires 750.2479); Anal. Calcd. for C70H52BF24NOPIr: C, 52.12; H, 3.25; N, 
0.87. Found: C, 52.21; H, 3.32; N, 0.81. 
 
(8S,10S)-(+)-2-[2’-(Diphenylphosphino)phenyl]-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene -η4-(1,5-cyclooctadiene) iridium(I) tetrakis-
[3,5-bis(trifluoromethyl)phenyl]borate (+)-133b 
C70H52BF24IrNP
Mol. Wt.: 1597.13
N
12
13
10
8
9
7
4
311 5
6 2
6'
2'
5'
3'
4'
1'
Ir+(COD)
-BArF
P
 
(+)-133b (92.6 mg, 58%): mp 65-67 °C (hexane:Et2O 1:1); [α]D26 +7.8 (c 1.0, CHCl3); IR 
(KBr) ν 3022 (s, C-H), 1424 (m, C=Car), 1353 (m, C=Car), 1277 (m, C=Car), 772 (s, C-Har) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 0.29 (d, J = 10.0 Hz, 1H, 9-H), 0.52 (s, 3H, 12-H), 0.95-
1.00 (m, 1H, CH2(COD)), 1.17-1.22 (m, 1H, CH2(COD)), 1.24 (s, 3H, 13-H), 1.27-1.34 (m, 
1H, CH2(COD)), 1.58-1.70 (m, 2H, CH2(COD)), 1.93-2.03 (m, 1H, CH2(COD)), 2.25-2.34 
(m, 1H, CH2(COD)), 2.36-2.61 (m, 4H, CH2(COD), 8-H, 9-H’, 10-H), 3.25 (dd, J = 18.0, 2.7 
Hz, 1H, 7-H), 3.32 (dd, J = 18.0, 2.7 Hz, 1H, 7-H’), 3.44-3.62 (m, 1H, CH(COD)), 3.85-3.95 
(m, 1H, CH(COD)), 4.32-4.51 (m, 1H, CH(COD)), 5.11-5.17 (m, 1H, CH(COD)), 7.02-7.14 
(m, 7H, aromH), 7.17-7.30 (m, 3H, aromH), 7.34-7.53 (m, 9H, aromH), 7.57-7.65 (m, 9H, 
aromH); 31P NMR (162.0 MHz, CDCl3) δ 19.2 (s); MS (FAB) m/z (%) 734 (M•+, 100), 626 
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(M•+-COD, 16), 450 (42); HRMS (FAB) 734.2529 (C38H40NPIr requires 734.2530); Anal. 
Calcd. for C70H52BF24NPIr: C, 52.64; H, 3.28; N, 0.88. Found: C, 52.38; H, 3.23; N, 1.01. 
 
(7R,8S,10S)-(+)-2-[2’-(Diphenylphosphino)phenyl]-7,11,11-trimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene -η4-(1,5-cyclooctadiene) iridium(I) tetrakis-
[3,5-bis(trifluoromethyl)phenyl]borate (+)-133c 
C71H54BF24IrNP
Mol. Wt.: 1611.16
N
12
13
10
8
9
7
4
311 5
6 2
6'
2'
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3'
4'
1'
Ir+
(COD)
-BArF
P
 
(+)-133c (83.8 mg, 52%): mp 61-63 °C (hexane:CH2Cl2 1:1); [α]D25 +2.8 (c 0.25, CHCl3); IR 
(KBr) ν 3020 (s, C-H), 1428 (m, C=Car), 1354 (m, C=Car), 1279 (m, C=Car), 770 (s, C-Har) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 0.51 (s, 3H, 12-H), 0.55 (d, J = 10.2 Hz, 1H, 9-H), 0.80-
0.85 (m, 1H, CH2(COD)), 1.00-1.10 (m, 2H, CH2(COD)), 1.34 (s, 3H, 13-H), 1.36-1.44 (m, 
1H, CH2(COD)), 1.60-1.70 (m, 1H, CH2(COD)), 1.85 (d, J = 7.1 Hz, 3H, CH3C(7)), 2.02-
2.04 (m, 1H, CH2(COD)), 2.08-2.12 (m, 1H, CH2(COD)), 2.40 (m, 1H, 9-H’), 2.52-2.62 (m, 
2H, CH2(COD), 8-H), 2.67 (t, J = 5.9 Hz, 1H, 10-H), 3.33-3.41 (m, 2H, CH(COD), 7-H), 
4.10-4.15 (m, 1H, CH(COD)), 4.24-4.29 (m, 1H, CH(COD)), 5.27-5.33 (m, 1H, CH(COD)), 
6.98-7.09 (m, 3H, aromH), 7.15-7.25 (m, 2H, aromH), 7.31-7.53 (m, 10H, aromH), 7.54-7.63 
(m, 3H, aromH), 7.66-7.74 (m, 10H, aromH); 31P NMR (162.0 MHz, CDCl3) δ 11.1 (s); MS 
(FAB) m/z (%) 748 (M•+, 100), 636 (48), 558 (22); HRMS (FAB) 748.2685 (C39H42NPIr 
requires 748.2687); Anal. Calcd. for C71H54BF24NPIr: C, 52.93; H, 3.38; N, 0.87. Found: C, 
52.88; H, 3.26; N, 0.98.  
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(7R,8S,10S)-(+)-2-[2’-(Diphenylphosphino)phenyl]-7-isopropyl-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene -η4-(1,5-cyclooctadiene) iridium(I) tetrakis-
[3,5-bis(trifluoromethyl)phenyl]borate (+)-133d 
C73H58BF24IrNP
Mol. Wt.: 1639.21
N
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13
10
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-BArF
P
 
(+)-133d (71 mg, 44%): mp 64-66 °C (hexane:Et2O 2:1); [α]D22 +28.8 (c 0.5, CHCl3); IR 
(KBr) ν 3020 (s, C-H), 1426 (m, C=Car), 1353 (m, C=Car), 1272 (m, C=Car), 770 (s, C-Har) 
cm-1; 1H NMR (400 MHz, CDCl3) δ 0.35 (d, J = 6.6 Hz, 3H, CH3CH), 0.38 (s, 3H, 12-H), 
0.66-0.76 (m, 1H, CH2(COD)), 0.83 (d, J = 10.2 Hz, 1H, 9-H), 0.96-1.09 (m, 2H, 
CH2(COD)), 1.18-1.22 (m, 1H, CH2(COD)), 1.26 (s, 3H, 13-H), 1.35 (d, J = 6.6 Hz, 3H, 
CH3’CH), 1.45-1.51 (m, 1H, CH2(COD)), 1.90-2.00 (m, 1H, CH2(COD)), 2.22 (td, J = 6.1, 
1.8 Hz, 1H, 8-H), 2.30-2.38 (m, 2H, CH2(COD), 9-H’), 2.57 (t, J = 6.1 Hz, 1H, 10-H), 2.58-
2.66 (m, 1H, CH2(COD)), 3.06 (brs, 1H, 7-H), 3.16 (td, J = 6.6, 3.5 Hz, 1H, CH3CHCH3), 
3.55-3.43 (m, 1H, CH(COD)), 3.90-3.96 (m, 1H, CH(COD)), 3.97-4.04 (m, 1H, CH(COD)), 
5.05-5.11 (m, 1H, CH(COD)), 6.84-6.90 (m, 2H, aromH), 6.91-6.97 (m, 2H, aromH), 7.04 
(tq, J = 7.1, 1.5 Hz, 1H, aromH), 7.20-7.28 (m, 3H, aromH), 7.30-7.50 (m, 10H, aromH), 
7.52-7.66 (m, 10H, aromH); 31P NMR (162.0 MHz, CDCl3) δ 8.9 (s); MS (FAB) m/z (%) 
776 (M•+, 100), 668 (M•+-COD, 5), 262 (58); HRMS (FAB) 776.3004 (C41H46NPIr requires 
776.3000); Anal. Calcd. for C73H58BF24NPIr: C, 53.49; H, 3.57; N, 0.85. Found: C, 53.12; H, 
3.38; N, 0.97. 
 
General Procedure for the Hydrogenation of Alkenes 78, 85 and Imine 136 
α-Methylstilbene 78 (39 mg, 0.2 mmol, 1 equiv), or ethyl trans-β-methylcinnamate 85 (38 
mg, 0.2 mmol, 1 equiv), or imine 136 (45 g, 0.2 mmol, 1 equiv) and the appropriate iridium 
catalyst (4.0 µmol, 2 mol%) were dissolved in CH2Cl2 (2 mL). The autoclave was then sealed 
and the hydrogenation was performed at room temperature under 10 bar of H2 for 2 d. After 
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releasing the hydrogen, the reaction mixture was directly passed through a short silica gel 
plug and flashed with a mixture of petroleum ether and ethyl acetate (4:1). The filtrate was 
evaporated and the residue was analysed by 1H-NMR to obtain the conversion of the reaction; 
chiral HPLC was used to determine the enantiomeric excess.  
 
1,2-Diphenylpropane 134 
C15H16
Mol. Wt.: 196.29
1
2
1'
2'
3'
4'
5'
6'
1''
2''
3''
4''
5''
6''
 
134: 1H NMR (400 MHz, CDCl3) δ 1.18 (d, J = 6.8 Hz, 3H, CH3CH), 2.71 (dd, J = 12.9, 8.0 
Hz, 1H, 2-H), 2.86-3.00 (m, 2H, 1-H, 2-H’), 7.02 (d, J = 7.0 Hz, 2H, aromH), 7.10-7.25 (m, 
8H, aromH); 13C NMR (100 MHz, CDCl3) δ 21.1 (CH3), 41.8 (CH-1), 45.0 (CH2-2), 125.8 
(CH-4’), 126.0 (CH-4’’), 127.0 (2×aromCH), 128.0 (2×aromCH), 128.3 (2×aromCH), 129.1 
(2×aromCH), 140.8 (C-1’), 146.9 (C-1’’) in agreement with the literature data;398H95a Chiral 
HPLC (Chiracel OJ-H, 0.5 mL.min-1, hexane/2-propanol, 99:1) tR = 13.2 min, tS = 19.3 min. 
 
Ethyl 3-phenylbutanoate 135 
1
21'
2'
3'
4'
5'
6'
O
O
3
4
C12H16O2
Mol. Wt.: 192.25  
135: [α]D26 +6.4 (c 1.4, CHCl3, 83% ee); 
1H NMR (400 MHz, CDCl3) δ 1.11 (t, J = 7.1 Hz, 
3H, CH3CH2), 1.23 (d, J = 7.2 Hz, 3H, 4-H), 2.46 (dd, J = 15.0, 7.2 Hz, 1H, 2-H),  2.54 (dd, J 
= 15.0, 7.2 Hz, 1H, 2-H’), 3.20 (q, J = 7.2 Hz, 1H, 3-H), 4.00 (q, J = 7.2 Hz, 2H, CH3CH2), 
7.13 (t, J = 7.1 Hz, 1H, 4’-H), 7.15 (d, J = 6.9 Hz, 2H, 2’-H, 6’-H), 7.22 (t, J = 7.1, 2H, 3’-H, 
5’-H); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3CH2), 21.8 (CH3-4), 36.5 (CH-3), 43.0 
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(CH2CH3), 60.2 (CH2-2), 126.3 (CH-4’), 126.7 (2×CH-2’, 6’), 128.4 (2×CH-3’, 5’), 145.7 
(C-1’), 172.4 (C=O-1) in agreement with the literature data;164F165 Chiral HPLC (IB, 0.75 
mL.min-1, hexane/2-propanol, 99:1) tR = 6.8 min, tS = 9.8 min. 
 
4-Methoxy-N-(1’-phenylethyl)aniline 137 
HN
1
1'
2'
3'
4'
5'
6' OMe
1''
2''
3''
4''
5''
6''
C15H17NO
Mol. Wt.: 227.30  
137: 1H NMR (400 MHz, CDCl3) δ 1.42 (d, J = 6.7 Hz, 3H, CH3), 3.61 (s, 3H, OCH3), 4.34 
(q, J = 6.7 Hz, 1H, 1-H), 6.40 (d, J = 8.9 Hz, 2H, 2’-H, 6’-H), 6.61 (d, J = 8.9 Hz, 2H, 3’-H, 
5’-H), 7.13 (tt, J = 7.3, 1.5 Hz, 1H, 4’’-H), 7.23 (td, J = 7.3, 2.0 Hz, 2H, 3’’-H, 5’’-H), 7.29 
(dd, J = 7.3, 1.5 Hz, 2H, 2’’-H, 6’’-H) in agreement with the literature data;399H130 Chiral HPLC 
(IB, 0.75 mL.min-1, hexane/2-propanol, 99:1) tR = 13.2 min, tS = 19.3 min. 
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6.4 38BSynthesis and Application of Pinene-Derived N-Oxides  
6.4.1 73BSynthesis of the First Generation of Catalysts 
(7R,8R,10S)-(+)-2-Phenyl-7-azido-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-
triene (+)-159 
N
12
13
10
8
9
7
4
311 5
6 2
N3
6'
2'
5'
3'
4'
1'
C18H18N4
Mol. Wt.: 290,36  
Diethyl azidocarboxylate (47 µL, 0.30 mmol, 1.3 equiv) was slowly added to an ice-cooled 
stirred solution of alcohol (+)-117b (59 mg, 0.22 mmol, 1.0 equiv) and triphenylphosphine 
(78 mg, 0.30 mmol, 1.3 equiv) in dry THF (3 mL). Diphenylphosphoryl azide (65 µL, 0.30 
mmol, 1.3 equiv) was then added dropwise, the reaction mixture was allowed to warm to 
room temperature and stirred for 24 h. The volatiles were then evaporated under vacuum. The 
residue was purified by chromatography on silica gel (25 g) using a mixture of petroleum 
ether and ethyl acetate (20:1) to yield (+)-159 as a colourless oil (51 mg, 80%): [α]D20 +42.3 
(c 1.0, CHCl3); IR (NaCl) ν 2936 (s, C-H), 2096 (s, N3), 1586 (m, C=Car), 1456 (m, C=Car), 
1441 (m, C=Car), 1251 (m, C-H methyl), 751 (m, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) 
δ 0.70 (s, 3H, 12-H), 1.47 (s, 3H, 13-H), 1.55 (d, J = 10.2 Hz, 1H, 9-H), 2.44 (td, J = 5.9, 3.3 
Hz, 1H, 8-H), 2.64 (dt, J = 10.2, 5.9 Hz, 1H, 9-H’), 2.83 (t, J = 5.9 Hz, 1H, 10-H), 4.91 (d, J 
= 3.3 Hz, 1H, 7-H), 7.36 (d, J = 7.9 Hz, 1H, 3-H), 7.39 (tt, J = 7.4, 1.3 Hz, 1H, 4’-H), 7.48 
(td, J = 7.4, 1.3 Hz, 2H, 3’-H, 5’-H), 7.59 (d, J = 7.9 Hz, 1H, 4-H), 8.06 (dd, J = 7.4, 1.3 Hz, 
2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 21.0 (CH3-12), 26.3 (CH3-13), 29.8 
(CH2-9), 44.0 (C-11), 45.1 (CH-8), 45.9 (CH-10), 63.0 (CH-7), 118.9 (CH-4), 126.7 
(2×CH-2’,6’), 128.72 (CH-4’), 128.75 (2×CH-3’,5’), 134.1 (CH-3), 139.0 (C-1’), 139.7 
(C-5), 154.2 (C-2), 155.2 (C-6); MS (EI) m/z (%) 290 (M•+, 24), 262 (M•+-N2, 96), 248 (M•+-
N3, 85), 206 (M•+-N3-C3H6, 97), 149 (100); HRMS (EI) 290.1530 (C18H18N4 requires 
290.1531). 
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NOE: Irradiation on 4.91 7-H enhanced 0.70 12-H and 2.44 8-H 
N7
N3
H
12
H
8
 
 
(7R,8R,10S)-(+)-2-Phenyl-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-trien-7-
amine (+)-160 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
NH2
C18H20N2
Mol. Wt.: 264,36  
Procedure A: Hydrogenation 
A mixture of Pd/charcoal (3.2 mg, 10 w/w %) and azide (+)-159 (32 mg, 0.11 mmol) in 
ethanol (1 mL) was stirred at room temperature overnight under a H2 atmosphere. The 
catalyst was removed by filtration through a celite pad. The filtrate was concentrated under 
vacuum and purified by flash chromatography on silica gel (5 g) using CH2Cl2 to remove the 
unreacted starting material, followed by methanol to afford (+)-160 as a colourless oil (10 
mg, 35%). 
 
Procedure B: Reduction with LiAlH4 
Lithium aluminum hydride (27 mg, 0.66 mmol, 2 equiv) was added portion-wise to an ice-
cooled solution of azide (+)-159 (96 mg, 0.33 mmol, 1 equiv) in THF (1 mL). The reaction 
mixture was allowed to warm to room temperature and stirred overnight. The excess of 
lithium aluminum hydride was quenched by addition of sodium sulfate decahydrate and the 
mixture was stirred at room temperature for 30 min. The precipitate was filtered off through a 
celite pad and washed with ethanol (20 mL). The filtrate was concentrated under vacuum and 
purified by flash chromatography on silica gel (5 g) using CH2Cl2 to remove the unreacted 
starting material, followed by methanol to afford (+)-160 as a colourless oil (86 mg, 98%): 
[α]D20 +7.9 (c 1.0, CHCl3); IR (NaCl) ν 3369 (m, N-H), 2954 (s, C-H), 1583 (m, C=Car), 
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1570 (s, NH2), 1453 (m, C=Car), 1439 (m, C=Car), 1216 (m, C-N), 755 (m, C-Har) cm-1; 1H 
NMR (400 MHz, CDCl3) δ 0.69 (s, 3H, 12-H), 1.41 (d, J = 10.0 Hz, 1H, 9-H), 1.46 (s, 3H, 
13-H), 2.01 (br s, 2H, NH2), 2.39 (td, J = 5.9, 2.9 Hz, 1H, 8-H), 2.63 (dt, J = 10.0, 5.9 Hz, 
1H, 9-H’), 2.81 (t, J = 5.9 Hz, 1H, 10-H), 4.20 (d, J = 2.9 Hz, 1H, 7-H), 7.29 (d, J = 7.8 Hz, 
1H, 3-H), 7.38 (tt, J = 7.3, 1.3 Hz, 1H, 4’-H), 7.43-7.50 (m, 3H, 4-H, 3’-H, 5’-H), 8.01 (d, J 
= 7.3 Hz, 2H, 2’-H, 6’-H); 13C NMR (100 MHz, CDCl3) δ 20.9 (CH3-12), 26.4 (CH3-13), 
29.0 (CH2-9), 43.5 (C-11), 46.6 (CH-8), 46.7 (CH-10), 54.2 (CH-7), 118.0 (CH-4), 126.5 
(2×CH-2’,6’), 128.4 (CH-4’), 128.6 (2×CH-3’,5’), 133.5 (CH-3), 139.47 (C-1’), 139.53 
(C-5), 154.8 (C-2), 159.2 (C-6); MS (EI) m/z (%) 264 (M•+, 43), 262 (M•+-NH3, 46), 206 
(M•+-NH2-C3H6, 42), 195 (100); HRMS (EI) 264.1624 (C18H20N2 requires 264.1626). 
 
(7R,8R,10S)-(–)-N,N,11,11-Tetramethyl-2-phenyl-1-azatricyclo[7.1.1.05,6]undeca-2,4,6-
trien-7-amine (–)-161 
N
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N
C20H24N2
Mol. Wt.: 292,42  
A solution of formaldehyde in water (37% w/w, 1 mL) was added to a cold (0 ºC) solution of 
amine (+)-160 (276 mg, 1.04 mmol) in formic acid (1 mL). The resulting mixture was stirred 
at 0 ºC for 1 h and then at 90 ºC for 4 h. The reaction mixture was cooled to room 
temperature and the volatiles were removed under vacuum. The residue was diluted with 
water (5 mL) and made alkaline by addition of an aqueous solution of sodium hydroxide 
(2M). The aqueous layer was extracted with CH2Cl2 (3 × 20 mL) and the combined organic 
extracts were dried over MgSO4, and concentrated under vacuum. The crude material was 
then purified by column chromatography on silica gel (10 g) using a mixture of petroleum 
ether and ethyl acetate (2:1) to afford (–)-161 as a colourless oil (266 mg, 87%): [α]D20 –28.9 
(c 1.0, CHCl3); IR (NaCl) ν 2932 (s, C-H), 1566 (m, C=Car),  1451 (m, C=Car), 1437 (m, 
C=Car), 1275 (m, C-H methyl), 775 (m, C-Har) cm-1; 1H NMR (400 MHz, CDCl3) δ 0.65 (s, 
3H, 12-H), 1.44 (s, 3H, 13-H), 1.62 (d, J = 9.7 Hz, 1H, 9-H), 2.55 (td, J = 5.8, 2.7 Hz, 1H, 
8-H), 2.61-2.67 (m, 7H, 9-H’, N(CH3)2), 2.75 (t, J = 5.8 Hz, 1H, 10-H), 3.89 (d, J = 2.7 Hz, 
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1H, 7-H), 7.29 (d, J = 7.8 Hz, 1H, 3-H), 7.36 (t, J = 7.3 Hz, 1H, 4’-H), 7.45 (t, J = 7.3 Hz, 
2H, 3’-H, 5’-H), 7.48 (d, J = 7.8 Hz, 1H, 4-H), 8.01 (d, J = 7.3 Hz, 2H, 2’-H, 6’-H); 13C 
NMR (100 MHz, CDCl3) δ 20.8 (CH3-12), 26.4 (CH3-13), 29.2 (CH2-9), 43.4 (CH-8), 44.0 
(C-11), 44.1 (2×CH3-N(CH3)2), 46.3 (CH-10), 66.0 (CH-7), 117.9 (CH-4), 126.7 
(2×CH-2’,6’), 128.2 (CH-4’), 128.5 (2×CH-3’,5’), 133.6 (CH-3), 139.8 (C-1’), 140.5 (C-5), 
154.5 (C-2), 156.6 (C-6); MS (CI-isobutane) m/z (%) 293 ((M+H)+, 100), 249 ((M+H)+-
N(Me)2, 54), 206 ((M+H)+-N(Me)2-C3H6, 8); HRMS (CI-isobutane) 293.2011 (C20H25N2 
(M+H)+ requires 293.2018). 
 
(7R,8R,10S)-(–)-11,11-Dimethyl-1-2-phenyl-1-azatricyclo[7.1.1.02,7]undeca-2,4,6-trien-7-
yl(dimethyl)amine-N,N’-bisoxide (–)-162 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
N
O
O
C20H24N2O2
Mol. Wt.: 324,42  
mCPBA (627 mg, 3.65 mmol, 4 equiv) was added portion-wise to a cold solution (0 °C) of 
the N,N-dimethylamine (–)-161 (265 mg, 0.91 mmol, 1 equiv) in CH2Cl2 (5 mL). The 
resulting mixture was allowed to warm up to room temperature and then stirred overnight. 
The organic layer was washed with a saturated aqueous solution of sodium carbonate (10 
mL), dried over MgSO4, and concentrated under vaccum. The crude material was then 
purified by column chromatography on silica gel (10 g) using pure ethyl acetate to remove 
the unreacted starting amine, followed by methanol to obtain (–)-162 as a colourless oil (183 
mg, 62%): [α]D20 –59.6 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.69 (s, 3H, 12-H), 
1.50 (s, 3H, 13-H), 1.60 (d, J = 10.0 Hz, 1H, 9-H), 2.76-2.85 (m, 2H, 10-H, 9-H’), 3.05 (s, 
3H, NCH3), 3.78 (td, J = 6.0, 1.9 Hz, 1H, 8-H), 4.12 (s, 3H, NCH’3), 4.47 (d, J = 1.9 Hz, 1H, 
7-H), 7.40 (t, J = 7.1 Hz, 1H, 4’-H), 7.43 (d, J = 7.9 Hz, 1H, 3-H), 7.47 (t, J = 7.1 Hz, 2H, 
3’-H, 5’-H), 7.61 (d, J = 7.9 Hz, 1H, 4-H), 7.92 (d, J = 7.1 Hz, 2H, 2’-H, 6’-H); 13C NMR 
(100 MHz, CDCl3) δ 20.8 (CH3-12), 26.1 (CH3-13), 29.5 (CH2-9), 41.4 (CH-8), 45.9 (C-11), 
46.5 (CH-10), 55.2 (NCH3), 64.7 (NC’H3), 80.0 (CH-7), 119.5 (CH-4), 126.4 (2×CH-2’,6’), 
128.8 (2×CH-3’,5’), 129.0 (CH-4’), 135.0 (CH-3), 138.7 (C-1’), 142.3 (C-5), 150.6 (C-2), 
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154.6 (C-6). Product synthesised at GSK, Harlow where no high resolution mass 
spectrometer was available. 
 
6.4.2 74BSynthesis of the Second Generation of Catalysts 
General Procedure for the Formation of 2-(acetoxyphenyl)pyridines 164a-c 
A mixture of 2-bromopyridine (0.96 mL, 10.0 mmol, 1.0 equiv) and the respective 
acetylphenylboronic acid 163a-c (2.07 g, 12.6 mmol, 1.3 equiv) was stirred in n-propanol (24 
mL) at room temperature for 15 min. Palladium(II) acetate (8.8 mg, 38.8 µmol, 0.4 mol%), 
triphenylphosphine (31.2 mg, 120 µmol, 1.2 mol%), an aqueous solution of Na2CO3 (2M, 3.9 
mL) and water (5 mL) were then added and the resulting mixture was refluxed overnight. The 
mixture was then cooled to room temperature, water (10 mL) was added, and the mixture was 
stirred for an additional 15 min. The mixture was made acidic by addition of an aqueous 
solution of hydrochloric acid (2M) and was extracted with ethyl acetate (3×20 mL). The 
remaining aqueous layer was made alkaline by addition of an aqueous solution of sodium 
hydroxide (2M). and was finally extracted with ethyl acetate (3×20 mL). The combined 
organic extracts from the second extraction were dried over MgSO4, filtered and concentrated 
under vacuum, affording pure 164a, 164b and 164c, respectively.   
 
2-(4’-Acetoxyphenyl)pyridine 164a 
N
O
C13H11NO
Mol. Wt.: 197.23
4
1'
3
2
5
6
2'
3'
4'
5'
6'
 
164a: (1.82 g, 92%): 1H NMR (400 MHz, CD2Cl2) δ 2.62 (s, 3H, CH3), 7.30 (ddd, J = 6.7, 
4.8, 2.0 Hz, 1H, 5-H), 7.81 (ddd, J = 8.0, 6.7, 1.7 Hz, 1H, 4-H), 7.83 (ddd, J = 8.0, 2.1, 1.1 
Hz, 1H, 3-H), 8.05 (d, J = 8.7 Hz, 2H, 3’-H, 5’-H), 8.14 (d, J = 8.7 Hz, 2H, 2’-H, 6’-H), 8.71 
(ddd, J = 4.8, 1.7, 1.1 Hz, 1H, 6-H); 13C NMR (100 MHz, CD2Cl2) δ 26.6 (CH3), 120.9 (CH-
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3), 123.0 (CH-5), 126.9 (2×CH-2’,6’), 128.6 (2×CH-3’,5’), 136.9 (CH-4), 137.3 (C-4’), 143.4 
(C-1’), 149.8 (CH-6), 155.8 (C-2), 197.5 (C=O) in agreement the with literature data.400H154 
 
2-(3’-Acetoxyphenyl)pyridine 164b 
N
C13H11NO
Mol. Wt.: 197.23
4
1'
3
2
5
6
2'
3'
4'
5'
6'
O
 
164b: (1.973 g, 100%): 1H NMR (400 MHz, CD2Cl2) δ 2.66 (s, 3H, CH3), 7.28 (ddd, J = 6.8, 
4.8, 1.8 Hz, 1H, 5-H), 7.58 (td, J = 7.8, 0.5 Hz, 1H, 5’-H), 7.80 (ddd, J = 8.0, 6.8, 1.8 Hz, 1H, 
4-H), 7.83 (ddd, J = 8.0, 1.8, 1.0 Hz, 1H, 3-H), 7.99 (ddd, J = 7.8, 1.8, 1.2 Hz, 1H, 6’-H), 
8.24 (ddd, J = 7.8, 1.8, 1.2 Hz, 1H, 4’-H), 8.61 (td, J = 1.8, 0.5 Hz, 1H, 2’-H), 8.70 (ddd, J = 
4.8, 1.7, 1.1 Hz, 1H, 6-H); 13C NMR (100 MHz, CD2Cl2) δ 26.6 (CH3), 120.4 (CH-3), 122.6 
(CH-5), 126.6 (CH-2’), 128.5 (CH-6’), 129.0 (CH-5’), 131.2 (CH-4’), 136.9 (CH-4), 137.7 
(C-3’), 139.8 (C-1’), 149.7 (CH-6), 156.1 (C-2), 197.7 (C=O) in agreement with the literature 
data. 401H154 
 
2-(2’-Acetoxyphenyl)pyridine 164c 
N
C13H11NO
Mol. Wt.: 197.23
4
1'
3
2
5
6
2'
3'
4'
5'
6'
O
 
164c: (1.785 g, 91%): 1H NMR (400 MHz, CD2Cl2) δ 2.17 (s, 3H, CH3), 7.28 (ddd, J = 7.4, 
4.9, 1.0 Hz, 1H, 5-H), 7.45-7.51 (m, 2H, 4’-H, 5’-H), 7.55 (dd, J = 6.2, 2.6 Hz, 1H, 3’-H), 
7.62-7.66 (m, 2H, 3-H, 6’-H), 7.81 (td, J = 7.4, 1.8 Hz, 1H, 4-H), 8.61 (ddd, J = 4.8, 1.8, 0.9 
Hz, 1H, 6-H); 13C NMR (100 MHz, CD2Cl2) δ 30.3 (CH3), 122.37 (CH-5), 122.39 (CH-6’), 
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127.5 (CH-5’), 128.6 (CH-4’), 129.1 (CH-3), 130.1 (CH-3’), 136.9 (CH-4), 138.7 (C-1’), 
141.9 (C-2’), 149.1 (CH-6), 157.4 (C-2), 203.8 (C=O) in agreement with the literature 
data.402H154 
 
General Procedure for the Synthesis of Kröhnke Salts 165a,b  
A solution of the respective substituted acetophenone 164a,b (1.97 g, 10 mmol, 1.0 equiv) 
and iodine (2.53 g, 10 mmol, 1.0 equiv) in pyridine (6 mL) was refluxed overnight. The 
reaction mixture was then cooled to room temperature, inducing the precipitation of a solid 
which was filtered off and washed with eher (3×20 mL). The remaining solid was then stirred 
overnight in ether (20 mL). The salts 165a and 165b were then isolated by filtration. 
 
1-{2-Oxo-2-[4’-(2’’-pyridinyl)phenyl]ethyl}pyridinium iodide 165a 
N
O
4''
4'
3''
2''
5''
6''
3'
2'
1'
6'
5'
N
I
1
2
2'''
3'''
4'''
5'''
6'''
C18H15IN2O
Mol. Wt.: 402.23  
165a: (3.62 g, 90%): 1H NMR (400 MHz, d6-DMSO) δ 6.57 (s, 2H, 1-H), 7.50 (ddd, J = 7.7, 
4.8, 1.0 Hz, 1H, 5’’-H), 7.81 (ddd, J = 7.9, 7.7, 1.8 Hz, 1H, 4’’-H), 8.15-8.22 (m, 3H, 3’’-H, 
2’-H, 6’-H), 8.31 (dd, J = 7.7, 6.1 Hz, 2H, 3’’’-H, 5’’’-H), 8.38 (d, J = 8.6 Hz, 2H, 3’-H, 
5’-H), 8.74-8.79 (m, 2H, 6’’-H, 4’’’-H), 9.05 (dd, J = 6.1, 1.0 Hz, 2H, 2’’’-H, 6’’’-H); 13C 
NMR (100 MHz, , d6-DMSO) δ 66.3 (CH2-1), 121.4 (CH-3’’), 123.8 (CH-5’’), 126.9 (2×CH-
3’,5’), 127.8 (2×CH-3’’’,5’’’), 128.7 (2×CH-2’,6’), 133.5 (C-1’), 137.9 (CH-4’’), 143.5 (C-
4’), 146.1 (2×CH-2’’’,6’’’), 146.3 (CH-4’’’), 149.4 (CH-6), 154.0 (C-2’’), 190.1 (C=O-2); 
MS (FAB) m/z (%) 275 (M•+, 100), 155 (18), 139 (22), 108 (17), 91 (18), 79 (14); HRMS 
(FAB) 275.1187 (C18H15N2O requires 275.1184). 
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1-{2-Oxo-2-[3’-(2’’-pyridinyl)phenyl]ethyl}pyridinium iodide 165b 
N
4''
4'
3''
2''
5''
6'' 3'
2'
1'
6'
5'
I
1
2
2'''
3'''
4'''
5'''
6'''
C18H15IN2O
Mol. Wt.: 402.23
O
N
 
165b: (3.58 g, 89%): 1H NMR (400 MHz, d6-DMSO) δ 6.63 (s, 2H, 1-H), 7.48 (dd, J = 7.2, 
5.1 Hz, 1H, 5’’-H), 7.81 (t, J = 7.8 Hz, 1H, 5’-H), 8.02 (t, J = 7.2 Hz, 1H, 4’’-H), 8.13 (s, 1H, 
2’-H), 8.16 (d, J = 7.8 Hz, 1H, 4’-H), 8.32 (t, J = 7.0 Hz, 2H, 3’’’-H, 5’’’-H), 8.48 (d, J = 7.8 
Hz, 1H, 6’-H), 8.74-8.80 (m, 3H, 3’’-H, 6’’-H, 4’’’-H), 9.05 (d, J = 7.0 Hz, 2H, 2’’’-H, 6’’’-
H); 13C NMR (100 MHz, d6-DMSO) δ 66.3 (CH2-1), 120.8 (CH-4’), 123.4 (CH-5’’), 126.1 
(CH-3’’), 127.8 (2×CH-3’’’,5’’’), 128.7 (CH-2’), 129.7 (CH-5’), 132.3 (C-6’), 134.1 (C-1’), 
138.0 (CH-4’’), 138.9 (C-3’), 146.1 (2×CH-2’’’,6’’’), 146.3 (CH-4’’’), 149.3 (CH-6’’), 154.1 
(C-2’’), 190.5 (C=O-2); MS (FAB) m/z (%) 275 (M•+, 82), 241 (33), 136 (37), 122 (100), 101 
(82), 82 (75); HRMS (FAB) 275.1181 (C18H15N2O requires 275.1184). 
 
General Procedure for the Kröhnke Annulation 166a,b 
A solution of pinocarvone (–)-16 (1.05 g, 7.0 mmol, 1.0 equiv), the respective Kröhnke salt 
165a (2.82 g, 7.0 mmol, 1.0 equiv) or 165b (2.82 g, 7.0 mmol, 1.0 equiv), and ammonium 
acetate (9.25 g) in acetic acid (12 mL) was refluxed for 6 h. The mixture was then cooled to 
room temperature, diluted with water (25 mL), made neutral by addition of an aqueous 
solution of sodium hydroxide (2M), and extracted with ethyl acetate (3×50 mL). The organic 
phase was successively washed with water (3×50 mL) and brine (50 mL) and dried over 
MgSO4. The solvent was removed under vacuum and the crude product was purified by flash 
chromatography on silica gel (20 g) using a mixture of petroleum ether and ethyl acetate (3:1) 
to afford pure (+)-166a and (+)-166b, respectively. 
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(8S,10S)-(+)-2-[4’-(2’’-Pyridinyl)phenyl]-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-
2,4,6-triene (+)-166a 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
N
2''
3''
4''
5''
6''
C23H22N2
Mol. Wt.: 326.43  
(+)-166a (484 mg, 22%): [α]D25 +79.6 (c 1.0, CHCl3); IR (NaCl) ν 2922 (m, C-H), 1583 (m, 
C=Car), 1465 (m, C=Car), 1435 (m, C=Car), 821 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.70 (s, 3H, 12-H), 1.32 (d, J = 9.5 Hz, 1H, 9-H), 1.43 (s, 3H, 13-H), 2.41 (tt, J = 
5.8, 2.8 Hz, 1H, 8-H), 2.71 (dt, J = 9.5, 5.8 Hz, 1H, 9-H’), 2.80 (t, J = 5.8 Hz, 1H, 10-H), 
3.21 (d, J = 2.8 Hz, 2H, 7-H), 7.23 (ddd, J = 7.0, 4.8, 1.5 Hz, 1H, 5’’-H), 7.27 (d, J = 7.8 Hz, 
1H, 3-H), 7.47 (d, J = 7.8 Hz, 1H, 4-H), 7.75 (td, J = 7.0 ,1.7 Hz, 1H, 4’’-H), 7.79 (ddd, J = 
7.0, 1.5, 1.0 Hz, 1H, 3’’-H), 8.10 (s, 4H, 2’-H, 3’-H, 5’-H, 6’-H), 8.71 (ddd, J = 4.8, 1.7, 1.0 
Hz, 1H, 6’’-H); 13C NMR (100 MHz, CDCl3) δ 21.4 (CH3-12), 26.1 (CH3-13), 32.1 (CH2-9), 
36.8 (CH2-7), 39.6 (C-11), 40.3 (CH-8), 46.4 (CH-10), 117.4 (CH-4), 120.6 (CH-3’’), 122.2 
(CH-5’’), 127.1 (2×CH-2’,6’), 127.2 (2×CH-3’,5’), 133.6 (CH-3), 136.8 (CH-4’’), 139.1 
(C-1’), 140.5 (C-5), 140.7 (C-4’), 149.7 (CH-6’’), 154.2 (C-2’’), 157.0 (C-2), 157.1 (C-6); 
MS (CI-isobutane) m/z (%) 327 ((M+H)+, 100); HRMS (CI-isobutane) 327.1860 (C23H23N2 
(M+H)+ requires 327.1861). 
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(8S,10S)-(+)-2-[3’-(2’’-Pyridinyl)phenyl]-11,11-dimethyl-1-azatricyclo[7.1.1.05,6]undeca-
2,4,6-triene (+)-166b 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
C23H22N2
Mol. Wt.: 326.43
N
 
(+)-166b (820 mg, 36%): [α]D18 +58.7 (c 1.0, CHCl3); IR (NaCl) ν 2936 (m, C-H), 1587 (m, 
C=Car), 1466 (m, C=Car), 1437 (m, C=Car), 761 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.63 (s, 3H, 12-H), 1.24 (d, J = 9.5 Hz, 1H, 9-H), 1.33 (s, 3H, 13-H), 2.32 (tt, J = 
5.8, 2.8 Hz, 1H, 8-H), 2.61 (dt, J = 9.5, 5.8 Hz, 1H, 9-H’), 2.70 (t, J = 5.8 Hz, 1H, 10-H), 
3.16 (d, J = 2.8 Hz, 2H, 7-H), 7.11 (ddd, J = 7.4, 4.8, 1.0 Hz, 1H, 5’’-H), 7.18 (d, J = 7.8 Hz, 
1H, 3-H), 7.44 (d, J = 7.8 Hz, 1H, 4-H), 7.49 (t, J = 7.8 Hz, 1H, 5’-H), 7.62 (td, J = 7.4 ,1.8 
Hz, 1H, 4’’-H), 7.74 (dt, J = 7.4, 1.0 Hz, 1H, 3’’-H), 7.97 (ddd, J = 7.8, 2.8, 1.6 Hz, 1H, 6’-
H),  8.00 (ddd, J = 7.8, 2.8, 1.6 Hz, 1H, 4’-H), 8.59 (t, J = 1.6 Hz, 1H, 2’-H), 8.64 (ddd, J = 
4.8, 1.8, 1.0 Hz, 1H, 6’’-H); 13C NMR (100 MHz, CDCl3) δ 21.0 (CH3-12), 25.8 (CH3-13), 
31.7 (CH2-9), 36.5 (CH2-7), 39.2 (C-11), 39.9 (CH-8), 45.9 (CH-10), 117.0 (CH-4), 120.3 
(CH-3’’), 121.8 (CH-5’’), 125.0 (CH-2’), 126.5 (CH-6’), 127.0 (CH-4’), 128.8 (CH-5’), 
133.2 (CH-3), 136.3 (CH-4’’), 139.4 (C-5), 140.2 (2×C-1’, 3’), 149.3 (CH-6’’), 154.1 
(C-2’’), 156.5 (C-2), 157.0 (C-6); MS (EI) m/z (%) 326 (M•+, 100), 283 (66); HRMS (EI) 
326.1780 (C23H22N2 requires 326.1783). 
 
General Procedure for the N-Oxidation of Pyridine Derivatives 166a-b 
m-Chloroperoxybenzoic acid (70%, 106 mg, 0.60 mmol, 4.0 equiv) was added portion-wise 
to a respective cool (0 °C) solution of (+)-166a (50 mg, 0.15 mmol, 1.0 equiv) or (+)-166b 
(50 mg, 0.15 mmol, 1.0 equiv) in CH2Cl2 (4 mL). The mixture was then allowed to warm up 
to room temperature and stirred overnight. The mixture was washed with an aqueous solution 
of NaHCO3 (10%; 5 mL) and dried over MgSO4. The solvent was removed under vacuum 
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and the residue was purified by chromatography on silica gel (10 g) using ethyl acetate to 
remove the unreacted starting material and some by-products, followed by methanol to afford 
pure   (–)-167a and (–)-167b respectively.  
 
(8S,10S)-(–)-2-[4’-(1’’-oxido-2’’-pyridinyl)phenyl]-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene-1-oxide (–)-167a 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
N
2''
3''
4''
5''
6''
O
O
C23H22N2O2
Mol. Wt.: 358.43  
(–)-167a (25 mg, 45%): [α]D20 –24.2 (c 1.0, CHCl3); IR (NaCl) ν 2932 (m, C-H), 1584 (m, 
C=Car), 1461 (m, C=Car), 1430 (m, C=Car), 1215 (m, N+-O-), 761 (s, C-Har) cm-1; 1H NMR 
(400 MHz, CDCl3) δ 0.65 (s, 3H, 12-H), 1.23 (d, J = 9.8 Hz, 1H, 9-H), 1.34 (s, 3H, 13-H), 
2.36 (tt, J = 5.7, 2.8 Hz, 1H, 8-H), 2.61 (dt, J = 9.8, 5.7 Hz, 1H, 9-H’), 2.74 (t, J = 5.7 Hz, 
1H, 10-H), 3.03 (dd, J = 19.1, 2.0 Hz, 1H, 7-H), 3.11 (dd, J = 19.1, 2.0 Hz, 1H, 7-H’), 6.88 
(d, J = 7.8 Hz, 1H, 4-H), 7.15 (d, J = 7.8 Hz, 1H, 3-H), 7.16-7.21 (m, 1H, 5’’-H), 7.26 (td, J = 
7.7 ,1.0 Hz, 1H, 4’’-H), 7.40 (dd, J = 7.7, 1.8 Hz, 1H, 3’’-H), 7.83 (s, 4H, 2’-H, 3’-H, 5’-H, 
6’-H), 8.26 (dd, J = 6.4, 1.0 Hz, 1H, 6’’-H); 13C NMR (100 MHz, CDCl3) δ 21.0 (CH3-12), 
25.7 (CH3-13), 31.0 (CH2-7), 31.3 (CH2-9), 39.1 (C-11), 39.2 (CH-8), 46.0 (CH-10), 123.2 
(CH-4), 123.8 (CH-3), 124.7 (CH-5’’), 126.1 (CH-4’’), 127.4 (CH-3’’), 128.8 (2×CH-2’,6’), 
129.3 (2×CH-3’,5’), 132.8 (C-1’), 134.3 (C-5), 140.3 (CH-6’’), 144.6 (C-4’), 146.2 (C-2’’), 
146.8 (C-2), 148.7 (C-6); MS (FAB) m/z (%) 359 ((M+H)+, 100); HRMS (FAB) 359.1829 
(C23H23N2O2 (M+H)+ requires 359.1827). 
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(8S,10S)-(–)-2-[3’-(1’’-oxido-2’’-pyridinyl)phenyl]-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene-1-oxide (–)-167b 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
O
C23H22N2O2
Mol. Wt.: 358.43
N
O
 
(–)-167b (32 mg, 60%): [α]D21 –22.3 (c 1.0, CHCl3); IR (NaCl) ν 2933 (m, C-H), 1586 (m, 
C=Car), 1463 (m, C=Car), 1430 (m, C=Car), 1215 (m, N+-O-), 760 (s, C-Har) cm-1; 1H NMR 
(400 MHz, CDCl3) δ 0.72 (s, 3H, 12-H), 1.31 (d, J = 9.8 Hz, 1H, 9-H), 1.42 (s, 3H, 13-H), 
2.44 (tt, J = 5.9, 2.9 Hz, 1H, 8-H), 2.69 (dt, J = 9.8, 5.9 Hz, 1H, 9-H’), 2.81 (t, J = 5.9 Hz, 
1H, 10-H), 3.10 (dd, J = 19.2, 5.9 Hz, 1H, 7-H), 3.18 (dd, J = 19.2, 5.9 Hz, 1H, 7-H’), 6.93 
(d, J = 7.8 Hz, 1H, 4-H), 7.22 (ddd, J = 7.6, 6.5, 2.0 Hz, 1H, 5’’-H), 7.27 (d, J = 7.8 Hz, 1H, 
3-H), 7.30 (td, J = 7.6, 1.3 Hz, 1H, 4’’-H), 7.52 (dd, J = 7.6, 2.0 Hz, 1H, 3’’-H), 7.56 (t, J = 
7.9 Hz, 1H, 5’-H), 7.87 (ddd, J = 7.9, 1.7, 1.2 Hz, 1H, 6’-H),  7.90 (ddd, J = 7.9, 1.7, 1.2 Hz, 
1H, 4’-H), 8.25 (t, J = 1.7 Hz, 1H, 2’-H), 8.31 (dd, J = 6.5, 1.3 Hz, 1H, 6’’-H); 13C NMR 
(100 MHz, CDCl3) δ 21.1 (CH3-12), 25.8 (CH3-13), 31.1 (CH2-7), 31.5 (CH2-9), 39.3 (CH-8, 
C-11), 46.1 (CH-10), 123.1 (CH-4), 124.0 (CH-3), 124.6 (CH-5’’), 125.8 (CH-4’’), 127.7 
(CH-3’’), 128.0 (CH-5’), 129.8 (CH-4’), 130.5 (CH-6’), 130.7 (CH-2’), 132.3 (C-5), 133.3 
(C-1’), 140.3 (CH-6’’), 144.6 (C-3’), 146.4 (C-2’’), 146.8 (C-2), 149.0 (C-6); MS (FAB) m/z 
(%) 359 ((M+H)+, 100); HRMS (FAB) 359.1829 (C23H23N2O2 (M+H)+ requires 359.1827). 
 
General Procedure for the Benzylic Alkylation of (+)-166b 
A solution of n-butyllithium in hexane (1.6M, 0.4 mL, 0.61 mmol, 1.0 equiv) was added 
dropwise to a solution of (+)-166b (200 mg, 0.61 mmol, 1.0 equiv) in anhydrous THF (2 mL) 
under argon at –40 °C. The solution was stirred at that temperature for 1 h, then the 
respective electrophile, iodomethane (40 µL, 0.61 mmol, 1.0 equiv) or 2-iodopropane (62 µL, 
0.61 mmol, 1.0 equiv) was added dropwise at –40 °C. The solution was then gradually 
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warmed up to room temperature and stirred overnight. The reaction was quenched by 
addition of water (10 mL). The mixture was extracted with CH2Cl2 (3×10 mL) and the 
combined organic extracts were washed with brine (10 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the residue was purified by chromatography on silica 
gel (15 g) with a mixture of petroleum ether and ethyl acetate (6:1) to give, respectively, pure 
(+)-169a, or pure (–)-169b.  
 
(7R,8S,10S)-(+)-2-[3’-(2’’-Pyridinyl)phenyl]-7,11,11-trimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (+)-169a 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
N
C24H24N2
Mol. Wt.: 340.46  
(+)-169a (64 mg, 31%): [α]D23 +7.1 (c 1.0, CH2Cl2); IR (NaCl) ν 2926 (m, C-H), 1637 (m, 
C=Car), 1585 (m, C=Car), 1460 (m, C=Car), 773 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.61 (s, 3H, 12-H), 1.27 (d, J = 9.8 Hz, 1H, 9-H), 1.35 (s, 3H, 13-H), 1.41 (d, J = 
7.1 Hz, 3H, CH3C(7)), 2.10 (td, J = 5.7, 2.5 Hz, 1H, 8-H), 2.50 (dt, J = 9.8, 5.7 Hz, 1H, 9-
H’), 2.71 (t, J = 5.7 Hz, 1H, 10-H), 3.20 (qd, J = 7.1, 2.5 Hz, 1H, 7-H), 7.15 (ddd, J = 7.6, 
4.8, 1.1 Hz, 1H, 5’’-H), 7.18 (d, J = 7.8 Hz, 1H, 3-H), 7.44 (d, J = 7.8 Hz, 1H, 4-H), 7.48 (t, J 
= 7.7 Hz, 1H, 5’-H), 7.68 (td, J = 7.6 ,1.8 Hz, 1H, 4’’-H), 7.75 (dt, J = 7.6, 1.1 Hz, 1H, 3’’-
H), 7.93 (ddd, J = 7.7, 1.7, 1.2 Hz, 1H, 6’-H), 8.02 (ddd, J = 7.7, 1.7, 1.2 Hz, 1H, 4’-H), 8.53 
(t, J = 1.7 Hz, 1H, 2’-H), 8.64 (ddd, J = 4.8, 1.8, 1.1 Hz, 1H, 6’’-H); 13C NMR (100 MHz, 
CDCl3) δ 18.3 (CH3C(7)), 20.9 (CH3-12), 26.3 (CH3-13), 28.7 (CH2-9), 38.9 (CH-7), 41.4 
(C-11), 46.8 (CH-8), 47.0 (CH-10), 117.2 (CH-4), 120.7 (CH-3’’), 122.1 (CH-5’’), 125.2 
(CH-2’), 126.8 (CH-6’), 127.3 (CH-4’), 129.0 (CH-5’), 133.3 (CH-3), 136.7 (CH-4’’), 139.7 
(C-5), 140.4 (C-1’), 140.5 (C-3’), 149.6 (CH-6’’), 154.1 (C-2’’), 157.6 (C-2), 160.6 (C-6); 
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MS (EI) m/z (%) 340 (M•+, 18), 325 (22, M•+-CH3), 82.9 (100); HRMS (EI) 340.1935 
(C24H24N2 requires 340.1939). 
(7R,8S,10S)-(–)-2-[3’-(2’’-Pyridinyl)phenyl]-7-isopropyl-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene (–)-169b 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
N
C26H28N2
Mol. Wt.: 368.51  
(–)-169b (84 mg, 37%): [α]D22 –1.9 (c 1.0, CH2Cl2); IR (NaCl) ν 2957 (m, C-H), 1585 (m, 
C=Car), 1565 (m, C=Car), 1434 (m, C=Car), 777 (s, C-Har) cm-1; 1H NMR (400 MHz, 
CDCl3) δ 0.58 (s, 3H, 12-H), 0.81 (d, J = 7.0 Hz, 3H, CHCH3), 1.18 (d, J = 7.0 Hz, 3H, 
CHCH’3), 1.35 (d, J = 9.8 Hz, 1H, 9-H), 1.36 (s, 3H, 13-H), 2.32 (td, J = 5.9, 1.8 Hz, 1H, 8-
H), 2.52 (dt, J = 9.8, 5.8 Hz, 1H, 9-H’), 2.68 (t, J = 5.8 Hz, 1H, 10-H), 2.80-2.90 (m, 1H, 
CH(CH3)2), 2.93 (dd, J = 4.2, 1.8 Hz, 1H, 7-H), 7.16 (ddd, J = 7.5, 4.1, 1.1 Hz, 1H, 5’’-H), 
7.19 (d, J = 7.8 Hz, 1H, 3-H), 7.48 (d, J = 7.8 Hz, 1H, 4-H), 7.50 (t, J = 7.7 Hz, 1H, 5’-H), 
7.69 (td, J = 7.5 ,1.7 Hz, 1H, 4’’-H), 7.75 (dt, J = 7.5, 1.1 Hz, 1H, 3’’-H), 7.94 (d, J = 7.8 Hz, 
1H, 6’-H), 8.06 (d, J = 7.8 Hz, 1H, 4’-H), 8.55 (s, 1H, 2’-H), 8.65 (ddd, J = 4.1, 1.7, 1.1 Hz, 
1H, 6’’-H); 13C NMR (100 MHz, CDCl3) δ 20.1 (CH3CH), 21.0 (CH3-12), 22.3 (C’H3CH), 
26.3 (CH3-13), 29.4 (CH2-9), 30.2 (CH(CH3)2), 41.2 (CH-8), 41.8 (C-11), 46.5 (CH-10), 49.1 
(CH-7), 117.0 (CH-4), 120.6 (CH-3’’), 122.0 (CH-5’’), 125.0 (CH-2’), 126.7 (CH-6’), 127.2 
(CH-4’), 129.0 (CH-5’), 133.3 (CH-3), 136.7 (CH-4’’), 139.6 (C-5), 140.5 (C-1’), 140.9 (C-
3’), 149.5 (CH-6’’), 153.6 (C-2’’), 157.5 (C-2), 159.1 (C-6); MS (EI) m/z (%) 368 (M•+, 22), 
325 (M•+-i-Pr, 100), 283 (71); HRMS (EI) 368.2249 (C26H28N2 requires 368.2252). 
 
General Procedure for the N-Oxidation of Pyridine Derivatives 169a-b 
m-Chloroperoxybenzoic acid (70%, 106 mg, 0.60 mmol, 4.0 equiv) was added portion-wise 
to a respective cool (0 °C) solution of (+)-169a (50 mg, 0.15 mmol, 1.0 equiv) and (–)-169b 
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(55 mg, 0.15 mmol, 1.0 equiv) in CH2Cl2 (4 mL). The mixture was then allowed to warm up 
to room temperature and stirred overnight. The mixture was washed with an aqueous solution 
of NaHCO3 (10%; 5 mL) and dried over MgSO4. The solvent was removed under vacuum 
and the residue was purified by chromatography on silica gel (10 g) using ethyl acetate to 
remove the unreacted starting material and some by-products, followed by methanol to afford 
pure   (–)-170a and (–)-170b respectively.  
 
(7R,8S,10S)-(–)-2-[3’-(1’’-oxido-2’’-pyridinyl)phenyl]-7-11,11-trimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene-1-oxide (–)-170a 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
N
O
O
C24H24N2O2
Mol. Wt.: 372.46  
(–)-170a (23 mg, 42%): [α]D14 –31.0 (c 1.0, CHCl3); IR (NaCl) ν 2933 (m, C-H), 1585 (m, 
C=Car), 1462 (m, C=Car), 1431 (m, C=Car), 1216 (m, N+-O-), 761 (s, C-Har) cm-1; 1H NMR 
(400 MHz, CDCl3) δ 0.57 (s, 3H, 12-H), 1.33 (s, 3H, 13-H), 1.36 (d, J = 9.9 Hz, 1H, 9-H), 
1.41 (d, J = 6.6 Hz, 3H, CH3C(7)), 2.08 (td, J = 6.0, 2.8 Hz, 1H, 8-H), 2.48 (dt, J = 9.9, 6.0 
Hz, 1H, 9-H’), 2.71 (t, J = 6.0 Hz, 1H, 10-H), 3.33 (qd, J = 6.6, 2.8 Hz, 1H, 7-H), 6.82 (d, J = 
7.8 Hz, 1H, 3-H), 7.12-7.18 (m, 2H, 4-H, 5’’-H), 7.22 (td, J = 7.7, 1.1 Hz, 1H, 4’’-H), 7.42 
(dd, J = 7.7, 2.0 Hz, 1H, 3’’-H), 7.48 (t, J = 7.8 Hz, 1H, 5’-H), 7.77 (dd, J = 7.8, 1.7 Hz, 2H, 
6’-H, 4’-H), 8.13 (t, J = 1.7 Hz, 1H, 2’-H), 8.24 (dd, J = 6.4, 1.1 Hz, 1H, 6’’-H); 13C NMR 
(100 MHz, CDCl3) δ 14.7 (CH3C(7)), 20.5 (CH3-12), 25.8 (CH3-13), 28.2 (CH2-9), 35.0 (CH-
7), 41.5 (C-11), 46.8 (CH-10), 47.3 (CH-8), 123.1 (CH-3), 124.3 (CH-3), 124.6 (CH-5’’), 
125.9 (CH-4’’), 127.7 (CH-3’’), 128.0 (CH-5’), 129.7 (CH-6’), 130.6 (CH-4’), 130.8 
(CH-2’), 132.3 (C-5), 133.5 (C-1’), 140.3 (CH-6’’), 144.6 (C-3’), 147.0 (C-2’’), 149.0 (C-2), 
150.1 (C-6); MS (FAB) m/z (%) 373 ((M+H)+, 31), 338 (100), 215 (10), 75 (96); HRMS 
(FAB) 373.1919 (C24H25N2O2 (M+H)+ requires 373.1916). 
Chapter 6. Experimental   158 
 
 
(7R,8S,10S)-(–)-2-[3’-(1’’-oxido-2’’-pyridinyl)phenyl]-7-isopropyl-11,11-dimethyl-1-
azatricyclo[7.1.1.05,6]undeca-2,4,6-triene-1-oxide (–)-170b 
N
10
5
4
3
2
6
7
8
11
12
13
1'
6'
2'
3'
5'
4'
9
2''
3''
4''
5''
6''
N
O
O
C26H28N2O2
Mol. Wt.: 400.51  
(–)-170b (27 mg, 45%): [α]D14 –64.0 (c 1.0, CHCl3); IR (NaCl) ν 2935 (m, C-H), 1587 (m, 
C=Car), 1465 (m, C=Car), 1436 (m, C=Car), 1216 (m, N+-O-), 762 (s, C-Har) cm-1; 1H NMR 
(400 MHz, CDCl3) δ 0.53 (s, 3H, 12-H), 0.88 (d, J = 7.0 Hz, 3H, CHCH3), 0.95 (d, J = 7.0 
Hz, 3H, CHCH’3), 1.33 (s, 3H, 13-H), 1.54 (d, J = 9.9 Hz, 1H, 9-H), 2.31 (td, J = 5.8, 2.4 Hz, 
1H, 8-H), 2.46 (dt, J = 9.9, 5.8 Hz, 1H, 9-H’), 2.67 (t, J = 5.8 Hz, 1H, 10-H), 3.10-3.20 (m, 
2H, 7-H,  CH(CH3)2), 6.81 (d, J = 7.8 Hz, 1H, 4-H), 7.11-7.17 (m, 2H, 3-H, 5’’-H), 7.21 (td, 
J = 7.7, 1.2 Hz, 1H, 4’’-H), 7.42 (dd, J = 7.7, 2.0 Hz, 1H, 3’’-H), 7.48 (t, J = 7.8 Hz, 1H, 5’-
H), 7.74-7.78 (m, 2H, 6’-H, 4’-H), 8.09 (t, J = 1.5 Hz, 1H, 2’-H), 8.24 (dd, J = 6.4, 1.2 Hz, 
1H, 6’’-H); 13C NMR (100 MHz, CDCl3) δ 20.6 (CH3-12), 20.9 (CH3CH), 21.5 (C’H3CH), 
25.8 (CH3-13), 27.8 (CH(CH3)2), 28.2 (CH2-9), 42.3 (CH-8), 42.9 (C-11), 45.5 (CH-7), 46.6 
(CH-10), 123.0 (CH-4), 124.3 (CH-3), 124.6 (CH-5’’), 125.8 (CH-4’’), 127.7 (CH-3’’), 128.1 
(CH-5’), 129.6 (CH-6’), 130.5 (CH-4’), 130.8 (CH-2’), 132.4 (C-5), 133.8 (C-1’), 140.3 (CH-
6’’), 145.2 (C-3’), 147.2 (C-2’’), 149.0 (C-2), 149.2 (C-6); MS (FAB) m/z (%) 401 ((M+H)+, 
100), 385 ((M+H)+-O, 26), 338 (23), 71 (20); HRMS (FAB) 401.2232 (C26H29N2O2 (M+H)+ 
requires 401.2229). 
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1-Phenyl-3-buten-1-ol 141 
  
OH
C10H12O
Mol. Wt.: 148.20
4
3
2
1
6'
2'
3'
5'
4'
1'
 
Allyl trichlorosilane (80 µL, 0.47 mmol, 1.1 equiv) was added dropwise to a solution of the 
appropriate N-oxide (0.04 mmol, 10 mol%), ethyldiisopropylamine (0.35 mL, 2 mmol, 4.0 
equiv) and benzaldehyde (41 µL, 0.4 mmol, 1.0 equiv) in CH2Cl2 (2 mL) at -20 °C and the 
resulting mixture was stirred at that temperature overnight. A saturated aqueous solution of 
NaHCO3 was added to quench the reaction, the aqueous layer was then extracted with 
CH2Cl2 (3×10 mL), and the combined organic extracts were dried over MgSO4, and the 
solvent was removed in vacuo. The residue was then purified by flash column 
chromatography on silica gel (15 g) using a mixture of petroleum ether and ethyl acetate (6:1) 
to afford pure 141 (for yields, see Table 23 and 24): 1H NMR (400 MHz, CDCl3) δ 2.06 (brs, 
1H, OH), 2.38-2.48 (m, 2H, 2-H), 4.65 (t, J = 6.2 Hz, 1H, 1-H), 5.04-5.11 (m, 2H, 4-H), 5.67-
5.78 (m, 1H, 3-H), 7.16-7.22 (m, 1H, 4’-H), 7.25-7.29 (m, 4H, 2’-H, 3’-H, 5’-H, 6’-H) in 
agreement with literature data;165F166 Chiral HPLC (IB, 0.75 mL.min-1, hexane/2-propanol, 
97.5:2.5) tR = 13.5 min, tS = 15.5 min. 
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